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ABSTRACT 
A Comparison Between Desensitization and 
Relaxation Training in the Treatment 
of Primary Dysmenorrhea 
by 
Susan Myrna Jones Carcell i. Doctor of Philosophy 
Utah State University, 1985 
Major Professor : Dr. William Dobson 
Department: Psychology 
The use of relaxation, desensitizat i on. and relaxation plus 
desensitization in the treatment of primary dysmenonhea was investi -
gated in this study . Subjects were 45 university women who experi-
enced either congestive or spasmodic dysmenorrhea. Each subject was 
individually treated in four, one-hour sessions during the first 20 
days of her menst r ual cycle . Subjects were divided into three 
groups : Group 1 obtained four hours of progressive relaxation train -
ing. group 2 was asked to self - relax while being administered scenes 
from a standardized menstrual hierarchy, and group 3 obtained both 
relaxation training and desensitization. Type of dysmenorrhea was 
assessed by the Menstrual Symptom Questionnaire (MSQ). Symptom 
intensity and duration were assessed by the Retrospective Symptom 
Scale, the Menstrual Semantic Differential, the Menstrual Activities 
Scale, and the Menstrual Behavior Scale, and were administered pre-
test, posttest, and at three-month follow-up. Skin temperature 
X 
xi 
dut·ing session 4 was obtained to evaluate the level of r·elaxation. 
Differences among tt·eatment gt ·oups wer·e analyzed using a one-way 
analysis of var·i ance. t-tests fot· con ·el ated samples wet·e used to 
analyze within group changes from pr·ett·eatment to posttr ·eatment. 
Results suggest al 1 tht ·ee tt ·eatments to be equally effective in 
t·educing symptoms, negative attitudes, pain mitigating behaviot ·s, and 
invalid hour·s. Symptom relief was not associated with skin tempera-
tur ·e inct·eases. The possibility of placebo playing a t·ole in these 
r·esults cannot be r·uled out. Finally, the division of pr-imar·y dys-
menon·hea into spasmodic and congestive types by the MSQ is i naccu -
r·ate, most pr·obably due to the confounding natur ·e of the scor·i ng 
system. 
(175 pages) 
CHAPTER I
INTRODUCTION 
One of the most frequent complaints encounter ·ed in medicine and 
gynecology is the pain accompanying mP.nstr·uation ter ·med "dysmenor·-
r·hea" (Odgen, 1970 ). Repor·ted incidence of dysmP.nonhea is var·i ed , 
usually r·anging from 21-80 % in women of childbear·ing age (Tasto & 
Chesney , 1974). 
In a mailed questionnait-e study of a family pr·actice population , 
Sobczyk , Braunstein , Solberg , and Schuman (1978) found that at least 
50% of women exper ·ience menstr ·ual pain at one time or· another. A 
minimum of 29% of all women expet'ien ced pain in any 60-day intet ·val 
of time, with the aver ·age dur·ation of th P.it- pain being gr·eat er· than 
one day. Of this gr·oup , 40% r·epor ·ted di sabi 1 i t y to t he point of 
becoming bedr ·i dden and missing both wor·k and r·ecr ·eati onal activity , 
14% t·epor ·ted being bedt ·idden and missing only wor·k, and 10% r·epor ·ted 
missP.d wor·k or· r·ecr-eation without being bedt'idden. Sobczyk et al. 
(1978) further · indicated that this index of disability agt ·ees with at 
least one other · published r·eview of the subject (Santamat'ina , 1969). 
Novak, Jones , and Jones (1975) similar ·ly point out that dysmen-
onhea is t:he greatest cause of 1 ost wor·k hout ·s among women. Despite 
thP. magnitude of disability involved , many t·esear ·chet ·s contend that 
dysmenonhea continues to be one of the most ovet ·l ooked di sot ·det ·s in 
existence (Sobczyk et al. , 1978). 
Dysmenonhea is sub divided into two maj ot· types. SP.cond,n-y 
dysmenonhea t·esults in conjunction with ot ·ganic pelvic disot ·det·s, 
thus t·equit-i ng gyneco 1 ogi cal tt ·eatment i ntet ·venti ons. Pt-i mary dys-
menorrhea occurs in the absence of gross pathological conditions in 
the pelvic region (Kistner, 1971). Benson, Beary, and Carol (1974) 
estimates that 80% of dysmenorrhea cases are of the "primary type." 
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Since primary dysmenorrhea is identifiable only via symptoms 
(i.e., the subjective experience of the woman) rather than signs 
(i.e., diagnosable pelvic disorder), the woman herself is typically 
the one who diagnoses her condition. Most researchers and physicians 
suggest that the diagnosis of primary dysmenorrhea also requires the 
woman to have sought pain relief either from a physician (Israel, 
1967) or from self-medication (Sobczyk et al., 1978). Psychological 
questionnaires (Chesney & Tasto, 1975a; Moos, 1968) have also been 
developed to be used to determine the severity, symptoms, and hypoth-
esized type of dysmenorrhea present. Although some researchers ques-
tion the validity of such subjective reports (Parlee, 1973, 1974), 
most researchers concede that since only the woman experiences her 
symptoms, only she can accurately assess them (Coppen & Kessel, 
1963); therefore such questionnaires continue to be widely used in 
this area of research. 
Definitions 
Primary dysmenorrhea has been subdivided into two different 
clinical entities; these are spasmodic and congestive dysmenorrhea. 
It is these two types of primary dysmenorrhea to which recent behav-
ioral therapies have been directed. The two types will be delineated 
below, as well as their respective etiologies and medical treatments. 
Spasmodic dysmenorrhea does not usually appear until age 15 or 
16, which is about two years after menarche, when ovulation begins, 
and t·at ·ely per·si sts beyond 30 yP.at·s of age. Chat ·actet ·i stically, the 
pain begins with the onset of menstt·uation and lasts a few hour ·s , 
al though in some cases the symptoms may continue tht ·oughout sevet ·al 
days. Although it is most frequently of a colicky, labot ·-like 
natut ·e, the pain is al so some ti mes deset ·i bed as a stuffy, aching 
feeling. The pain may fut·ther t·adiate to the lowet· back and along 
the thighs. Symptoms may necessitate bed t·est from om~ to sever ·al 
days each month , and may be accompanied by di anhea, nausea , head-
aches , vomiting , and i ni tabil i ty (Novak et al. , 1975). 
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Congestiv e dysmenonhea , unlike the spasmodic type , appeat·s to 
bj:> an indit·ect consequence of the menstt ·ual flow . Pain is expet ·i -
enced appt·oximately onP. week ot · mot·e pt'iot· to the onset of menses and 
continues tht-ough the fit-st day of bleeding. Symptoms at·e of in-
et ·eas i ng heaviness and a dul 1 aching pain in the 1 owe1· abdomen, and 
may be acc ompanied by nausea , anot ·exia, constipation, headaches , 
fatigue , backaches , and bt ·east pain (Dal ton , 1969). These symptoms 
at ·e al so accompanied by such psychological symptoms as anxiety, 
tension, dept ·ession , hostility , initability, and emotional lability. 
Also, unlike its spasmodic countet ·pat ·t , these symptoms do not abate 
with age, but continue until menopause ot· even thet ·eaftet ·. Con-
gestive dysmenonhea is not so cleat ·ly definable as its spasmodic 
countet ·par ·t, since its majot · ct ·itet'ia ar ·e cycl icity and time of 
occunence in t·elation to the pet·iod (Rosenthal, 1978). 
Congestive dysmenonhea is al so commonly t·efened to as "pt·emen-
stt ·ual tension," ot · "pt ·emenstt ·ual syndt ·ome" (PMS), al though the tet ·m 
"PMS" is typically t ·eserved fot· the most pt ·onounced cases (Dal ton , 
1979). In this paper these two terms will be used interchangeably, 
with the original language of the researcher cited maintained. 
Etiology 
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The etiologies of spasmodic and congestive dysmenorrhea also 
appear to be quite distinct from each other. A recent breakthrough 
in the understanding of spasmodic dysmenorrhea is the discovery of 
the role prostaglandins play in the etiology of menstrual cramps. 
Prostaglandins are minute substances produced in many body tissues 
which cause contraction of smooth muscle fibers. Cramps result from 
a diminished flow of blood to the uterine muscle which has been 
contracting, which is a situation brought about by excess prosta-
glandins (Marx, 1979). Filler and Hall (1970) recorded the motility 
pattern of the uterus in several groups of women in different phases 
of the menstrual cycle, using latex intrauterine balloons connected 
to a pressure meter. They found that " ... patients with dysmenorrhea 
have an inherent hypercontractibility of the uterus demonstrated more 
by elevated ton us than by change in the intensity of contractions" 
(p. 105). Filler and Hall also observed that during menstruation 
patients did not complain of severe pain even if the contractions 
were of high amplitude. But when the contractions were dysrhythmic 
and showed a "notching" pattern, the patients experienced severe 
pain. They concluded that elevated uterine muscle tonus and dys-
rhythmic tetany (sustained contractions) resulted in focal ischemia 
(loss of adequate blood supply) and hypoxia in the myometrium (the 
uterine smooth muscle tissue), thus causing the pain sensation. 
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Pr·ostagl andi n excess is al so hypothesized to account for · the 
nausea, vomiting, di anhea, headaches, and other · symptoms such as 
fainting that constitute spasmodic dysmenonhea, due to the effects 
of pt ·ostagl andins on the smooth muscles of the gastr·ointestinal tr·act 
and the blood vessels (Mat·x, 1979). However ·, it should be noted that 
although pr·ostaglandin t·eseat ·ch has significantly contt·ibuted to the 
undet·standi ng of spasmodic dysmenonhea , it does not t·ul e out other· 
potential contt ·ibutor·s, si nee some women with low pt ·ostagl andi n 
levels also expet'ience menstt ·ual ct ·amping (Sommer·, 1982). 
The etology of congestive dysm enonhea t·emains fat · less cleat ·. 
Some r·esear ·chet·s (Sommer·, 1982) contend that "pt·emenstt·ual syndrnme" 
as a specific syndr·ome does not exist , since it does not cons t itut e a 
r·eliable , predictable entity. However ·, Reid and Yen (1981) c all PMS 
"a major · clinical entity affecting a lat·ge segment of the femal e 
population" (p. 5). Tl1ey hypothesize that the under ·lying mechanism 
of congestive dysmenonhea involves the neur ·oendoct·i ne events within 
the hypothalamic - pi tui tat·y axis that modulate neur ·otr ·ansmi tter· 
function. Other · postulated causes of PMS include excessive estr ·ogen 
levels , inadequate pr·ogester·one, vitamin B6 deficiency , and altered 
glucose metabolism (Gonzales , 1981) , as well as incr ·eases of pr·olac -
tin (Canol & Steiner ·, 1978). Other · factor ·s which have been impl i -
cated as possible contr ·ibutor ·s to the syndr ·ome include fluid and 
electr·olyte imbalances, hypoglycemia, pelvic congestion and fibr ·osis , 
metatoxicity, changes in blood ser ·otonin level, and changes in rapid-
eye movement sleep (Sommer·, 1982). 
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Medical Tr·eatments 
Medical tr·eatment str·ategies for · spasmodic and congestive dys-
menonhea ar ·e al so di ffer ·enti ated. For · spasmodic dysmenonhea, 
recently developed dr-ugs that inhibit pr·ostaglandin activity appear · 
to significantly r·educe menstr·ual cr ·amps ("Two dr-ugs," 1979). How-
ever· , potential side effects can include vomiting and dizziness , and 
these agents ar ·e contr ·aindicated for those individuals with ulcer ·s 
and other · gastr ·ointestinal disor ·der·s (Schwar ·tz, Zoe, Lindner ·, & Naor· , 
1974). 
Or·al contr ·aceptives are al so often pr·escr ·ibed for · spasmodic 
dysmenonhea; these do not dit-ectly inhibit pr ·ostaglandin , but 
instead contr·ibute to a r·eduction in pr·ostaglandin pr·oduction by the 
uter·us via suppr ·ession of ovulation (Sommer ·, 1982). Their · use is not 
univer ·sally advocated by physicians due to contr ·aindications such as 
epilepsy , side effects such as thr·ombophlebitis and pulmonary embo-
lism , and nuisances which may develop such as weight gain , nausea , 
and br ·east changes (Tyler ·, 1973). Fully 40% of women that attempt 
this tr ·eatment r·epor·t some sor ·t of pi 11-r ·el ated adver ·se r·eacti on. 
Since congestive dysmenonhea is a much mor·e ill-defined syn-
dr·ome, it is not sur ·pr·ising that medical tr ·eatment str ·ategies for · it 
have been much less efficacious. Although Dalton (1969, 1979) has 
anecdotally r·epor ·ted successes with the use of natur ·al pr ·ogester·one 
by vaginal supposi tor·y for · the tr ·eatment of PMS, a study of double 
blind tr·ials of pr·ogester ·one and a placebo indicated no significant 
di ffer ·ences (Sampson, 1979). Sampson noted that 60 % of both gr·oups 
r·epor ·ted being helped , and that this success t·ate was similar· to many 
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other· tr·eatments for · PMS using uncontr ·olled tt-ials. A similat · suc-
cess r·ate for · the use of or·al contr ·aceptives (which would al so alter · 
the estr ·ogen/pr ·ogester ·one r·atio) was also noted (Silberheld , Bt-ast , & 
Noble , 1971 ) , al though the r·esear ·chers indicated that in some cases , 
PMS symptoms wet ·e exacerbated by this tt ·eatment. 
Reid and Yen (1981) similar ·ly repor ·t a "str·iking" placebo effect 
in the di sordet ·. They state that even with a sugar · pi 11 tt ·eatmPnt , 
symptoms tend to disappear ·, only to t·eappear · in fout · or five months. 
It can be concluded from the pt ·evious t ·eview descr ·ibing the 
etiologies and medical tr ·eatments of the two types of pt ·imar ·y dys-
menon ·hea t hat, 
1 . in the case of the spasmodic type , the medical tt ·eatments 
have both danger ·ous and uncomfot ·tabl e side effects ; 
2 . in the c as e of the congestive type , medical tt ·ea t ments ha ve 
been histo r·i c ally ineff ectiv e . 
In light of these pt ·oblems , it is inter ·esting to note the t·ecent 
investigations into the effect of behavior thet ·apy techniques , bio -
feedback techniques , and t·el axation tr ·aining on pr·imat ·y dysmenon-hea. 
The t·easons for the boost of such non - medical t·esi:>ar·ch in this at ·ea 
wi 11 next be discussed. 
The Behavi ot ·a l Tr·eatment of Dysmenonhea 
A number · of factor ·s have given impetus to the but ·geoning use of 
behavior ·al str ·ategies in the tt ·eatment of pr·imar·y dysmenonhea. The 
fi r·st factor· , which is the hi stor ·y of po ten ti ally har-mful and/ot · 
ineffective medical tt ·eatments for · this disot ·det·, has been outlined 
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above. If dysmenon ·hea symptoms had been hi stor-i cal ly t·esponsi ve to 
gynecologic intet·vention then thet ·e would have been less intet ·est in 
the development of alternative tt·eatments. 
Secondly, the success expet ·i enced by reseat ·chet·s and cl ini ci ans 
using t·elaxation tt ·aining and biofeedback tt·aining to alleviate dis-
ot·det ·s such as insomnia , hypet ·tensi on , headaches , and spastic mus-
cul at · disot ·det · has t·esulted in continued intet ·est in the explot ·ation 
of other · disot·det ·s pt·eviously defined as "medical" (Heczey , 1978 ). 
This intet·est had also been impelled by afflicted individuals who 
expt ·ess int e t·est in contt ·olling mild to modera t e levels of symptom-
a tology tht·ough sel f-contt ·ol stt ·ategi es t·athet · than t·esot ·ti ng to 
tt ·ials of medi cation. 
Thit-dly , despite inet ·eased undet ·standing of the physiologi c 
ante cedents of pr-imat ·y dysmenon ·hea , most t·e se a t·chet ·s continue to 
acknowledge the r ole that psychological factot ·s play in menst r ual 
pt ·oblems , pat·ticulat·ly in the symptoms of congestive dysmenonhea. 
Even the st aunchest defender · of the hot ·monal theot-y of PMS, Dal ton 
(1979) , acknowledges that dysmenonhea is influenced by psychological 
factot ·s , and it thet ·efot ·e logically follows that psychologi c al tt ·ea t -
ments might also be effective. 
One psychological factor· that has been implicated in dysmenot ·-
t·hea i c symptomatology is the put·pot ·ted t·ol e of the women's self -
mediated cognitions. Suppot ·t for this psychological vat ·iable's 
effect on pt ·emenstt·ual and menstrnal symptoms (together sometimes 
t·efen·ed to as "pat ·amenstrnal symptoms") was made by Beaumont, 
Richat ·ds, and Geldet · (1975), who compat ·ed psychological and physical 
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symptomatic changes ovet · the cout·se of the menstt·ual cycles of not·-
mal ly menstr-uati ng women and women who had undet·gone simple hys-
tet ·ectomi es. Both gt·oups had similar · cyclic hot ·monal fluctuations , 
but only the nor·mal ly menstt ·uati ng gt·oup t·epot ·ted si gni fi cant changes 
in symptoms dut ·ing the vat·ious phases of their · cycles. The authot·s 
indicate that a possible hypothesis to account fot· these t·esults is 
that the level of symptomatology is as dependent on the woman's 
awat·eness of theit· position in the menstr-ual cycle as it is on any 
undet ·lyi ng biological change. 
Finally , a number · of t·eseat·chet ·s have t·easoned that, despite the 
inct ·eased undet·standing of the physical antecedents of dysmenon-hea 
(pat·ticul at·ly the spasmodic type), both types of pt"imat ·y dysmenon·hea 
continue to involve much unsuccessfully tt·eated discomfot·t fot· the 
suffet ·et·s . This pain has been fut ·t het · hypothesized to cause height-
ened dt ·ead of dysmenonhea , and concomitant i net·eased anxiety, which 
in tut·n causes even mor·e pain (Heczey, 1978). This identified "pain 
spit-al" has t·esul ted in Russ (1977) and othet ·s suggesting that men-
stt ·ual di stt ·ess is influenced by complex i ntet ·acti ons between psycho-
1 ogi cal pt ·ocesses , physiological changes, and social /cul tut·al /envi-
t·onmental factot ·s. 
This intet ·action between the physiological and the psychological 
is also noted by Stut ·gis (1970): 
No single factot · has ever· been shown to be wholly 
t·esponsi bl e fot· the sevet·i ty of these painful episodes .•. 
Thet·e at·e two components, however ·, that have been genet ·al ly 
accepted as t·esponsible fot · all such complaints. The fit-st 
of these is physical: the action of pr·ogestet·one on the 
menstt·uati ng utet·us ••• The second is psychological: the 
reaction of the individual to pain associated with feminine 
function. (p. 150) 
Tr·eatment success with a combination of an anxiety r·educing , 
cognitive/educational approach has al so been r·epor ·ted by the gyne-
cologist Kistner · (1971). By citing case studies and other · physi-
cians' obser ·vati ons, he suggests that "psychother ·apy" in the for·m of 
simple guidance , open discussions , and infor ·mation r·egar ·ding the 
natur ·al phenomenon of menstr ·uation can help to alleviate dysmenor ·-
r·hei c symptoms. 
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In conclusion, a number · of factor ·s have influenced the advent of 
behavior -al str ·ategies to tr ·eat pr·imar ·y dysmenon·hea. 
Thes e i nc lude: 
1 . the hi stor-i ca l ly poor · r·esul ts in tr ·eati ng dysmenonhea by 
t r adi ti onal applicati ons and t echniques; 
2 . th e successes not ed in t he li t e r·a tu r·e in t he tea ching of 
self contr ·ol str ·ategi es in the tr ·eatment of othe r· psy c ho-
physiological disor ·der ·s ; 
3. the contention that cognitions r·egar ·ding menses pl ay a 
r·o 1 e in menstr-ual di scomfor ·t; and 
4. the r·ecent discussion r·egarding the specific t·ole played by 
anxiety in either · incr ·easing or· mediating the 
psychophysiological exper ·ience of pain. 
Pr·obl em Statement 
The existence of pr·i mar·y dysmenonhea as a major · pain di sor ·der · 
in women is well documented. Ther ·e exists a continued need to 
develop successful tr ·eatment str ·ategies to counter · the debilitating 
effects of the periodic pain and discomfor ·t experienced by its 
suffet·et ·s. Given the pt ·eviously identified pt ·oblems with medical 
tt-eatments, as well as the established sevet·ity of tt1e pt ·oblem area, 
ample justification exists in exploring and expanding t·esearch into 
the behavioral tt ·eatment of pt ·imat ·y dysmenonhea. 
Put ·pose of the Study 
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This study sought to tt·eat women who t·eported expet ·i enci ng 
either · congestive ot · spasmodic dysmenonhea with one of tht·ee behav-
iot ·al tt·eatments. The put ·pose of this study was to detet ·mi ne 
whethet ·: (a) a t·elaxation only tt ·eatment, a desensitization only 
tt ·eatment, ot · a com bi nation relaxation/ desensi ti zati on tt·eatment 
would dect ·ease dysmenonhea symptoms, (b) a t·el axation only tt ·eatment 
ot · a desensitization only tt ·eatment would dect ·ease dysmenonhea symp-
toms as much as a combination t·el axation-desensitization tt·eatment 
pt ·eviously shown to be effective , and (c) any of the tht ·ee behaviot ·al 
tt ·ea tments i den ti fi ed above would di ffet ·enti ally dect ·ea se spasmodic 
dysmenonhea or congestive dysmenonhea symptoms. 
To wit , the pt ·imat-y put ·pose of the pt ·esent study was to compat ·e 
the effects of t·elaxation only, desensitization only, and t·elaxation 
plus desensitization on the symptoms of pt ·imary dysmenonhea in 
t·el ati on to type of dysmenonhea. 
Secondat-y objectives were: (1) to detet ·mine if thet ·e existed a 
subgt ·oup of women expet ·i enci ng dysmenonhea who wet·e i ntet ·ested in 
managing theit · symptoms via self-control stt ·ategies, and (2) to 
t·elate numbet· of home pr·actices , levels of relaxation achieved at 
pt·acticP., skin temperatut ·e measut ·es when relaxing , and ability to 
successfully visualize menstr·ual imaget-y to tt ·eatment outcome. 
Hypotheses 
To deal with the study's outlined put ·poses, tht ·ee hypotheses 
wet·e developed. The following null hypotheses wet·e tested: 
1. Expet ·imental tt ·eatment hypothesis. Thet ·e is no diffet ·ence 
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in the degt ·ee of expet ·i enced di stt ·ess of pt·i mat-y dysmenonhea between 
expet'imental gt ·oups exposed to fout · sessions of eithet · (a) individual 
t·elaxation training , (b) individual desensitization tt ·aining , ot · (c) 
individual t·elaxation plus desensitization tt ·aining. 
2. Time hypothesis. Thet ·e is no diffet ·ence in the degt ·ee of 
expet ·i enced di stt ·ess of pri mat-y dysmenonhea in expet ·i mental gt ·oups 
pt ·iot· to compat ·ed to aftet · exposut ·e to fout · tt·eatment sessions. 
3. Spasmodic vs. congestive hypothesis. Thet ·e is no diffet ·-
e nce in the degt ·ee of expet'ienced distt ·ess of pt ·imat-y dysmenon ·hea 
between a gt ·oup expet ·iencing spasmodic dysmenonhea and a gt ·oup 
expet ·i enci ng congestive dysmenonhea. 
CHAPTER I I 
REVIEW OF LITERATURE 
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The pur ·pose of this chapter · is to review and summar·i ze r·ecent 
r·esear ·ch in the ar ·eas of desensitization , biofeedback , and r·elaxation 
tr ·aining in the tr ·eatment of pr·imar·y dysmenonhea , and to relate such 
r·esear ·ch to the pr·esent disser ·tation study. 
Reich (1972) , in a study examining the effects of gr·oup r·elaxa-
tion plus systematic desensitization on the symptoms of pr·imar·y 
dysmenon-hea (type unspecified) in r·elation to anxiety , tr ·eated 
twelve college women in four · sessions with gr ·oup systematic desensi-
tization focused on menstr ·uati on. Rei ch al so uti 1 i zed a no-tt ·eatment 
control gr·oup. The subjects wer·e treated in smal 1 gt ·oups , with semi-
automated pr·ocedures such as tape t·ecor ·di ngs and standar·di zed hi er ·-
ar ·chi es. The Semiobjective Cr·iter-ia of Teen Age Dysmenonhea was 
used to measur ·e the degr ·ee of pr·imar-y dysmenonhea , and subsequent 
change in dysmenonhea symptoms. The Taylor · Manifest Anxiety Scale 
(Taylor ·, 1953) was used to deter ·mine the anxiety level of the 
subjects. 
Study r·esul ts indicated a si gni fi cant di ffer ·ence in amount of 
change in primar ·y dysmenon-hea between the treated and untr ·eated 
(contr ·ol) subjects. Also noted was a significant inter ·action between 
tr·eatment and anxiety level , indicating that the subjects r·eceiving 
the most benefit from tr·eatment wer·e those belonging to both the 
tr ·eatment and the low anxiety groups. Reich fur ·ther · pointed out that 
since systematic desensitization , which is an anxiety r·eduction tech-
nique , was effective in reducing dysmenonheic symptoms , anxiety in 
14 
some form was probably responsible for part of the pain involved. 
This finding was also supported by a significant interaction and a 
-.66 correlation between trait anxiety scores and change in dysmenor-
rhea. 
In a similar study, Tasto and Chesney (1974) treated seven 
female college students suffering from primary dysmenorrhea with a 
combination of a standard behavior therapy muscle relaxation proce-
dure and the imagination of common scenes (as differentiated from 
Reich's [1972] hierarchies) associated with menstrual pain reduction 
(e.g., reclining in a warm bathtub, using a heating pad). The major 
question explored was whether a subject who had learned to associate 
relaxation with menstrual pain reduction imagery could transfer such 
learning to the onset of real menstrual pain and therefore mitigate 
its occurrence. Two parts of the Symptom Rating Scale and the Men-
strual Activities Scale were administered on three occasions, with 
treatment occurring between the second and the third administrations. 
Significant differences were not obtained between the first and the 
second administrations, but were obtained on these measures after 
treatment intervention, supporting the contention that behavior 
therapy can be an effective means of treating primary dysmenorrhea in 
college age women. This outcome was maintained at a two-month 
follow-up. 
Continuing their research into behavioral treatments for primary 
dysmenorrhea, Chesney and Tasto noted that in their 1974 study, some 
subjects were unresponsive to treatment. They suggested the possi-
bility of two types of primary dysmenorrhea, only one of which was 
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t·esponsive to behaviot ·al therapy. This theory had been first pre-
sented by Dalton (1969) who wr-ote, "Thet ·e ar·e two ver-y different , in 
fact opposite types of (primar-y) dysmenonhea known as spasmodic and 
congestive" (p. 23). The spasmodic type refers to spasms of pain 
simil at · to 1 abot · pains which begin the first day of menstruation; the 
congestive type to a vat·iation of the premenstrual syndt ·ome with 
dull, aching pains accompanied by lethat ·gy and dept ·ession prior to 
the onset of menstruation. Chesney and Tasto (1975a) constrncted a 
questionnaire based on suggestions from Dal ton's theor-y. The first 
set of 51 items had mean test-retest reliabilities of 0.76, and 
yielded two cl early di sti net factors in support of the two-type 
hypothesis. When items with factor · loadings less than -0.35 wet·e 
discarded, 25 items r emained , with mean test-retest t·eliability of 
.78. Again , two cleat ·ly distinct factot ·s emer·ged defining spasmodic 
and congestive dysmenot ·thea. 
Chesney and Tasto (1975b) next utilized their · newly developed 
Menstt ·ual Symptom Questionnair ·e to diagnose women tepor ·ting menstr ·ual 
discomfor ·t as suffer ·ing fr ·om either · spasmodic or· congestive dysmenor-
r·hea. Subjects for · the study wer·e 69 co 11 ege student vo 1 unteer ·s. 
Subjects al so completed the Symptom Sever ·i ty Seale to assess the 
degr ·ee to which they expet ·ienced discomfor ·t dut ·ing their · last men-
str ·ual per ·iod. The subjects in the two gr·oups repr ·esenting the two 
types of dysmenonhea wer·e rank ordered by total scor ·e on the Men-
strual Symptom Questionnaire, and then r·andomly assigned to one of 
thr ·ee tr ·eatment conditions, for ·ming a 2 x 3 factot ·ial design with the 
two types of dysmenonhea, and the thr ·ee treatment conditions (behav-
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i or· ther-apy, pseudott-eatment, and waiting list). Behavior- thet ·apy 
consisted of t·elaxation combined with pt·emenstt-ual imager·y (Tasto & 
Chesney, 1974). The pseudotr·eatment involved a self-dit-ected gr·oup 
discussion with a thet ·apist pt·esent. The put·pose of the waiting list 
gr·oup was to i den ti fy changes in the t·epot ·ted sevet ·i ty of dysmenot ·-
t·hea over · time and/ot· due to test taking behavior ·. 
Results of the study indicated that the behavi ot· thet ·apy tt ·eat-
ment pt·ocedut ·e was highly effective in t·educi ng the t·epot ·ted symptoms 
of women suffet ·ing from spasmodic dysmenon-hea, but was ineffective 
in t·educi ng symptoms of women suffet ·i ng from congestive dysm e nonhea. 
Chesney and Tasto (1975b) also indicated that many of the successful -
ly tr ·eated clients spontaneously n~pot·ted using theit · t·elaxation 
e xe t·c ises in vivo dut ·ing menstt ·ual distt ·ess. 
It should be noted that since the constt·uction of the Menstt ·ual 
Symptom Questionnait-e (MSQ) (Chesney & Tasto, 1975a), some authot·s 
have explicitly questioned the basic assumptions undet ·lying its 
development. Cox (1977), although confit-ming the MSQ's test-t·etest 
t·eliability and ability to discr-iminate along a congestive - spasmodic 
dimension, suggested that this dimension was continuous, t·athet · than 
dichotomous as suggested by Tasto and Chesney. Cox noted that in his 
study thet ·e wet ·e t·oughly equal numbet·s of t·espondents in each thit-d 
of the di stt·i buti on. These findings at ·e al so suppor·ted by othet· 
t·eseat·cher·s (Rosenthal, 1978; Balick, El fnet ·, Moot·e, & May, 1982) and 
also agt ·ee with Golub, Menduke, and Lang's (1959) asset·tion that 
women expet ·iencing pt ·emenstr-ual tension ar ·e just as likely to have 
fl ow pet·i od di str ·ess as not. 
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Web stet ·, Mar·tin , Uchal ik , and Gannon (1979) al so insist that the 
concept of congestive and spasmodic dysmenonhea as all-inclusive 
categor ·ies should be t·etit-ed. In this t·eport of a multiple gt ·oup 
factor · analysis , both confi t·matot · and expl ot ·atot· factor · analyses 
yielded little suppot ·t fot · the theot-y of spasmodic and congestive 
dysmenonhea as used in the MSQ. These authot ·s point out that 
Dal ton 1 s (1969) widely accepted theot-y of two types of pt ·imat·y dys -
menonhea upon which the MSQ rests was not based on empit-ical evi -
dence. 
Webster · et al. (1979) instead suggest that the most constr-uctive 
way to view these symptoms is as eithet · menstt ·ual ot · pt ·emenstt ·ual 
(i.e. , as time r·elated) with sevet ·al different categot'ies within each 
type. They fut ·thet · contend that the major· flaw of the questionnait-e 
lies in the scot ·i ng of the i nstr-ument, which is a dit-ect application 
of the mutually exclusive pt ·opet ·ties of the two types of dysmenonhea 
pr ·oposed by Dalton (1969). Since some women do expet ·ience both 
pt ·emenstrual and menstt ·ual symptoms, these author·s suggest that the 
scoring pt ·ocedut ·e is entit·ely confounded, since scot ·es that fall 
midt ·ange on the measut ·e can eithet · be t·eflecting a mixt:ut ·e of the two 
types of dysmenonhea ot · no symptoms at all. They conclude that the 
MSQ as it stands is an inadequate instr-ument with which to execute 
either· clinical diagnoses ot · empit-ical t ·esearch. 
Despite the impot ·tant methodological and conceptual pr-oblems of 
the MSQ outlined above , t·eseat·chet·s have continued to use it as the 
classification instt ·ument of choice (Balick et al., 1982; 
Bt·eckem·idge, 1981; Cox & Meyer·, 1978; Hart , Mathison, & Pt-atet ·, 
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1981; Rosenthal, 1978). 
Duson (1977), in a study compar-ing a gt ·oup t·elaxation plus 
systematic desensitization tt ·eatment and a combination of t·elaxation, 
systematic desensi ti zati on , and cognitive t·estrnctut ·i ng to a delayed 
tt ·eatment contrnl gt·oup, found both tt·eatments supet·iot · to the 
delayed tr-eatment contt·ol gr-oup in reducing self-t ·epor-ted sevet'ity of 
menstt ·ual symptoms and t·epot·ted inter-ference with not ·mal activity. 
Each gt·oup met fot · 1-1/2 hout ·s twice a week for tht ·ee weeks , fot · a 
total of six sessions. The subjects wet·e 25 college students. Meas-
ur-es used wet·e (1) the Menstt ·ual Activity Scale, (2) two forms of the 
Symptom Sevet'ity Scale, (3) the Menstt ·ual Behaviot · Scale, (4) the 
Activities Intet ·fer-ence Scale, and (5) the Menstrnal Symptom Ques-
tionnait ·e. Duson also commented that differ-ences on two of the 
measut ·es gave some slight suppot ·t to Chesney and Tasto's (1975b) 
noted supet ·iot · t·esponsiveness of spasmodic ovet· congestive subjects 
to the systematic desensitization tt ·eatment. She noted that study 
limitations included the small numbet · of subjects, a lat·ge (and 
di ffet ·enti al) attt·i ti on t·ate between her tt ·eatment grnups, and the 
shot ·t length of tt ·eatment used. 
In an exceptionally well ot·ganized and conceptualized study, Cox 
and Meyet· (1978) tt ·eated 14 women with pt ·imat ·y dysmenonhea individ-
ually with fout · progressive relaxation plus systematic desensitiza-
tion sessions between two menstt ·ual cycles. Noting the t·epot ·ted wide 
vat'iation in t·esponse to tt ·eatment in pt·evious gt·oup-administet ·ed 
studies (Reich, 1972; Tasto & Chesney, 1974), Cox and Meyet· post.u-
1 ated that grnup tt·eatments wet·e not effective fot · somP subjects due 
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to the fact that dur ·ing the tr ·eatment some subjects would be men-
str ·uating , and ther ·efor ·e wouid al so be contending with their · dys-
menon·hea while attempting to lear·n relaxation skills. Cox (1977) 
had pr·eviously suggested that such gr·oup-administer ·ed treatment might 
al so negatively bi as congestive suffer ·er ·s si nee they ar·e typically 
distr·essed mor·e days per· month than their · spasmodic counter·par ·ts, 
thus leading to Chesney and Tasto's (1975b) r·epor ·ted differ ·ential 
tr ·eatment r·esponse. 
Study results indicated that menstrnal symptoms as measur ·ed by 
the Daily Symptom Seale , the Retr ·ospe c ti ve Symptom Seale, and the 
Menstr ·ual Semantic Differ ·ential , medication units consumed , and 
r·epor ·ted invalid hour ·s all s i gni fi cantly i mpr·oved posttr ·e a tm ent. Cox 
and Meyer· (1978) al so r-epor·ted a total scor ·e r·eduction of 43% for · 
tr ·eated subjects , noting that tr ·eatment e ffects appear ·ed to be gen-
er ·al , equally r·educi ng symptom frequency and seve r·ity , and equally 
r·elieving cr ·amping , systemic complaints , and emotional distr ·ess. At 
pr·etr ·eatment , the treatment gr·oup scor ·es wer·e significantly differ ·ent 
from those of a nor·mative contr ·ol gr·oup (calculated to r1ssess the 
"aver ·age" distr-ibution of the dependent var-iables) but at posttr ·eat-
ment , gr·oup scor ·es wer·e not si gni fi cantly di ffer ·ent from one another ·. 
Cox and Meyer- (1978) fur ·ther · noted that tr ·eatment outcome was 
unr ·elated to previous anxiety level (a finding contr·adicting Reich's 
[1972]), type of dysmenonhea (again , a conclusion at odds with 
Chesney and Tasto [1975b] and Duson [1977]), or · r·eduction to either· 
EMG or· per-ipher·al temper ·atur ·e measur ·es. This 1 ast finding suppor·ts 
other · similar · r·esults (Balick et al. , 1982; Har·t et al. , 1981). Six-
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month follow-up indicated that symptom relief had continued to 
impt·ove but that menstrual attitude scot·es had t·egr ·essed to baseline. 
Cox and Meyer 1 s (1978) t·esul ts and conclusions at ·e methodo-
logically stt ·engthened by the use of a contt·ol gr·oup that diffet ·ed 
from the tn~atment gt ·oup only by the gt·oup 1 s lack of t·epot ·ted dys-
menonhea symptoms. By uti 1 i zing such a contr ·o 1 group, as wel 1 as a 
1 arge normative group from the genet ·al population, Cox was able to 
compat ·e his tt·eatment results to both a speci fi cal ly nondi stt ·essed 
gr·oup and a lat·ge not·mative gr·oup of "typical" women. Previous to 
his t·eseat ·ch , statistically significant tt ·eatment r·esults had been 
repot·ted , but it was unknown if such impt ·ovements wet ·e al so of pt ·ac-
tical significance. 
Cox and Meyer· (1978) at ·e as appat ·ently pet ·pl exed as previous 
t·eseat ·chet ·s t·egat ·di ng possible mechanisms fot · subject impt ·ovement. 
They rule out such poss ·ible theories as tonic sympathetic impi-ove -
ment , shift in pain tht·eshold, phasic shifts in sympathetic at ·ousal , 
and attitude shifts , and concluded that a desensitization effect 
(e.g. , a t·eduction of anticipatot-y anxieties) is the most t·easonable 
explanation of tt·eatment gains. They suggest that fut ·thet · t·eseat ·ch 
wi 11 be necessary to clarify whether desensitization, t·el axation 
tt ·aining, self monitot ·ing, ot · placebo is the active thet ·apeutic agent 
in such successful outcomes. 
As pat·t of theit · study, Cox and Meyer· (1978) al so demonstt ·ated 
thei t· Retro spec ti ve Menstt ·ual Symptom Seale (RSS) to have test-t·etest 
reliability (t ·anging from .73 to .85) and concunent, constt ·uct, and 
content validity on tht ·ee independent par ·ametet ·s of menstr·ual dis-
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tt ·ess (symptoms , medication usage , and invalid hout·s). Concunent 
validity between the RSS and il daily symptom scale was t·epot ·ted to be 
0.95 and 0.96 on two sepat ·ate admi ni str ·ations. These t·epot ·ted t·el i a-
bility and validity checks at ·e extr·emely impot·tant due to pt·eviously 
used measut·es 1 lack of these checks (Moos, 1969), and concet ·ns 
regat ·ding the susceptibility of these measur ·es to ster ·eotypy , as well 
as possible influence on them by memot-y factot ·s (Parlee, 1973, 1974). 
In a methodologically weak study, Ben-Menachem (1980) tr·eated 
ten women aged 16-22 suffet ·ing from dysmenon ·hea with four · weeks of 
t wice-weekly , gr·oup admi ni stet·ed t·el axati on and 11posthypnoti c sugges -
ti ons11 t·egat ·ding the not·malcy of menstt ·uation. Dependent measur·es 
wer·e an unspecified dysmenonhea questionnait- e based on Moos' (1968) 
Menstr ·ual Di stt ·ess Questionnait-e and a self-judgment sheet. No con-
tr ·ol gr·oup was utilized. Results indicated that the symptoms of 
cr ·amps and nausea wet·e significantly impr·oved. 
Despite the identified weaknesses of th e above study , such as 
unnot ·med measur ·es, and unspecified tr ·eatment (which , pan~ntheti cal ly , 
appear · all too commonly in published gynecological journals) , the 
study does pt·ovide some conver ·gent suppor ·t to t·ecent contentions as 
to the impot·tance of cognitive factot ·s in the successful behaviot ·al 
tr ·eatment of dysmenonhea . In this case , Ben-Menachem (1980) sug-
gested that the intenuption of a 11pain spit-al 11 involving fear and 
tension inct ·easing sensations of discomfot ·t was impor·tant to his 
successful results. 
Biofeedback Treatments 
of Pt ·imat-y Dysmenonhea 
Mot·e r·ecently, r·eseat ·chet ·s have focused on the use of diffet ·ent 
biofeedback tt·eatment modalities in the tt·eatment of dysmenonhea. 
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In a study explot·ing the r·elative efficacy of EMG ft ·ontalis and 
temper ·atur ·e tr ·aining in the tt ·eatment of pt ·imar-y dysmenonhea , Hat·t 
et al. (1981) tr ·eated 11, mostly null ipar ·ous college women vol unteet·s 
for · six months. The pt"Ogt·am consisted of two months of baseline data 
gathet ·ing , two months of (13 30-minute sessions) individually admin-
i ster ·ed biofeedback tt·aining (either · EMG frontalis tt ·aining or· skin 
tempet ·atut ·e tt·a i ning) and two months of fol low-up data gathering. 
Dut·i ng the two months of the biofeedba c k tt ·a i ni ng , subjects wer·e al so 
instrnc t ed t o pet ·fot ·m an unspecified type of home practice once 
daily. Measur ·es used wer·e the Symptom Sevet ·ity Scale and the 
Menstr-ual Symptom Questionnait-e. Subjects wer·e tr ·eated by ten male 
doctor·al students in clinical psychology. 
Tt-eatment results indicated that both biofeedback modalities 
wet ·e effective in t·educing the symptoms of pt ·imat-y dysmenonhea , and 
that thet ·e was no statistically si gni fi cant di ffet ·ence between the 
EMG and the tempet ·ature tt ·aining groups. No t·epot ·t was made of any 
change in psychophysi o 1 ogi cal measut ·es as a t·esul t of biofeedback 
training. Although the MSQ was ostensibly used in this study to 
classify subjects in regat ·d to congestive vs. spasmodic dysmenonhea , 
no repot ·t in this study was made t·egat ·ding possible diffet ·ential 
t·esponse to tt ·eatment by the two gr·oups. Post hoc analysis of symp-
toms that wet·e t·epor ·ted impr ·oved wet ·e: ct·amps , headache, backache , 
dept ·ession , initability , gener ·al aching, and abdominal pain. 
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Nausea, vomiting, anot ·exia, leg aches , dizziness, weakness, dian·hea, 
and facial blemishes did not t·espond to ei thet· tt·eatment. 
Noting that in both tt·eatment gr·oups symptom t·eduction continued 
even aftet· tt ·eatment was discontinued, Hart et al. (1981) theorized 
that repor·ted symptom sever ·i ty may actually depend mot·e on a sub-
ject's feeling of contt ·ol ovet· the pain than on actual contr ·ol of 
physiological function. To support their contention, they cited a 
study on low back pain (Nouwen & Solinget ·, 1979) that found that self 
t·epor ·t of pain decr·eased in many patients into the follow-up phase 
~ though EMG measut ·ements r·etur·ned to baseline. However ·, placebo 
effect cannot be r·uled out as being r·esponsible for · symptom dect ·ease , 
since no contt ·ol group was used. Attributing the t·esults to the 
effect of tile chat ·actet ·istics of the therapist can be rnled out , 
howevet ·, si nee mor·e than one thet·api st was used. 
Balick et al. (1982), in a study utilizing single subject multi -
ple baseline design with multiple tr ·eatments , tt ·ained seven dysmenor ·-
rhei c women in EMG and thermal biofeedback pt ·ocedut ·es with concunent 
autogenic t·el axation pt ·actice. The Menstrnal Symptom Questionnaire 
indicated that five women had spasmodic dysmenonhea, two had conges-
tive dysmenonhea , and "two suffered from a combination of both 
types" (p. 503). The dependent measut ·e used was the Daily Symptom 
Scale, and was completed by each subject on each of the ffrst two 
days of her menstrnal period. The treatment outline was as follows: 
6 months of baseline data gathering (4 months of DSS only, 1 ast two 
months DSS, and 3 sessions of baseline physiological measut ·es); 2 
months' tt ·eatment consisting of 12 40-minute sessions of autogenic 
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tt·aining and then either· EMG ot · skin tempet·atut·e biofeedback; 1 month 
of DSS and 3 sessions of physiologic measut·es; and 2 mot·e months of 
continued autogenic tt·aining in conjunction with the t·emaining bio-
feedback modality. Thet·efot ·e tt ·eatment 1 ength was for 11 months 
total dut·ation. 
Tt-eatment results indicated that all subjects evidenced allevia-
tion of their · total daily disability t·esul ting from dysmenon·hea, as 
wel 1 as t·eported number· of i net ·eased hout ·s of bedrest and medication 
used. No apparent t·el ationship was noted between total DSS scot ·es 
and physiological data. Also, symptoms wet·e t·eported to be alle-
viated regat ·dl ess of type of dysmenonhea. Both sequences of bi o-
feedback appeat·ed equally effective , and symptom alleviation appeat·ed 
to be mot·e related to time in tt ·eatment than to sequence of training , 
al though thet ·e was some indication that symptom t·eduction was mor·e 
t·elated to muscle t·elaxation than pet ·iphet ·al tempet ·atut ·e warming. 
Tt·eatment t·ecommendations wet·e fot · autogenic t·el axation concomitant 
with EMG tt ·aining for mor·e than two menstt ·ual cycles. 
An impot ·tant weakness of this study is that the daily symptom 
t·epot·ts wet ·e only collected on the fit-st two days of menstt ·uation. 
Such a t·eport schedule would make it difficult to obtain appt·opr-iate 
data from congestive dysmenorrhea suffet·et·s whose symptoms at ·e pt ·ima-
t'i ly premenstr-ual rather · than menstr-ual. 
As in the case of Hat· t et a 1 • ( 19 81 ) , Ba 1 i ck et a 1 • ( 19 8 2) a 1 so 
speculated on hypothesized psychological factor ·s that played a t·ole 
in symptom reduction. Inct ·eased sense of self contr-ol, change in 
attitude toward menstt ·uation, and dect ·eased anxiety towat·d menses 
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wer·e al 1 cited as po ten ti al sour·ces of influence. 
Conclusions 
This liter ·atur ·e r·eview suggests four· major · conclusions: 
1. Despite wide acceptance of the hypothesized congestive-
spasmodic dichotomy of primar·y dysmenonhea (Dal ton, 1969), many 
questions have been r·ecently r·aised in the liter·atur·e r·egar·ding the 
validity of the Menstr ·ual Symptom Questi onnai r·e , which is the cl assi-
fication tool purpor·tedly able to discr ·iminate dysmenonhea suffer·er·s 
into these two types (Cox, 1976; Webster · et al., 1979). Major· objec-
tions of the test ar ·e that its scor ·i ng system cannot di ffet ·enti ate 
between moder·a te 1 evel s of dysmenonhea and no dysmenon ·hea , and is a 
direct application of a theor ·y (a) that has nevet · been empirically 
confirmed and (b) about which ther ·e exists anecdotal evidence of 
r·efutation (Golub et al., 1959). 
2. Aftet · systematic suppot ·t in the 1 itet ·atut ·e t·egat ·ding the 
effectiveness of behaviot ·al stt ·ategies in the tt·eatment of pt ·imat-y 
dysmenonhea (Chesney & Tasto, 1975b; Duson , 1977; Reich , 1972; Tasto 
& Chesney, 1974) mot·e t·ecent t·eseat ·ch has focused on tt ·eatment manip-
ulations calculated to enhance tt·eatment effectiveness. These 
include: 
(a) inct ·eased length of treatment dut ·ation (Balick et al., 
19 8 2; Hat · t et a 1 • , 19 81 ) ; 
(b) increased focus on individual ovet · group tt·eatment (Balick 
et al., 1982; Cox, 1976; Hart et al., 1981); 
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(c) incr-eased intet ·est in the hypothesized r·ole that cognitions 
play in symptom reduction (Balick et al., 1982; Ben-
Menachem, 1980; Cox & Meyer , 1978; Har·t et al., 1981 ); 
specifically, (1) inet ·eased sense of self control , (2) 
impr ·oved attitudes towat ·d menstt ·uation, and (3) deet ·eased 
anxiety. 
3. There presently exists in the l iter ·atut·e no suppor ·t of a 
t·el ati onshi p between physi ol ogi cal measur ·es and symptom i mprnvement 
even when the major aspect of tr ·eatment is simple biofeedback tt·ain-
i ng (Balick et al., 1982; Cox & Meyer ·, 1978; Har-t et al., 1981). 
4. All the t·eviewed studies , with the possible exception of 
one (Hat·t et al., 1981) , r·epor ·t impr ·oved dysmenonheic symptoms in 
their- subjects using either · pr·ogt ·essive t·elaxation ot · autogenic 
tr ·aining combined with either · systematic desensitization (Cox & 
Meyer·, 1978; Duson , 1977; Reich , 1972; Tasto & Chesney, 1974) , post-
hypnotic suggestions t·egat ·ding the normalcy of menstt ·uation (Ben-
Menachem, 1980) , or· biofeedback (Balick et al. , 1982). The one 
excepted study to this conclusion repor ·ted an unspecified type of 
daily home pr·actice for · its biofeedback tr·ainees that may al so have 
involved some for ·m of t·elaxation tr ·aining. 
A study evaluating the effectiveness of r·el axati on only compared 
to a pt ·eviously effective combination tt ·eatment would be valuable on 
both pr·actical and theor·etical levels. Since simple r·elaxation 
tr ·aining in clinical settings is a mor·e quickly accomplished , sim-
pler ·, and subsequently less expensive pr·ocedut·e than is r·elaxation 
plus any other · treatment, r·elaxation alone should be the trer1tment of 
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choice if both prncedut ·es at ·e found to be equally effective. 
On a theot ·eti cal 1 evel, such an evaluative study would begin to 
cl ar-i fy and t·efi ne the specific 1 ocus of tt ·eatment that is addt·essed 
in the behaviot·al tt ·eatment of dysmenonhea. If dysmenonhea can 
best be visualized as fitting a phobic model as at·gued by Cox and 
Meyet· (1978), then the use of desensitization imaget ·y as an anxiety 
t·eduction technique in the tt ·eatment pat ·adigm is of impot·tance, since 
such a combination tt ·eatment should be significantly mor-e effective 
than a t·elaxation only tt ·eatment. Howevet·, it can also be pt ·esently 
at ·gued that tt ·eatment effectiveness may stem simply from the tr-aining 
of subjects in t·elaxation stt ·ategies pet· se since all ot · neat ·ly all 
of the t·epor-ted studies used t·el axation tt·aining as pat ·t of their' 
tt·eatment. If this is the case, then the use of systematic desensi -
tization hiet ·at ·chies , hypnosis, ot · biofeedback modalities in the 
tt ·eatment may be enthely unnecessat ·y. 
These questions at ·e those the pt ·esent study attempts to address. 
A desct ·iption of the subjects, instt ·uments , and tt·eatments used in 
this study wi 11 be pt·esented in the fo 11 owing chaptet ·. 
CHAPTER II I 
METHOD 
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This chapter · wi 11 t·evi ew subject chat ·actet'i sti cs and t·eet ·ui tment 
and pt ·ovide a descr-iption of the instrnments and tt ·eatments used. 
Subject and Subject Selection 
Fifty-nine women pat ·ticipated in the study. Subjects wet·e pt·i-
mat ·i ly women undet ·gt ·aduate and gt ·aduate students ent ·o 11 ed at Utah 
State Univet ·si ty from Spt·ing Quat ·tet ·, 1982 to Spt ·ing Quat ·tet ·, 1983. 
In an attempt to bt·oaden the subject pool , tht ·ee women staff members 
and tht·ee clients of the Beat · Rivet · Community Mental Heal th Center· 
wet ·e also t·ecrnited for- pat ·ticipation. 
The student subjects wet·e t·ect'Uited from dance, nutt ·ition, 
family studies, nur ·sing, and elementat-y education classes , sot ·ot ·it_y 
meetings , and dot ·mitot-y meetings wher-e they wet ·e invited to pat·tici-
pate in a study tt·aining them in a t·elaxation stt ·ategy to contt ·ol 
menstrnal and pt ·emenstt ·ual di scomfot-t. The mental heal th centet ·-
based subjects wet ·e t·ect ·uited tht·ough an or-al pt ·esentation to centet · 
staff r-equesting volunteet ·s and client t·efenals for- participation. 
I nstrnctot ·s of the above cout ·ses and 1 eadet·s of the above gt ·oups 
wet ·e contacted pt'iot · to the classes/meetings to gain a few minutes of 
time fot· the purpose of announcing the study. The classes selected 
had in common a pt ·eponderance of women in the cl ass t·egi strati on. 
Each gt ·oup was told of the ongoing tt ·eatment pt'Ogt ·am that might 
be of potential benefit to them that was being offet·ed by the Psy-
chology Depat ·tment to help women to use t·elaxation to contt·ol both 
PMS and dysmenorrhea symptoms. The women were assured that such 
symptoms "are not in your head," and that physiologically-based 
symptoms could be treated by psychological interventions much like 
Lamaze training's helpfulness in the management of childbirth pain. 
The group was also informed that the relaxation training could also 
be possibly helpful to them in the management of anxiety associated 
with test-taking and public speaking as well as in the control of 
such psychophysiologic symptoms as tension headaches and insomnia, 
but that participation in the study required the presence of dysmen-
orrhea. Further requirements of the study were next outlined ; these 
involved (1) a $10 refundable deposit, (2) attendance at four ind i-
vidually arranged one-hour treatment sessions over the course of 
three weeks, and (3) agreement to practice at least once but prefer-
ably twice daily to a tape recorded relaxation procedure. 
After the presentation, a paper was passed around the room with 
the researcher's name and phone number; interested individuals were 
asked to list their names and phone numbers. 
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The experimenter experienced some difficulty in recruiting sub-
jects for participation; however, unlike those noted by Reich (1972) 
and Cox (1976), the difficulty appeared to involve subject concern 
about making the necessary time commitment that participation 
required rather than their noted subject embarrassment over the topic 
of "menstrual cramps." This difference was possibly due to the fact 
that the presenter emphasized that all researchers and trainers 
involved were also women. It should be noted that many potential 
subjects appeared interested in participation in the study due to the 
potential benefit of managing other · anxiety-r ·elated discomfor·ts in 
their· lives besides their· dysmenonhea. 
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Thr·ee subjects wer·e also contacted thr·ough an ad placed in the 
univer ·sity student newspaper ·, which also outlined the r·equir ·ements of 
the study. 
Vol unteet ·s who signed the 1 i st at the ti me of the pr·esentati ons 
wer ·e contacted by the investigator · within thr-ee weeks. At that time, 
questions about the study wet·e answet ·ed, and the study' s t·equi t·ements 
wer·e t·ev i ewed. If the vol unteet · continued to expt ·ess i nter ·est in 
pat ·ticipation, a pr·etest appointment was scheduled and dit-ections to 
the Psychology Depar·tment Community Clinic wer·e given. Infor ·mation 
about 1 ast menstr ·ual pet'i od was al so obtained to deter·mi ne when 
tr·eatment co uld begin. Appr·oximately fifteen to twenty-five volun-
teer·s wer·e eliminated at this point due to i nabi 1 i ty or· unwi 11 i ngness 
to make the necessar-y ti me commitment. 
Of the 59 subjects who agr ·eed to par ·ticipate , 14 did not com-
plete the study. Of this gr·oup, six completed tr·aining , but left the 
ar·ea without sending in their· posttest data; ail of these women wer·e 
leaving the ar ·ea at the time due to the end of the r·egulat · school 
year ·. Six subjects dt ·opped out dut ·ing tr ·eatment due to time con-
str·ai nts, one dt ·opped out befor·e the tr-eatment began due to a mis-
cani age. One subject who did complete the tt ·eatment became amenor ·-
r·hei c and did not complete the follow-up data. 
Demogr·aphi c data of the 45 subjects who completed tr ·eatment ar·e 
pr·esented in Table 1. Subjects' ages r·ange from 18 to 42 year-s. 
Sixty-nine per·cent of the subjects wer·e either · unmani ed or- di vor ·ced 
31 
Table 1 
Table of Demogr·aphic Var-iables for the Subjects 
Who Completed Tt·eatment (N=45) 
Desensitization Relaxation Combination A 11 Gr·oups 
Age n (%) n (%) n ( % ) N ( % ) 
18-22 8 (54) 6 (40) 11 (72) 25 (56) 
23-27 2 (14) 3 (20) 1 ( 7) 6 ( 13) 
28-32 4 (26) 4 (26) 1 ( 7) 9 (20) 
33-42 1 ( 7) 2 (14) 2 (14) 5 ( 11) 
Mat·ital Status 
Single 11 (73) 9 (60) 10 (66) 30 ( 67) 
Man ·i ed 4 (27) 6 (40) 4 ( 27) 14 ( 31) 
Di vor ·ced 0 0 1 (7) 1 ( 2) 
Pat·ity 
None 15 (100) 13 (86) 14 (93) 42 (94) 
One 0 1 ( 7) 1 ( 2) 
Tht·e e 0 1 (7) 1 ( 2) 
Nine 0 1 ( 7) 1 ( 2) 
Medic-1tions* 
None 7 (47) 10 (66) 6 (40) 23 (52) 
Anti-inflammatory 
agents 3 (20) 3 
Pr·oloid (thyr ·oid 
(20) 2 (13) 8 (18) 
r·epl acement) 1 ( 7) 0 1 ( 7) 2 (4) 
Antihistimines 1 ( 7) 0 1 ( 7) 2 (4) 
Inder ·al (anti-
hyper ·tensi ve) 2 ( 13) 1 ( 7) 0 3 ( 7) 
Analgesics 1 (7) 1 ( 7) 2 ( 13) 4 ( 9) 
Antibiotics 0 0 1 (7) 1 ( 2) 
Anti depr·essants 0 1 (7) 1 ( 7) 1 ( 2) 
Asthma 
medication 0 0 i (7) 1 ( 2) 
Bit-th Contt ·ol 
None/bani er · 
method 13 (86) 13 ( 87) 13 (86) 39 ( 87) 
B.C. pills 1 ( 7) 0 1 ( 7) 4 (9) 
I.U.D. 1 (7) 2 (13) 1 (7) 2 (4) 
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Desensitization Relaxation Combination All Groups 
Chief Complaints* n ( % ) n ( % ) n (%) N ( % ) 
Unknown 1 ( 7) 2 (13) 0 ( 0) 3 ( 7) 
(Menstrual Symptoms) 
Cramping 10 ( 67) 8 (53) 12 (80) 30 ( 67) 
Nausea 1 ( 7) 0 (0) 1 ( 7) 2 ( 4) 
Abdominal 
pressure 0 ( 0) 0 (0) 1 ( 7) 1 ( 2) 
Menstrual Symptoms 
Percentage: (74) (53) ( 94) (73) 
(Premenstrual Symptoms) 
Tension 1 ( 7) 6 (40) 2 ( 13) 9 (20) 
Headache 2 (13) 0 (0) 3 (20) 5 ( 11) 
Depression 2 (13) 0 ( 0) 3 (20) 5 ( 11) 
Backache 4 ( 27) 0 (0) 1 ( 7) 5 ( 11) 
Bloating 1 (7) 0 
Premenstrual 
(0) 0 (0) 1 ( 2) 
Symptoms Percentage ( 67) (40%) (60%) (55) 
(Paramenstrual Symptoms) 
Pain at 
ovulation 0 (0) 1 ( 7) 0 (0) 1 ( 2) 
Past Training in Relaxation 
None 7 ( 47) 9 (59) 11 (73) 27 (60) 
<1 week 5 (33) 1 ( 7) 1 ( 7) 7 (16) 
>1 week, 
<1 month 0 0 1 ( 7) 1 ( 2) 
>1 month, 
<6 months 1 ( 7) 3 (20) 1 ( 7) 5 ( 11) 
>6 months, 
<1 year 2 (13) 1 ( 7) 1 ( 7) 4 (9) 
~ 1 year 0 1 ( 7) 0 1 ( 2) 
*Some subjects gave more than one response, so percentages will not 
equal 100%. 
33 
and thi t·ty-one percent wet ·e mani ed. Ni nety-fout· pet ·cent wet ·e nul 1 i -
pat ·ous and six pet ·cent wet·e parnus. Eighty-seven pet·cent of the 
subjects used either no bit-th contrnl ot· a baniet· method, nine 
percent used ot·al contt·aceptives, and fout · pet·cent used an IUD. 
Regat ·ding pt·evious tt·aining in t·elaxation, sixty pet ·cent had expet'i-
enced none; fot ·ty pet·cent had experienced some tt·aining t·anging from 
1 ess than one week to more than one yeat ·. Fifty-two pet·cent of the 
subjects took no regul at · medications; the t·emai ni ng fot ·ty-ei ght pet· -
cent t·egularly took some medications , which at ·e specifically listed 
in Table 1. Seventy-tht ·ee pet ·cent of all subjects compla i ned of 
menstt ·ual symptoms , and fifty-five pet ·cent indicated difficulty with 
pt·emenstrnal symptoms. 
Table 2 pt ·e sents the demogt ·aphic chat ·acteristics of the 14 women 
who did not complete treatment. Si nee many wet ·e undet ·gt ·aduate 
students that had left the at ·ea at the end of the school yeat ·, it is 
not sut ·pt ·i sing to note that this gt ·oup is younget ·, single , mor·e often 
null ipat ·ous and less 1 ikely to use medication than the gt ·oup that 
completed tt·eatment. This gt ·oup was al so mot·e 1 i kely than the gt ·oup 
that completed tt ·eatment to com plain of menstr ·ual t·athet · than pt·emen-
stt ·ual symptoms. 
Expet ·imental Tt·eatment 
An outline of the study's expet'imental tt ·eatment pr·ocedu1 ·es will 
next be pt·esented. Included in each tt ·eatment set·ies was a tt·eatment 
pt ·etest interview and fout · tt ·eatment sessions. 
Table 2 
Table of Demogt·aphic Vat·iables fot· the 
Fout·teen Subjects Who Did Not Complete 
Tt·eatment (N=14) 
Desensitization Relaxation Combination All Gt·oups 
Age 
18-22 
23-27 
28-32 
33-42 
Mat·ital Status 
Single 
Mani ed 
Di vot·ced 
Pat'ity 
None 
One 
Tht·ee 
Medications* 
Mott'i n/Ponstel 
Et·ytht-omyci n 
No medications 
Bi t·th Contt·ol 
None 
B.C. pills 
I.U.D. 
(n=5) (n=4) (n=5) (N=14) 
n (%) 
4 (80) 
1 (20) 
4 (80) 
1 ( 20) 
5 (100) 
1 (20) 
1 (20) 
4 ( 80) 
4 (80) 
1 ( 20) 
n (%) 
4 (100) 
4 ( 100) 
4 (100) 
4 (100) 
3 (75) 
1 (25) 
n (%) 
4 (80) 
1 (20) 
3 (60) 
2 (40 ) 
5 (100) 
4 ( 80) 
1 (20) 
2 (40) 
5 (100) 
N ( % ) 
12 (86) 
2 (14) 
11 ( 79) 
3 (21) 
14 (100) 
5 (36) 
2 (14) 
10 (71) 
12 (86) 
2 (14) 
0 
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Desensitization Relaxation Combination A 11 Groups 
( n =5) ( n=4) ( n=5) ( N=l4) 
Past Training 
None 4 {80) 2 {50) 4 (80) 10 {72) 
<l week 1 (20) 1 (25) 2 (14) 
>l week 
<l month 
>l month 
<6 months 1 (25) 1 {20) 2 (14) 
>6 months 
<l year 
.:_l year 
Chief Complaints* 
(Menstrual Symptoms) 
Cramps 5 {100) 4 {100) 4 {80) 13 {93) 
( Premenstrual Symptoms) 
Hot fl ashes 1 {20) 1 ( 7) 
PM tension 1 {20) 1 (7) 
*Some subjects gave more than one response, so percentages will not 
equal 100%. 
Tt·eatment Pt·etest I ntet"vi ew 
Each pt"etest intet ·view was conducted by the investigator· at the 
Psychology Depat ·tment Community Clinic, and lasted appt"Oximately 
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15 minutes. The tt·eatment contt ·act (Appendix A) was t·ead and signed, 
the subject data sheet (Appendix B) was filled out, the $10 deposit 
was collected, and the pt·etest packet consisting of the Physician's 
Appt·oval Fot·m (Appendix C), the Rett·ospective Symptom Scale (Appendix 
D), the Menstt·ual Semantic Diffet ·ential (Appendix E) , the Menstt·ual 
Activities Scale (Appendix F), the Menstt·ual Behavior · Scale (Appendix 
G), and the Menstt"Ual Symptom Questionnait-e (Appendix H) was given to 
subjects to fill out. The Tt·eatment Rationale (Appendix I) was given 
to each subject to t·eview. The date of the last menstt ·ual pet ·iod was 
t·econfit·med , and the fit ·st tt·eatment session was scheduled to coin-
cide with the subject's day 3-5 of het · own cycle with day 1 consti-
tuting the fit-st day of menstr-ual bleeding. At this point each 
subject was t·andomly assigned to one of tht·ee tr·eatment gt ·oups. 
These gt ·oups wet·e (1) a "Relaxation" gr·oup that obtained four · 
sessions of pt ·ogr ·essive t'elaxation, (2) a "Desensitization" gt'oup who 
obtained four · sessions of self-dit·ected t·elaxation while being admin-
istet ·ed scenes from the Standat ·d Menstt·ual Hiet ·at ·chy (Appendix L) 
(Reich, 1972), and (3) a "Combination" gt·oup who obtained both t·elax-
ation tt·aining and desensitization. 
Tt·eatment fot' all subjects was completed in the fit-st 23 days of 
thei t· t·espective cycles, and was admi ni stet ·ed on an i ndi vi dual basis. 
No attempt was made to contt·ol fot · time of day of tr ·eatment, since 
sessions wet·e ananged at each subject's convenience. A 16-day 
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treatment schedule, as devised by Cox and Meyer (1978) was used with 
Session 1 taking place on days 3-5 of an individual subject's men-
strual cycle, Session 2, 7 days later (cycle days 11-13), Session 3, 
4 days later (cycle days 15-17), and Session 4, 4 days later (cycle 
days 19-21). An attempt was made to keep treatments to the ideal 16-
day schedule outlined above, but due to the Psychology Department's 
Community Clinic hours, treatments that fell on a weekend day were 
rescheduled to a weekday time. 
The four treatment sessions, each lasting approximately 45 
minutes, will be next described. The Combination Group, Desensi-
tization Group, and Relaxation Group treatment outlines are presented 
in Appendices M through 0. In all sessions, the relaxation and 
desensitization procedures were tape recorded to ensure treatment 
reliability. An outline of the treatment is presented in Table 3. 
Session 1 
For both the Relaxation and the Combination Groups, Session 1 
consisted primarily of relaxation training of 16 muscle groups, 
fol lowing the procedure outlined by Bernstein and Borkovec (1973). 
This procedure involves physically tightening and relaxing the muscle 
groups twice to facilitate discrimination between tension and relaxa-
tion states and to induce relaxation. Immediately following relaxa-
tion exercises, each subject was instructed to attend to her breath-
ing and self-instruct with the cue word "relax" on each exhalation. 
Practice of this cued breathing is intended to classically condition 
the relaxation response (Benson et al., 1974; Cox, 1976) with 
Table 3 
Outline of Treatments 
Group 
Relaxation 
Combination 
Desensitization 
1 
(-Day 4) 
16 muscle 
relaxat1on 
training 
Cued 
breathing 
16 muscle 
relaxation 
training 
Cued 
breathing 
Self-
administered 
relaxation 
Hierarchy 
1 terns 1-4 
Session 
2 
( r-Day 12) 
7 muscle 
relaxation 
training 
Cued 
breathing 
7 muscle 
relaxation 
training 
Cued 
breathing 
Hierarchy 
i terns 1-4 
Self-
adm1n1stered 
relaxation 
H1 erarchy 
i terns 5-8 
3 
( ,_Day 16) 
4 muscle 
relaxation 
training 
Cued 
breathing 
4 muscle 
relaxation 
training 
Cued 
breathing 
Hierarchy 
i terns 5-9 
Self-
administered 
relaxation 
Hierarchy 
items 9-11 
4 
( --Day 20) 
Relaxation 
through recall 
training 
Cued 
breathing 
Relaxation 
through 
rec a 11 
Cued 
breathing 
Hierarchy 
items 10-14 
Self-
administered 
relaxation 
Hierarchy 
i terns 12-14 w 
co 
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contr ·olled self-instt-ucted br·eathing to allow the subject an effi-
cient r·el axati on pr·ocedur ·e. As noted befot ·e, the t·el axati on pt·oce-
dur·e itself was tape t·ecot·ded and the same fot · each subject. Follow-
ing the tt·aining, the subject was given a Home Relaxation Sheet 
(Appendix J) to advise about home t·el axati on pt·ocedut ·es. A Rel axa-
ti on Monitot·ing Scale (Appendix K) was given to t·ecord levels of 
t·elaxation, to monitor· possible "unstr·essing" exper·iences (Luthe , 
1969), and to encour ·age home pr·actice. Each subject was al so given 
the cassette tape of the t·ecot ·ded t·el axati on and cued bt ·eathi ng 
instt ·uctions used dut ·ing the session to use dut·ing home practice, and 
was encour ·aged to pt ·actice with it at 1 east once but pt·efet ·ably twice 
daily, as outlined by Cox and Meyer · (1978). Expecting univet ·sity 
student subjects to pt ·actice mor·e often than that without pay was 
consi det·ed um·eal i sti c (Chesney & Tasto, 1975b). 
For· the Desensitization Gt·oup, Session 1 consisted of instr ·uct-
ing the subject to spP.nd a few minutes t·elaxing "in the way that is 
best and most comfat ·table" for · her ·. After · this, the subject was t·ead 
a hiet·ar ·chy item from Reich's (1972) Standat·dized Menstt·ual Hier·ar ·chy 
scenes (Appendix L) and was asked to signal with her· r·ight index 
finger · when she cleat ·ly imaged the scene, and to r·aise her · left index 
finger· if and when she expet"ienced anxiety. If anxiety was signaled, 
the subject was t·equested to "t ·elax it away in the way that is best 
and most comfot·tabl e" fot · her·, and to signal with the t·i ght index 
finger· when this was accomplished. As the pr·ocedur ·e was tape 
r·ecor·ded, all items wet ·e pr·esented twice for · a 30-second inter·val at 
each pr·esentati on. Thet·efor·e, this desens i ti zati on str ·ategy was ver-y 
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similat· fot· all subjects. 
All of Reich's (1972) items wet·e pt ·esented in this mannet ·. 
Items 1-4, 5-8, 9-11, and 12-14 wet·e pt ·esented in the Desensitization 
Gt·oup Sessions 1, 2, 3, and 4, t·espectively. The hi et·at·chy used was 
constt·ucted on the basis of questi onnai t·e t·esponses from 100 female 
students at the Univet·sity of New Mexico and was subsequently suc-
cessfully used by Reich in his t·eseat·ch (Reich, 1972). Individual 
t·esponses to the hi et ·at ·chy i terns wet·e noted and t·ecot·ded on the 
Client Data Sheets (Appendix B) via obser-vation thr-ough a one-way 
mi not ·. In this way, desens i ti zati on data wet ·e col 1 ected fot· each 
subject. The Home Relaxation Sheet and the Relaxation Monitot ·ing 
Scale wet ·e distt"ibuted to the Desensitization Gt·oup subjects in a 
mannet · simil at · to the other two gt·oups. 
Between the fi t·st and second thet·apy sessions, the thet ·api st 
telephoned all subjects to discuss home pr·actice questions, to 
encout ·age the suggested twice daily pt·actice sessions, and to t·econ-
fit-m the Session 2 appointment. 
Session 2 
Fot · the Relaxation Gt·oup, Session 2 consisted of tt ·aining 
Ber-nstei n and Bot·kovec' s (1973) condensed seven-muscle t·el axati on 
pt ·ocedut ·e, which consists of combining sevet ·al of the 16 muscle 
gt·oups. Cued bt-eathing again followed immediately aftet · the exet ·-
cises. 
In the Combination Gt·oup, the seven-muscle t·elaxation tt·aining 
(as outlined above) was followed by cued bt·eathing and items from 
Rei ch' s ( 1972) Standat ·d Menstt·ual Hi et ·at·chy. Fo 11 owing pt·ocedut ·es 
descr-ibed by Cox (1976), each subject was t·ead a hiet ·at·chy item and 
was asked to signal with het · t"ight index finget · when the scene was 
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cl eat·ly imaged and to t·ai se het· t·i ght index fi nget · when and if she 
exper-ienced anxiety. The subject was t·equested to t·elax away any 
expet·ienced anxiety with cued bt ·eathing and to signal with het · t·ight 
index fi nge1· when this had been accomplished. Each hi et ·at·chy i tern 
was pt ·esented fot · 30 seconds, and was pt ·esented two ti mes. As with 
the Desensitization Gt·oup, all of Reich's (1972) 14 standat·d men-
str-ual hi et·at ·chy scenes wet ·e twice pt·esented to the Combination Gt·oup 
in this man ne t·; scen e s 1- 4, 5-10, and 11- 14 wet ·e pt ·esented dut ·i ng 
Se ssions 2, 3, a nd 4, t·esp ectively . As wi th the pt ·ogt ·essiv e t·el axa-
ti on exe t·ci ses, these i terns wet·e t ape t·ecot ·ded to ensur ·e tt ·ea t me nt 
t·eliability act ·oss a ll subjects . Subj ects' signals wet ·e obse1 ·ved 
thr-ough a one-way min ·ot · in an adjoin i ng t·oom a nd r·espons e s we t·e 
t·ecot ·ded on t he Cli e nt Data Sheet (Appendix B). 
Session 2 fo1 · the Desensitization Gt·oup involved self-1 ·ela xa tion 
and the admi ni str ·ati on of hi er·at ·chy i terns 5-8. 
The Relaxation Moni tor ·i ng Seale fot ·ms wet·e collected fo1 · ea c h 
subject at al 1 of the gt ·oup tr ·eatment Sessions 2, 3, and 4, and a t 
posttest, so that data evaluating numbet · of pr·acti ces and 1 evel s of 
t·el axati on dut ·i ng home pr-acti ce could be collected and 1·epot ·ted. 
A telephone call by the ther ·api st to the subject foll owed 
Session 2 to encout·age continued home pt·actice of imagety (Desensiti-
zation and Combination Gt·oups) and the seven muscle t·elaxation tr ·ain-
ing and cued bt ·eathing (Relaxation and Combination Gt·oups), as well 
as to confit-m the Session 3 appointment. 
Session 3 
Session 3 for · both the Relaxation and the Combination Gt·oups 
consisted of tr-aining in Bet ·nstein and Bot·kovec 1 s (1973) four· muscle 
gr·oup pr·ocedut ·e, and cued bt·eathing. In addition, the Combination 
Gt·oup t·ecei ved hi er ·ar ·chy i terns 5-9. 
42 
Session 3 for · the Desensitization Gr-cup involved self-t ·elaxation 
and the admi ni str ·a ti on of hi et·at ·chy i terns 9-11. 
Session 4 
The last tr·eatment session consisted of Bet·nstein and Bot-kovec 1 s 
(1973) 11t·elaxation by t·ecall 11 pr ·oced ut·e and cued bt·eathing fot· both 
the Relaxation and Combination Gr-oups. 11Relaxation by t·ecall 11 
involves no physical muscular · activity but only uses the cognitive 
t·ecol l ecti ons of sensations of muscul at · tension and r-el axati on sensa -
tions. 
A 1 ong with the 11t·el axati on thr-ough r·ecal l II pt ·ocedut ·es and cued 
bt ·eathi ng, the Com bi nation Gt·oup al so obtained desensi ti zati on hi et·-
at ·chy images 10-14. 
Session 4 for · the Desensitization Gt·oup involved self-t ·elaxation 
and the administt ·ation of the desensitization hiet ·at ·chy images 11-14. 
For · all tht·ee gt ·oups, skin tempet ·at ut·e measut·es wet ·e al so ob-
tained dut·ing Session 4. After · the initial homewot ·k gather-ing and 
instr-uction pat ·t of the session (see Appendices Mand N), a skin 
tempet ·atut·e thet·mi stet · was attached to the meaty pat·t of the nondomi-
nant hand of the subject. Thr-ee minutes of baseline tempet·atut ·e data 
wet ·e obtained, at which point the tape t·ecot ·ded 11r·el axati on tht·ough 
t·ecall 11 and cued bt·eathing (fot · the Relaxation and Combination 
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Gt·oups) and the desensitization hiet ·at·chy items (fot · the Combination 
and Desens i ti zati on Gt·oups) wet ·e pt·esented. After · the tape, an 
additional tht·ee minutes of baseline data wer·e coll!?cted and an 
additional six minutes of skin tempet ·atur ·e monitor ·ing dut ·ing self-
administet·ed t·elaxation and/or · desensitization was obtained. Lastly , 
tht·ee mot·e minutes of baseline skin tempet·atut ·e measut ·ement was made. 
Skin tempet·atut ·e pt·ocedut·es at·e outlined in Table 4. 
Skin tempet·atut·e measur·es wet·e obtained using an Autogen 2000b 
Feedback Thet·mometet ·. Data wet ·e compiled with an Autogen 5600 Data 
Acquisition Center · and pt ·inted with an Autogen PSOOO pt·intet ·. 
Session 4 fot · all subjects concluded with the dist t·ibution of 
two copies each of the RSS, MAS, MBS, and MSD. One copy of each 
meas ur·e was enclosed in a stamped, add t·e ssed envelope with instt ·uc-
tions to t·etur ·n the completed fot ·ms in tht·ee months time. These 
fot ·ms compt ·i sed the tht ·ee-month foll ow- up data. The t·emai ni ng fot ·ms, 
along with the final Relaxation Monitor-ing Scale wet·e t·equested to be 
kept and t·etut·ned at the end of the next menstt ·ual cycle (posttest) 
to the Community Clinic t·ecepti oni st. 
Fot ·ty-one of the subjects wet ·e tt ·eated by this author ·. Fout · of 
the subjects who completed the study wet ·e tt·eated by another · female 
gt ·aduate student in psychology. Tt-aining sessions for· this ther·apist 
wet ·e r-igot·ous and consisted of t·ole playing, t·eading Bot·kovec and 
Bet·nstei n1 s Pt-ogt ·essi ve Relaxation Tt·ai ni ng (1973), l eat·ni ng success-
ful t·elaxation het·self, and familiat"izing het ·self with the specific 
tt·eatment outlines ( see Appendices M, N, and 0). Thr thet ·api st was 
obset·ved completing actual sessions and was able to successfully (1) 
Table 4 
Skin Temperature Procedure Used in Session 4 
(Tape recorded treatment) 
3 min. "relaxation through recall" and 3 min. 
/ cued breathing (R) ~
BL ~ "relaxation through recall, "cued BL 
~breathing and hierarchy items 11-14 (C) 
#1 self-administered relaxation and #2 
3 min. 
--4 6 minutes self-administered--? BL 
relaxation for all groups 
#3 
hierarchy items 11-14 (D) 
BL= 3 minutes of Baseline 
+:> 
~ 
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utilize the tt ·eatment outlines to pt ·esent the tt ·eatment t·ati onal e in 
a t·elaxed and compt ·ehensive manner , (2) maintain the ordet · of topics 
as pt ·esented in the tt·eatment outlines , and (3) t·espond appt ·opt·iately 
and knowledgeably to the common types of questions asked by subjects. 
Subjects who had t·ecently completed the it- menstrnal pet ·i ods 
pt ·iot · to the pt·etest intet ·view , but had fewet · than 25 days t·emaining 
in theit · cycles (appt·oximately those in days 10-18 of theit · respec-
tive cycles) wet ·e asked to fi 11 out one set of the dependent measut ·es 
(RSS, MAS, MBS, and the MSD) fot · thei t· recently completed cycle and 
wet·e given anothet · to fill out at the end of theit · upcoming mens t t·ual 
pet'i od. These subjects wet·e told that a woman's menstt ·ual expet ·i ence 
could vat-y from month to month , and gaining data about two pat ·ticulat · 
cycles would give the t·eseat ·chet · mot·e infot ·mation about how theit-
pat ·ti cul at · menstrnal expet ·i ence vat ·i ed. Except fot · fi 11 i ng out two 
sets of measut·es pt'i ot · to tt·eatment , these subjects wet·e tt ·eated 
identically to the t·emaining subjects. 
Measut ·es 
Both d_ysmenonhea-cl assi fyi ng and di scomfot ·t-assessi ng measut ·es 
wet ·e selected to advance the pt ·esent study' s stated put·poses and 
evaluate the pt·oposed hypotheses compar-ing the effects of t·elaxation 
only, desensitization only, and t·elaxation plus desensitization on 
the symptoms of pt'i mat·y dysmenonhea in t·el ati on to type of dysmenot ·-
r-hea. 
Dysmenonhea-Cl assi fyi ng Measut·e 
As stated above, two types of measur·es wer·e used in the pr·esent 
study. One type was an instr ·ument designed to assess the kind of 
dysmenonhea expet'i enced by the subjects and classify this 
dysmenonhea into either· a congestive or· a spasmodic subtype. The 
dysmenonhea-cl assi fyi ng measur·e used was the Menstr-ual Symptom 
Questi onnait-e ( MSQ). 
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The Menstr ·ual Symptom Questionnafre (MSQ) (Appendix H) is a 25-
item , factor · analyzed questionnait-e that loads on two factor·s: spas -
modic and congestive dysmenonhea. Twenty-four · of the 25 items ar ·e 
statements about symptoms , with five r·esponse choices r·eflecting the 
degr ·ee to which the symptom is exper ·ienced by the r·espondent. Twelve 
of the 24 items ar ·e char ·acter ·istic of spasmodic and 12 chat ·actet ·istic 
of congestive dysmenonhea . The final item consists of two pat ·a-
gr·aphs desct ·i bing each type of dysmenonhea. The subject is asked to 
select the pat ·agt ·aph which most accut ·ately t·efl ects het · condition. 
The mor·e a score is below 77, the mot·e congestive the dysmenon ·hea it 
r·efl ects; the mor·e a scot ·e is above 77 , the mot·e spasmodic the dys-
menonhea. Total scor ·e test-r·etest t·el i abi 1 i ty is t·eported to be .78 
(Chesney & Tasto, 1975a). Classification of subjects on this dimen-
sion was pt ·edictive of systematic desensitization effectiveness for · 
dysmenonheic women in one study (Chesney & Tasto, 1975b) and not 
pt ·edictive in othet ·s (Balick et al., 1982; Hart et al., 1981; Webster · 
et al., 1979). 
In the pt ·esent study , the Menstrual Symptom Questionnafre scot ·e 
fot · each subject was calculated . Test scor·e r·ange was 29-125; 
scot·es fot· subjects of the pt·esent study t·anged from 55-94. Scot·es 
from 29-76 at·e classified by Chesney and Tasto (1975a) as scot·es 
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t·efl ecti ng congestive dysrnenonhea, and scot·es from 78-125 t·epot ·tedly 
t·efl ect spasmodic dysmenonhea. 
MSQ scot·es fot· the subjects at·e pt·esented in gt·aph fot·m in 
Figure 1. Of the fot·ty-fi ve subjects, thit-ty-fout · scot·ed in the 
congestive t·ange, nine scot·ed in the spasmodic t·ange, and two sub-
jects scor ·ed at the test midpoint (77) and wet·e thet·efot ·e unclassifi-
able. Because of this t·ange of scot ·es, the Spasmodic vs. Congestive 
hypothesis could not be statistically evaluated due to the di set·ep-
ancy in the number · of subjects suffet·ing from each type of dysmenor ·-
t·hea. 
It is notewot·thy to t·efet· back to Table 1 and t·eca ll that 73% of 
all subjects completing tt·eatment complained of menstr ·ual symptoms, 
while the MSQ only classified 20% of subjects as suffer-i ng from 
spasmodic dysmenon ·hea. Such t·esul ts cast continued skepticism on 
the t·eliability of the MSQ to classify dysmenon-hea suffet ·et·s. 
Di scomfot·t-Assessi ng Measut ·es 
The second type of instt ·ument used in the pt ·esent study measur ·ed 
the intensity and dur ·ation of pain and discomfot ·t associated with 
subjects' dysmenonhea expet·ience. A set·ies of fout · instt ·uments wet·e 
used to detet·mine amount and intensity of the subjects' discomfort 
The measut·es used ar ·e the Retr·ospective Symptom Scale (RSS), the 
Menstt·ual Semantic Diffet·ential (MSD), the Menstr ·ual Activities Scale 
(MAS), and the Menstt ·ual Behavior· Scale (MBS). These "discomfot ·t-
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NUMBER 
OF SCORES 
Scores on Menstrual Symptom Questionnaire 
Figure 1. Distribution of subjects' scores on the Menstural 
Symptom Questionnaire. 
• indicates congestive type symptoms. 
0 indicates spasmodic type symptoms. 
~ indicates neither symptom type. 
Note: The possible range in test scores was 29 to 125, with a mid-
point of 77. The actual range in test scores was 55 to 95, 
with a median of 72.5, and a mode of 76. 
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assessing measut ·es" were al so used to assess the change in amount of 
dysmenonhea that was expet ·ienced by the subjects ovet · time, and wet·e 
administet·ed pt ·iot · to tt ·eatment, aftet · tt·eatment, and at tht·ee-month 
follow-up. 
The Retrospective Symptom Scale (RSS) (Appendix D) 1 ists 18 
symptoms: the first symptom is ct ·ampi ng , the next 14 symptoms are 
systemic somatic complaints , and the last tht ·ee at·e emotional indi-
cator·s. Each symptom t·eceives a frequency and a severity t·ati ng. 
The frequency seal e on the RSS t·efl ects the i ntet·val of the fl ow 
pet ·i od. The scale al so t·ecot·ds medication usage and hout·s of bed 
rest due to menstruation. The RSS gives a global retr·ospective index 
of di stt ·ess and was used by Tasto and Chesney (1974), Chesney and 
Tasto (1975b), Cox (1976), and Duson (1977). A dect ·ease in scot·es 
t·efl ects a decrease in dysmenonhea symptoms. 
The Menstt ·ual Semantic Diffet·ential (MSD) (Appendix E) is a 
semantic diffet ·ential with seven-point scales between seven polat · 
adjectives such as "good/bad" and "clean/dit'ty." The subject is 
asked to indicate the degt·ee of feeling she has concerning het · last 
menstr ·ual pet'iod. The scales wet·e developed by Mullen (1968) and 
disct ·iminated change in his study and in Cox and Meyet ·'s (1978) but 
did not t·eflect change in Tasto and Chesney's (1974) study. 
The Menstt·ual Activities Scale (MAS) (Appendix F) was con-
structed by Chesney and Tasto (1975b) fot · the pUt·pose of assessing 
the extent to which a woman's expet·ience of menstt·ual pain and dis-
comfort alters her chat ·actet'istic behaviors. The scale consists of 
six questions for · which five t·esponses at·e: (1) vet·y often, (2) to 
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an extent, (3) sometimes, (4) not vet ·y often , (5) never·. The MAS was 
used in the pt·esent study to detet·mi ne the degree to which dysmenot ·-
t·hea intet·fet ·es with subjects' normal activities. The scot"ing of 
this scale is t·evet ·sed so that a dect ·ease in scot ·es on all scales 
consistently indicates a positive change. 
Reliability data fot · the Rett ·ospective Symptom Scale, the Men-
str ·ual Semantic Diffet ·ential , and the Menstr ·ual Activities Scale at ·e 
pt ·ovided by Chesney and Tasto (1975b) , when the tht ·ee scales wer·e 
administet·ed ten weeks befor ·e tt·eatment , immediately befot ·e tt·eat-
ment , and two months follow i ng tt ·eatment . When t-tests wet·e pet ·-
fot·med on the data , no significant di ffet ·ences wet·e found between 
scot ·es on the fit-st and second admi ni str ·ati ons , suggesting test-
t·etest t·eliability fot · all tht ·ee scales. Duson (1977) similat ·ly 
noted that con-elations between administt ·ations six weeks apat ·t on 
these scales wet ·e .74 fot· the Rett·ospective Symptom Scale , .75 fot · 
the Menstr-ual Semantic Diffet ·ential , and .97 fot · the Menstt ·ual 
Activities Scale. 
The Menstt ·ual Behavior Scale (MBS) (Appendix G) was constt·ucted 
by Duson (1977) to supplement the MAS. The scale lists ten behaviot ·s , 
each of which is t·ated on the extent to which the subject's last 
menstr ·ual period led her · to engage in that activity. Behaviot ·s 
included at ·e pain t·esponses such as staying in bed, taking aspit-i n, 
and et·ying. Items at·e t·ated on a five-point scale. Duson (1977) 
t·epot·ted that scot ·es on this seal e wer·e highly con-elated (V = .80) 
with scot ·es on the MAS. Test-r ·etest t·el i abi 1 i ty on this seal e was 
.85 (Duson, 1977). 
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Hyrotheses Tests 
Experimental Treatment hypothesis. To test the hypothesis that 
thtre is no difference in the degree of experienced distress of 
pr1mary dysmenorrhea between experimental groups exposed to four 
se~sions of either (a) individual relaxation training, (b) individual 
de~ensitization training, or (c) individual relaxation plus desensi-
ti,ation training, the posttest score means of the three experimental 
trEatment groups were compared. A one-way analysis of variance was 
calculated. The alpha level for testing the hypothesis was set at 
.05. 
Time hypothesis. To test the hypothesis that there is no 
cifference in the degree of experienced distress of primary 
cysmenorrhea in experimental groups exposed to four treatment 
sessions prior to treatment compared to after exposure to the four 
treatment sessions, t-tests for correlated means were conducted on the 
p:>sttest scores of all of the dependent measures (RSS, MSD, MBS, MAS, 
rredication units consumed, and invalid hours), to compare pretest 
~i th posttest means. To determine if symptom improvement was main-
nined at three-month follow-up, t-tests for correlated means were 
onducted on the follow-up scores on the dependent measures to com-
pire posttest with follow-up means. The alpha level for testing the 
hrpothesis was set at .05. 
Spasmodic vs. Congestive hypothesis. As noted above, this 
h1pothesis could not be evaluated statistically due to the discrep-
a1cy in the number of subjects reporting spasmodic-type dysmenorrhea 
anl those t·epot ·ti ng congestive type. 
A d1 i ti on al An al y s i s 
Tt·eatment component data wet ·e tested by computing one-way 
anilyses of vat ·iance to compat ·e tr·eatment gt ·oup diffet·ences in (a) 
nunbet· of home pt·actices, (bl levels of t·elaxation achieved while 
pt · cticing, and (c) skin tempet·atut·e measut ·es dut'ing Session 4. Fot · 
al analyses the alpha level was set at .05. 
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Data collected dut ·i ng the desensi ti zati on pt·ocedut·es admi ni s-
te ·ed to the Desens i ti zati on and the Combination Gt·oups dut ·i ng tt·eat-
me1t wet ·e analyzed using the chi-squat ·e test of significance. The 
al1ha level fot · this analysis was also set at the .05 level. 
Lastly, data of the subjects who wet·e tested twice pt ·io t· to 
tt ·iatment wet·e analyzed using one-way analyses of vat ·iance fot · each 
of the four · dependent vat'i ables, fot · invalid hout ·s, and fot · medi ca-
ti cn units consumed to detet ·mine the significance of any obser-ved 
di fer ·ences among means. The t-test fot · con-elated means wet ·e con-
ducted on the Pt-etest 1 and Pt-etest 2 scot·es of al 1 of the dependent 
meiSUt·es to compat·e mean scot ·es of this gr·oup dut ·i ng the pt ·ett·eatment 
i n1et ·va l. 
Results of these analyses will be pt ·esented in Chapter · IV. 
CHAPTER IV 
RESULTS 
The purpose of this study was to compare the effects of rel axa-
tion only, desensitization only, and relaxation plus desensitization 
on the symptoms of pt ·imat ·y dysmenonhea in t·el ation to type of dys-
menonhea. Hypotheses were then pt ·esented to fot ·ward the study' s 
stated put ·pose. The t·esul ts of the analyses which tested these 
hypotheses will next be pt ·esented. 
For· ot ·ganizational put ·poses, each hypothesis and the accom-
panying statistics used fot · data analysis will be pt ·esented sepat ·ate-
ly. Finally, additional analyses of data collected dut'ing tt ·eatment 
will be t·eported. These treatment components include: (a) skin 
tempet ·atut ·e measut ·es , (b) repot·ted pt·actice data , including numbet · of 
pt ·actices and level of t·elaxation achieved , (c) desensitization 
tt ·aining data , and (d) data of subjects tested twice pt ·iot · to tt ·eat -
ment. 
Expet ·imental Tt·eatments 
The expet ·i mental treatment hypothesis posits no difference in 
the degr ·ee of expet'i enced di stt ·ess of pt'i mat·y dysmenon ·hea between 
expet'imental gt ·oups exposed to fout · sessions of eithet · (a) individual 
t·elaxation tt ·aining, (b) individual desensitization tt ·aining, ot · (c) 
individual t·elaxation plus desensitization tt ·aining. 
This hypothesis was tested using one-way analyses of variance. 
The four· dependent measut·es used to test this hypothesis at·e 
discussed sepat ·ately in the following sections. 
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A. Retrospective Symptom Scale (RSS) 
Analysis was made by conducting a one-way analysis of variance 
that used the RSS posttest scores as the dependent variable and the 
three treatment conditions as the independent variable. 
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Before this analysis was conducted, the comparability of RSS 
scores for each group was determined. The RSS scores at pretest 
appeared to be discrepant (see Table 5) (Desensitization Group Mean 
75.1, Relaxation Group Mean 78.4, Combination Group Mean 68.3). An 
analysis of variance was calculated to determine if pretest scores 
were statistically different from each other. Results of analysis of 
variance on pretest RSS scores indicated that the three groups were 
comparable at pretest before intervention began [F (2,37) = 0.24, p > 
.8]. 
Posttest means were then analyzed, and are presented in Table 6. 
Results indicate no differences at posttest among the three treatment 
groups [F (2,38) = 0.5, p >.6]. 
The experimental treatments hypothesis, which postulated that 
there would be no differences among the means of the treatment groups 
on the RSS, was confirmed . The analysis of variance results indi-
cated that the differences among the means were not statistically 
significant at the .05 level. This hypothesis was accepted for the 
RSS measure. 
Medication units. The RSS includes an item that evaluates the 
number of pills of any type consumed by subjects as a result of 
menstrual distress. Analysis of this item was made by conducting a 
one-way analysis of variance that used the posttest report of medica-
Table 5 
Retrospective Symptom Scale Pretest, Posttest and 
Follow-up Means and Standard Deviations by Treatment Group 
Groups 
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Desensitization Relaxation Combination 
Pretest Mean 75.1 78.4 
(Standard Deviation) (31.3) (29.0) 
n 15 14 
Posttest Mean 44.5 52.5 
(Standard Devi ation) ( 32. 7) ( 31. 9) 
n . 14 14 
Foll ow- up Mean 38.4 30.3 
(Standard Deviation) (30.4) (18. 5) 
n 13 11 
Table 6 
Retrospective Symptom Scale Analysis of Variance 
of Posttest Scores by Treatment Groups 
Groups 
Error 
Total 
Sums of squares 
956.6 
35733.2 
36689.8 
df 
2 
38 
40 
Mean 
squares 
478.3 
940.3 
F ratio 
0.5 
68.3 
(25.4) 
15 
49.8 
(26.1) 
15 
53.9 
(32.5) 
9 
Probability 
level 
0.605 (n.s.) 
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ti on uni ts consumed as the dependent vat'i able and the tht·ee tr ·eatment 
conditions iiS the independent vat·i able. Posttest means analyzed, and 
t·esults pt·esented in Table 7, indicate no diffet ·ences at posttest 
among the tht ·ee tt·eatment gt ·oups (p = .439). Table 8 pt ·esents means 
and standat ·d deviations fot· all gr·oups at pt·etest., posttest, and at 
foll ow-up. The gt·oup means scot·es at pt·etest wet·e extt·emely si mi 1 at ·. 
(Desensi ti zati on Gt·oup mean = 5.4, Relaxation and Com bi nation Gt·oups 
means= 5.5). Posttest mean scot·es wet·e less similar · with the Relax-
ation Gr·oup mean 4.3 compat·ed to the Desens i ti zati on Gr-oup mean of 
2.0 and the Combination Gt·oup mean of 2.8. 
Invalid hout ·s. The finnl item on the RSS evaluated the t·epot ·ted 
numbet · of extt ·a hout ·s spent in bed due to dysmenon-heic symptoms. 
Tab 1 e 9 pt ·esents the means and standat ·d deviations fot· the 
tht·ee tt ·eatment gr·oups on this measut ·e. Pt ·etest means indicates a 
possible diset ·epancy among gt ·oups on this measut·e at pt·etest (Desen -
sitization Mean= 6.1, Relaxation Mean= 3.1, Combination Mean= 
3.1 ). An analysis of vat·i ance was calculated to detet·mi ne if pt·etest 
invalid hour· scot·es of the tht·ee tt-eatment gt ·oups wer·e stntistically 
di ffer ·ent from each other ·. Results of this analysis of vat·i ance on 
pt·etest item scot ·es t·evealed that the tht·ee gt·oups wet·e compar ·able at 
pt ·etest befot ·e inter ·vention began [F(2,36) = 2.39, p = 0.106]. 
Results of the analysis of vat'i ance on posttest scot·es al so indicate 
no diffet·ences among gt·oups (p = .214). These t·esul ts at ·e pt·esented 
in Table 10. 
The expet·i mental tt·eatments hypothesis, which postulated that 
thet·e would be no di ffet·ences among the means of the tt ·eatment gt·oups 
.Table 7 
Reported Medication Units Consumed Analysis of 
Variance of Posttest Scores by Treatment Groups 
Groups 
Error 
Total 
Table 8 
Sums of squares 
42.2 
1053.9 
1095.9 
df 
2 
42 
44 
Mean 
squares 
21.1 
25.1 
F ratio 
.84 
Reported Medicati on Units Consumed Pretest, Postest, 
Follow-up Means and Standard Deviations by Treatment 
Groups 
Desensitization Relaxation 
Pretest Mean 5.4 5.5 
(Standard Deviation) (4.5) ( 3. 5) 
n 14 15 
Posttest Mean 2.0 4.3 
(Standard Deviation) ( 2. 5) (7.2) 
n 15 15 
Follow-up Mean 3.8 3.3 
(Standard Deviation) (3.5) (2.5) 
n 12 11 
and 
Probability 
1 evel 
0.439 
Group 
57 
Combination 
5. 5 
( 5. 9) 
15 
2.8 
( 4. 2) 
15 
3. 3 
(2.9) 
9 
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Table 9 
Reported Invalid Hours Pretest, Posttest and Follow-up 
Means and Standard Deviations by Treatment Group 
Groups 
Desensitization Relaxation Combination 
Pretest Mean 6.1 3.1 3.1 
(Standard Deviation) (5.9) ( 2 .1) (2.6) 
n 14 14 15 
Posttest Mean 3.3 1.9 1.1 
(Standard Deviation) (4.1) ( 2. 0) ( 1. 3) 
n 15 15 15 
Follow-up Mean 2. 5 1.3 3.2 
( Standard Deviation) (2.6) ( 1.3) (6.4) 
n 13 11 9 
Table 10 
Reported Invalid Hours Analysis of Variance 
of Posttest Scores by Treatment Groups 
Groups 
Error 
Total 
Sums of squares 
19.2 
226.7 
245.9 
df 
2 
38 
40 
Mean 
squares 
9.6 
6.0 
F ratio 
1.60 
Probability 
1 evel 
0.214 
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on the invalid hour ·s measur ·e, was confit·med. The analysis of var ··i-
ance r·esul ts indicate that the di ffer ·ences among the means wer·e not 
statistically significant at the .05 level. This hypothesis was 
accepted fot· the invalid hour ·s i tern on the RSS. 
B. Menstr·ual Behavior· Scale (MBS) 
Analysis was made by conducting a one-way analysis of variance 
that used the MBS posttest scor·es as the dependent var ·i able and the 
tht·ee tt·eatment conditions as the independent vat'iable. Results of 
this analysis ar ·e pr·esented in Table 11, and indicate no significant 
differ·ences among tr ·eatment gr·oups (p = .818). Pr·etest, posttest, 
and foll ow-up means and standat·d deviations of this measur·e acr·oss 
the tht ·ee groups at·e pr·esented in Table 12. This table r·eflects the 
homogeneity of the MBS scor·es acr·oss the thr·ee gr·oups at pt ·etest, 
posttest,and foll ow-up. The l at ·gest mean di ff e r·ence between gr·oups 
in the table is noted at follow-up; even this differ ·ence is less than 
2 points (Desensi ti zati on Gr-oup Mean = 14.9, Relaxation Gt·oup Mean = 
15.2, Combination Gt·oup Mean= 16.4). A decr ·ea se in the MBS scor ·e 
t·efl ects a decr ·ease in the extent to which subjects r·epor·ted engaging 
in pain-mitigating behavior·s. 
The exper-imental tr ·eatments hypothesis, which postulated no 
di ffer ·ences among the means of the tr·eatment gr·oups on the MBS, was 
confit-med. The analysis of var-iance r·esults indicated that the 
diffet·ences among the means wer·e not statistically significant at the 
.05 level. This hypothesis was accepted for· the MBS measur·e. 
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Table 11 
Menstrual Behavior Scale Analysis of Variance 
of Posttest Scores by Treatment Groups 
Mean 
Sums of squares df squares 
Groups 7.9 2 3.9 
Error 740.9 38 19.5 
Total 748.8 40 
Table 12 
F 
Menstrual Behavior Scale Pretest, Posttest, and 
Probability 
ratio level 
0.20 .818 (n.s.) 
Follow-up Means and Standard Deviations by Treatment Group 
Groups 
Desensitization Relaxation Combination 
Pretest Mean 23.8 23.2 22.4 
(Standard Deviation) (5.5) ( 6. 7) (5.5) 
n 14 15 14 
Posttest Mean 16.7 16.1 15.7 
(Standard Deviation) ( 5. 0) (4.6) ( 3. 4) 
n 15 15 15 
Foll ow-up Mean 14.9 15.2 16.4 
(Standard Deviation) (3.0) (3.0) (4.0) 
n 13 11 9 
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C. Menstt·ual Semantic Differ ·ential (MSD) 
Analysis was made by conducting a one-way analysis of vat ·i a nee 
that used the MSD posttest scot·es as the dependent var·iable and the 
tht·ee tt ·eatment conditions as the independent vat·i able. Results of 
this analysis at ·e or·esented in Table 13, and indicate no differ ·ences 
at oosttest among the tht·ee tr ·eatment gt·ouos (o = .769). The means 
and standat·d deviations fot · the tht ·ee tr ·eatment gt·oups at·e pt ·esented 
in Table 14. It should be noted that a t·eduction in scor ·e means 
r·efl ect a t·educti on in negative attitudes. 
The expet ·imental tt ·eatments hypothesis, which postulated no 
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di ffet ·ences among the means of the tt ·eatment gt·oups on the MSD, was 
con fit-med. The analysis of vat ·i ance t·esults indicated that the 
diffet ·ences among the means wet·e not stat i stic a lly significant at th e 
.05 l evel. This hypothesis was accepted fot · the MSD measur ·e. 
D. Menstt·ual Activities Scale (MAS) 
Analysis was made by conducting a one - way analysis of variance 
that used the MAS posttest scot ·es as the dependent var ·i able and the 
tht ·ee tt·eatment conditions as the independent vat"i ab 1 e. Results of this 
analysis at ·e pt ·esented in Table 15, and indicate no differ·ences among 
tt ·eatment gr·ouos (p = 0.60). Pt-etest, post test, and fol 1 ow-up means 
and standat ·d deviations at·e pt ·esented in Table 16. 
The expet"i mental tt·eatments hypothesis, which postulated no 
di ffet·ences among the means of the tt ·eatment gr·oups on the MAS, was 
confit-med. The analysis of vat"iance t·esults indicated that the 
diffet ·ences among the means wet ·e not statistically significant at the 
.05 1 evel. This hypothesis was accepted fot· the MAS measur·e. 
Tablel3 
Menstrual Semantic Differential Analysis of Variance 
of Posttest Scores by Treatment Groups 
Groups 
Error 
Total 
Table 14 
Sums of squares 
42.0 
3019.5 
3061.5 
df 
2 
38 
40 
Mean 
squares 
21.0 
79.5 
F ratio 
0.26 
Menstrual Semantic Differential Pretest, Posttest, and 
Probability 
level 
.769 (n.s.) 
Follow-up Means and Standard Deviations by Treatment Group 
Groups 
Desensitization Relaxation Combination 
Pretest Mean 33.3 36.2 33.6 
(Standard Deviation) (7.2) (10.4) ( 8. 6) 
n 15 15 14 
Posttest Mean 27.0 27.8 25.6 
(Standard Deviation) (8. 7) (8.3) (10.6) 
n 15 13 14 
Follow-up Mean 23.6 25.4 23.6 
(Standard Deviation) (7.5) (8.6) ( 11.0) 
n 11 11 9 
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Table 15 
Menstrual Activities Scale Analysis of Variance 
of Posttest Scores by Treatment Groups 
Sums of squares 
40.5 
1143.3 
1183 .8 
df 
2 
38 
40 
Mean 
squares F ratio 
Groups 
Error 
Total 
20.2 
30.1 
0.67 
Probability 
1 evel 
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0.516 (n.s.} 
Table 16 
Menstrual Activities Scale Pretest, Posttest, and 
Follow-up Means and Standard Deviations by Treatment Group 
Groups 
Desensitization Relaxation 
Pretest Mean 18.6 20.3 
(Standard Deviation) (5.6) ( 4. 9) 
n 14 15 
Posttest Mean 14.5 14.9 
(Standard Deviation) ( 5. 7) (5.2) 
n 15 15 
Follow-up Mean 13.6 13.7 
(Standard Deviation) (4.8) ( 2. 8) 
n 13 11 
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Combination 
18.6 
( 5 .o) 
15 
13. 9 
(6.0) 
15 
14.8 
( 4. 7) 
9 
Time 
The ti me hypothesis posits no di ffet ·ence in the degt ·ee of expe-
t·i enced di stt ·ess of pt ·imar ·y dysmenorrhea in experimental gt ·oups 
exposed to four · tt ·eatment sessions pt·iot · to tt ·eatment compat·ed to 
after · exposure to fout · tt ·eatment sessions. 
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This hypothesis was tested using t-tests fot · con-elated samples. 
The fout · dependent measut ·es used to test this hypothesis at ·e dis-
cussed sepat·ately in the following sections. 
A. Ret r·ospective Symptom Scale (RSS) 
t-tests of si gni fi cance fot · con ·el ated samples wet·e conducted to 
compat ·e pt ·etest to posttest means of the RSS to exam i ne if subjects 
repot ·ted t·educed symptomato 1 ogy aft e r· tt ·eatment i nte t·venti on. On the 
RSS, a s on al 1 the dependent measut ·es , a decr ·ease in mean scot ·es 
t·efl ects a deet ·ease in t·epot ·ted symptoms. t - test t·esul ts at ·e pt ·e-
sented below in Table 17. Even though thet ·e wet·e no diffet ·ences 
among gr-oups, al 1 treatment gt ·oups expet'ienced a decr ·ease in repot ·ted 
symptoms as measut ·ed by the RSS. The Relaxation Gt·oup obtained the 
highest pt ·etest mean (i.e. , mot·e and/or · mot·e sevet ·e symptoms). 
Al though stat ·ti ng with mor·e t·epot ·ted di stt ·ess at pt ·etest , at posttest 
Relaxation Gt·oup scot ·e means wet·e similar · to that of the Combination 
Gr-oup (p = .020). The Combination Gt·oup scot·ed the lowest on the RSS 
at pt ·etest (i.e., fewer- and/ot · less sevet·e symptoms). Their · posttest 
scot ·es indicated the least amount of impt ·ovement and posttest score 
mean wer·e similar · to that of the Relaxation Gt·oup (p = .013). The 
Desensi ti zati on Gt·oup pt ·etest scot ·e means wet ·e midway between the 
Table 17 
t-test for Correlated Means Conducted 
on Pretest and Posttest Means by Treatment 
Group on the Retrospective Symptom Scale 
Mean Differences 
(Probability level) 
* = p .2. .05 
Desensitization 
26.3 
(.001)* 
Groups 
Relaxation 
29.4 
(. 020 )* 
Combination 
18.5 
(.013)* 
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Combination and the Relaxation Grnups (e.g., modet ·ate number· and/ot · 
modet·ate levels of symptoms). Posttest scor ·es indicated the most 
i mpt·ovement in symptoms ( p = .001) fot · this gt·oup. These findings 
will be fur·ther· discussed in Chapter · V. 
Posttest to foll ow-up t-tests for · con-elated samples wer·e then 
conducted to detet·mine whether· ot · not subjects maintained symptom 
r·educti on tht-ee months l atet ·. Results of these analyses ar ·e pt·e-
sented in Table 18, and indicate no diffet ·ences in mean scor·es fr·om 
posttest to follow-up on the RSS, thus indicating that symptom r·educ-
ti ons wer·e maintained thr ·ee months l atet ·. The Relaxation Gr·oup 
obtained the highest pr·etest mean, and scor ·ed the lowest follow - up 
mean, t hus indicating the highest and/or · most sever ·e symptoms at 
pr·e t es t, and the most amount of symptom i mpt·ovement at fo 11 ow-up 
(Mean= 30.3, p = .141). The Combination Gt·oup, who obtained the 
lowest pr·etest mean, scot ·ed the highest mean scor ·es at follow-up, 
thus suggesting the lowest amount of symptom impr ·ovement at follow-up 
(Mean = 53.9, p = .681 ). The Desens i ti zati on Group scor·ed between 
the other · two gr·oups at pr ·etest and at follow-up, thus indicating 
moder ·ate initial levels of symptomatology and moder ·ate impt·ovement at 
foll ow-up (Mean = 38.4, p = .160). Some gr·oup attt ·i ti on is noted at 
foll ow-up on the RSS (Desensi ti zati on Gr·oup = 13, Relaxation Gr·oup = 
11, Combination Gr·oup = 9). These t·esults will be fur ·thet · discussed 
i n Ch apter· V. 
The time hypothesis, which postulated that thet ·e would be no 
di ffer·ences between means of any of the tt ·eatment gr·oups on the RSS, 
from pt ·etest to posttest, was r·ejected. The t-test for· con-elated 
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Table 18 
t-test for Correlated Means Conducted 
on Posttest and Follow-up Means by Treatment 
Group on the Retrospective Symptom Scale 
Mean Differences 
(Pr obability level) 
Desensitization 
8.2 
(.160) 
Groups 
Relaxation 
13. 7 
(. 141) 
Combination 
2.6 
( .681) 
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samples t·esul ts indicated that the di ffet ·ences between the means in 
all thr ·ee tt ·eatment gt·oups from pt ·etest to posttest wet·e statistical-
ly significant at the .05 level. This hypothesis was t·ejected fot· 
the RSS measur·e. 
Medication units. The RSS includes an item that evaluates the 
numbet · of pi 11 s of any type consumed by subjects as a t·esul t of 
menstr ·ual distr·ess. Analysis of this item was made by conducting t-
tests of si gni fi cance for- con-elated samples to compar-e pr·etest to 
posttest means of medication units consumed to deter ·mine if tr ·eatment 
i nter-venti on t·educed medication consumption. These t·esul ts ar·e pr·e-
sented in Table 19. Even though thet·e wer-e no differ ·ences among 
gr·oups, both the Desensitization and the Combination Gt·oups expet ·i -
enced a decr ·ease in medication units consumed (i.e. , extr ·a medica-
tions r·equit-ed to manage dysmenonheic symptoms) aft e r· tr ·eatment 
i nter-venti on. The Relaxation Gt·oup did not expet ·i ence a si mil at · 
dect ·ease in extr ·a medications t·equit-ed (p = .555). The t·esul ts of 
these analyses will be fut ·thet· discussed in Chapter· V. 
Finally, posttest to follow-up t - tests of significance fot · cot ·-
t·el ated samples wet·e conducted to detet ·mi ne if (in the case of the 
Desensi ti zati on and the Com bi nation Gr·oups) dect·eased medication 
uni ts consumed was maintained at thr ·ee-month foll ow-up. For· the 
Relaxation Gt·oup, this statistic was calculated to detet·mine if the 
number · of medication units consumed at posttest was maintained at 
foll ow-up. Results of these analyses at·e pt ·esented in Table 20, and 
indicate no diffet·ences in mean scot·es of medication units consumed 
from posttest to foll ow-up fot· the Desensi ti zati on and the Relaxation 
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Table 19 
t-test for Correlated Means Conducted 
on Pretest and Posttest Means by Treatment 
Group on Medication Units Consumed 
Mean Differences 
(Probability level) 
* = p ~ .05 
Table 20 
Desensitization 
3.8 
( .006)* 
t-test for Correlated Means Conducted 
Groups 
Relaxation 
1.1 
( .555) 
on Posttest and Follow-up Means by Treatment 
Group on Medication Units Consumed 
Mean Differences 
(Probability level) 
* = p ~ .05 
Desensitization 
-2.2 
(.123) 
Groups 
Relaxation 
-1.6 
(.008)* 
Combination 
2.7 
( .039 )* 
Combination 
.6 
(.686) 
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Gt·oups {p = .123 and .686, t·espectively). At 1J1t·ee-month follow-up, 
the Relaxation Gt·oup had i nct ·eased the uni ts of medications consumed; 
that is, had wot·sened on this index of disability from posttest to 
foll ov,.-up. This t·esul t wi 11 al so be fut ·thet· discussed in Chaptet · V. 
As with the othet · measut·es, gt ·oup attt"i ti on at posttest is noted 
on this measut·e (follow-up "n's" t·ange from 9 to 12 subjects). These 
t·esul ts will be fut·thet · discussed in Chaptet · V. 
The time hypothesis, which postulated no diffet ·ences between the 
means of any of the tht·ee tt ·eatment gt·oups on medication units con -
sumed from pt ·etest to posttest, was t·ej ected. The t - test fot · con ·e-
1 ated samples t·esul ts indicated di ffet ·ences between means in the 
Desensi ti zati on and the Com bi nation Gt·oups at posttest wet ·e s t ati s-
ti cal ly signficant at the .05 level. The time hypoth e sis was 
ac cepted fot · the t·epot ·ted medication uni ts consumed measut·e fot · the 
Relaxation Gt·oup, and t·ejected fot · the Desensitization and the Com-
bination Gt·oups. 
Invalid hout ·s. The final item on the RSS evaluated the t·epor·ted 
number · of ext.t ·a hout ·s spent in bed due to dysmenonheic symptoms. 
To evaluate the time hypothesis, t-tests of significance fot · 
con-elated samples wet ·e conducted to compat ·e pt·etest to posttest 
means of the invalid hout ·s measut ·e fot · each tr ·eatment gr·oup. Results 
of the t-test at·e pt·esented in Table 21. Even though thet ·e wet ·e no 
di ffet ·ences among gr·oups, all gt ·oups expet"i enced a dect ·ease in extt·a 
hout ·s spent in bed due to symptoms (p = .007, .042, and .002, t·espec-
tively. As noted in Table 21, mean diffet·ences among the thr ·ee 
gt·oups wet·e vat ·ied, t·anging from 3.4 (Desensitization Gt·oup) to 1.3 
Table 21 
t-test for Correlated Means Conducted 
on Pretest and Posttest Means by Groups 
on Reported Invalid Hours 
Mean Differences 
(Probability level) 
* = p 2 .05 
Desensitization 
3.4 
(.007)* 
Groups 
Relaxation 
1.3 
(. 042 )* 
Combination 
2.0 
(. 002 )* 
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(Relaxation Gr-oup). These mean differ ·ences r·eflected the initial 
differ·ences noted at pr ·etest (Desensi ti zati on Gr·oup Mean Score = 6.1, 
Relaxation Gr·oup Mean Scor ·e = 3.1, Combination Gr·oup Mean Scor ·e = 
3.1). These findings will be fur ·thet· discussed in Chapter · V. 
Posttest to foll ow-up t-tests of si gnfi cance for · con-elated 
samples wer·e al so conducted to deter ·mi ne whether · or· not subjects 
scor·ed differ ·ently on the invalid hours measur·e from posttest to 
tht·ee-month follow-up. Results of these analyses ar·e pr·esented in 
Table 22, and indicate no differ ·ences in mean scor ·es from posttest to 
follow-up on the invalid hout ·s measur ·e. These r·esults indicate that 
symptom r·eduction was maintained for· all tr ·eatment gr·oups at tht ·ee-
month follow-up. As in the RSS, gr·oup attt'ition is noted at follow -
up, with the Combination Gr·oup losing the most subjects (Combination 
Gt·oup = 9, Relaxation Gr·oup =- 11, Desensitization Gr·ouo = 13). These 
r·esul ts wi 11 be fur ·ther · discussed in Chapter· V. 
The time hypothesis, which postulated that thet ·e would be no 
di ffet ·ences between the means of any of the tr ·eatment gr·oups on the 
invalid hour·s measur ·e from pt·etest to posttest, was r·ejected. The t-
test for· con-elated sample r·esults indicate that the differ ·ences 
among the means wer·e statistically significant at the .05 level. 
This hypothesis was t·ejected for· the invalid hour·s item on the RSS. 
B. Menstr·ual Behavior · Scale (MBS) 
Analysis was made by conducting t-tests of significance for · 
conel ated samples to compar·e pr·etest to posttest means of the MBS to 
examine if subjects r·epot ·ted a r·eduction in engaging in pain-miti-
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Table 22 
t-test for Correlated Means Conducted 
on Posttest and Follow-up Means by Groups 
on Reported Invalid Hours 
Mean Differences 
(Probability level) 
* = p 2 .05 
Desensitization 
0.5 
( . 570) 
Groups 
Relaxation 
-3.0 
( . 689) 
Combination 
-2.2 
(.355) 
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gating behaviot·s aftet· tt ·eatment. Results of the t-tests at·e pt·e-
sented in Table 23. Cleat·ly, even though thet·e wer·e no diffet ·ences 
among gt·oups, all tt·eatment gt·oups expet·i enced a dect·ease in the 
number· of pain-mitigating activities in which they engaged (Desensi-
tization Gt·oup p = .000, Relaxation Gt·oup p = .004, Combination Gr-oup 
p = .001 ). Mean di ffet ·ences from pt ·etest to posttest wet·e al so 
si mil at· fot · all tht·ee tt·eatment gt ·oups (Desensi ti zati on Gt·oup = 6.9, 
Relaxation Gt·oup = 7.1, Combination Gt·oup = 6.8). These findings 
wil 1 be fut ·thet· discussed in Chapter· V. 
Lastly , posttest to follow-up t-tests of significance fot · con-e-
lated samples wet ·e conducted to detet·mine whether · ot · not tt ·eatment 
gr·oups maintained a dect ·ease in their · t·epot ·t of pain-mitigating 
activities. Results of these analyses at·e pt ·esented in Table 24 and 
indicate no differences in mean scot ·es from posttest to follow-up on 
the MBS, thus indicating that the t·eduction in pain-mitigating 
behavi ot·s was maintained tht ·ee monthe 1 atet · (Desensi ti zati on Gt·oup p 
= .212, Relaxation Gt·oup p = .513, Combination Gt·oup p = .656). 
The time hypothesis, which postulated no diffet·ences between the 
means of the tt·eatment groups on the MBS from pt ·etest to posttest, 
was t·ejected. The t-test fot · con-elated samples t·esul ts indicated 
that the diffet·ences between the means wet·e statistically significant 
at the .05 level fot· all tht·ee tt·eatment gt·oups from pt ·etest to 
posttest. The time hypothesis was t·ejected fot · the MBS measut·e. 
C. Menstt ·ual Semantic Diffet·ential (MSD) 
Analysis was made by conducting t-tests of significance fot · 
con-elated samples to compat ·e pt·etest to posttest means of the MSD, 
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Table 23 
t-test for Correlated Means Conducted 
on Pretest and Posttest Means by Treatment 
Group on the Menstrual Behavior Scale 
Mean Differences 
(Probability level) 
* = p ~ .05 
Table 24 
Desensitization 
6.9 
( .000)* 
t-test for Correlated Means Conducted 
Groups 
Relaxation 
7.1 
( . 004 )* 
on Posttest and Follow-up Means by Treatment 
Group on the Menstrual Behavior Scale 
Mean Differences 
(Probability level) 
De sensitization 
1.2 
( .212) 
Groups 
Relaxation 
-0.7 
(. 513) 
Combination 
6.8 
( .001 )* 
Combination 
0.7 
( • 656) 
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to examine if subjects t·epot·ted a t·eduction in negative attitudes 
towat·d menstt ·uati on aftet· tt·eatment. It should be noted that a 
dect ·ease in scot ·e means t·efl ects a t·educti on in negative attitudes. 
Results of the t-test at·e pt·esented in Table 25, and t·efl ect a si g-
nifi cant dect·ease in negative ot·ientation towat ·d menstt ·uation after 
tt ·eatment fot· al 1 tht·ee tt ·eatment gt ·oups. The Relaxation Gt·oup 
obtained the highest pt·etest mean (i.e., mot·e and/ot · mot·e pt·onounced 
negative attitudes towat·d menstt ·uation). This gt·oup also t·eflected 
the highest posttest mean, although the posttest mean was vety simi-
1 at · to that of the Desensi ti zati on Gt·oup (Relaxation Gt·oup posttest 
mean 27.9, p = .017; Desensitization Gt·oup posttest mean 27.0, p = 
.021 ). The Com bi nation Gt·oup scot ·ed midway between the othet · two 
tt ·eatment gr·oups at pr·etest (35.4 vs. 33.3 and 34.2). Howevet ·, thei t· 
posttest scor ·e was near·ly two points 1 ower · than the other · two tt·eat-
ment gt ·oups (25.7, p = .006). 
Posttest to foll ow-up t-tests of si gni fi cance for· con ·el ated 
samples wet ·e al so conducted to detet·mine whether · ot· not subjects 
maintained a t·eduction in negative attitudes towar ·d menstt ·uation at. a 
tht ·ee-month follow-up. Results of these analyses at·e pt·esented in 
Table 26 and indicate no differ·ence in mean scot·es from posttest to 
follow-up on the MSD. These t·esults give indication that negative 
attitude r·eduction was maintained at tht·ee-month fol low-up. Gt·oup 
means at follow-up wet·e extt·emely similar · fot · the Desensitization and 
the Combination Gr·oups (Mean = 23.6). Relaxation Gt·oup mean was 
slightly higher · at follow-up (Mean = 25.7). Some gr·oup attt"ition is 
noted at follow-up (Desensitization Gt·oup = 11, Relaxation Gt·oup = 9, 
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Table 25 
t-test for Correlated Means Conducted 
on Pretest and Posttest Means by Treatment 
Group on the Menstrual Semantic Differential 
Mean Differences 
(Probability level) 
* = p _s_ . 05 
Table 26 
Desensitization 
6.3 
(.017)* 
t-test for Correlated Means Conducted 
Groups 
Relaxation 
7.5 
(.021)* 
on Posttest and Follow-up Means by Treatment 
Group on the Menstrual Semantic Differential 
Mean Differences 
(Probability level) 
Desensitization 
3.1 
(.154) 
Groups 
Relaxation 
0.9 
(. 780) 
Combination 
8.5 
( .006 )* 
Combination 
4.0 
(.213) 
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Combination Gt'Oup = 9). These t·esul ts wi 11 be fut·thet · discussed in 
Chaptet· V. 
The time hypothesis, which postulated no diffet·ences between the 
means of the tt ·eatment gt·oups on the MSD ft·om pt ·etest to posttest, 
was t·ejected. The t-test fot · conel ated samples t·esults indicated 
that the di ffet·ences between the means in a 11 tht·ee tt·eatment gt·oups 
from pt ·etest to posttest wet ·e statistically significant at the .05 
level. This hypothesis was thet·efot·e t·ejected fot · the MSD measur ·e. 
D. Menstt·ual Activities Scale (MAS) 
Analysis was made by conducting t-tests of significance fot · 
con ·el r1ted samples to compat·e the thr ·ee tt ·eatment gt"Oup means from 
pr·etest to posttest on the MAS. Results of the t-tests ar ·e pt ·e sented 
in Table 27, and r·eflects a decr ·ease in the extent to which subjects 
al ter ·ed their- usua ·1 behavior · in r·esponse to menstr-uation. Reduction 
in scor ·es (as noted in Table 27) r·eflect a r·eduction in the extent 
that subjects r·epor ·ted deviating from their· cha r·acter·i sti c behavior · 
because of their · menstr ·ual cycles. The Relaxation Gr·oup, which 
scor ·ed slightly higher · at pr·etest, al so scor ·ed slightly higher · than 
the other · two tt ·eatment gr·oups at posttest (pr ·etest mean - 14.9, p = 
.003). Both the Desensitization and the Combination Gr·oups scor ·ed 
simil ar·ly at pr·etest and postest (pr·etest mean for· both = 18.6, p = 
.003). 
Posttest to foll ow-up t-tests for · conel ated samples wer·e con-
ducted to deter·mine whether· or· not subjects maintained tr ·eatment 
gains (in this case, a maintained t·eduction in the modification of 
80 
Table 27 
t-test for Correlated Means Conducted 
on Pretest and Posttest Means by Treatment 
Group on the Menstrual Activities Scale 
Mean Differences 
(Probability level) 
* = p ~ .05 
Desensitization 
4.5 
( .003)* 
Groups 
Relaxation 
5.4 
( .003 )* 
Combination 
4.7 
(.003)* 
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char ·actet'i sti c behavi or ·s due to menstt-ual cycle) at thr ·ee-month 
follow-up. Results of these analyses ar ·e pr·esented in Table 28 and 
indicate no differences in mean scor ·es from posttest to follow-up on 
the MAS. These r·esults indicate that the tr ·eatment gains wer·e main-
tained. Gr·oup mean scor·es at follow-up were similar · for · the Desensi-
tization and the Relaxation Gr·oups (Mean 13.6 and 13.7, r·espective-
ly). Combination Gr·oup scor ·ed slightly higher · at posttest (Mean = 
14.8). Some gr·oup attt'ition was also noted in follow-up (Desensiti-
zation Group= 13, Relaxation Gr·oup = 11 , Combination Gr·oup = 9). 
These r·esults will be fur ·ther· discussed in Chapter· V. 
The ti me hypothesis, which postulated no differ ·ence between the 
means of any of the treatment gt·oups on the MAS from pr·etest to 
posttest , was r·ejected. The t-test for · con-elated samples r·esul ts 
indicated that the di ffer ·ences between the means in all three tr ·eat-
ment gr·oups from pretest to posttest wet·e statistically significant 
at the .05 level. The time hypothesis was r·ejected for · the MAS 
measure. 
Spasmodic vs. Congestive Dysmenonhea 
The spasmodic vs. congestive hypothesis posits no differ ·ence in 
the degr ·ee of experienced di stt·ess of pr·imary dysmenonhea between a 
gr·oup exper·iencing spasmodic dysmenon ·hea and a gr·oup expet'iencing 
congestive dysmenon·hea. 
As noted in the pr·evi ous chapter ·, the di sct ·epancy between the 
number · of subjects in each of the two conditions pr·ecluded the calcu-
lation of eithet · a two-way analysis of vat'iance statistic or· a chi-
squat·e statistic to test the hypothesis. When the thr·ee tr ·eatment 
Table 28 
t - test for Correlated Means Conducted 
on Pretest and Posttest Means by Treatment 
Group on the Menstrual Activities Scale 
Mean Differences 
(Probability level} 
Desensitization 
0.5 
(. 647} 
Groups 
Relaxation 
0.6 
(.745} 
Combination 
0.0 
( 1.0} 
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gr·oups wer·e divided into spasmodic and congestive types, only thr·ee 
spasmodic dysmenonhea subjects wer·e classified in each gr·oup. Table 
29 pr·esents these data in tabul at · for·m. 
This hypothesis, which postulated no differ·ence between the 
dependent var ·iables' means for· the congestive-type dysmenonhea gr·oup 
and the spasmodic-type dysmenonhea gr·oup, was ther·efor·e not test-
able. 
Skin T emper·a tu r·e Mea su r·es 
As t·epor ·ted in Chapter· III, subject skin temper·atur·e was meas-
ur·ed dur·ing Session 4. These measur ·es of skin temper·atur·e wer·e 
aver ·aged thr ·oughout Session 4 over· t ht ·P.e-mi nute uni ts of ti me. Hie 
fit-st thr·ee-minute unit constituted the baseline skin temper ·atur ·e 
(BL1). At thi s point the taped r·elaxation and/or · de sensitization 
tt ·a ining commenced. The tape t·ecor ·ded tr·aining vat'ied in length 
among the gr-oups, from 9 minutes (Desensitization Gr-oup) to 21 
minutes (Combination Gr·ouo). All subjects' skin temper·atur ·e data 
continued to be aver ·aged over · thr·ee-mi nute uni ts of ti me dur·i ng the 
taped tr ·a ining. 
After · the tape r·ecor·ded tr ·ai ni ng, a second thr·ee-mi nute baseline 
skin temper ·atur·e measur ·e was made (BL2 ). Following BL2 , each subject 
was instr-ucted to self-administer· the r·elaxation and/or· desensitiza-
tion pr·ocedur-es outlined in the tape for · six minutes (SA1 & zl. 
Lastly, the thit-d and final thr·ee-rninute baseline skin temper ·atur ·e 
measur ·e was collected (BL3 ). 
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Table 29 
Subject Type of Dysmenorrhea by Treatment Group 
Group 
Type of 
Dysmenorrhea Desensitization Relaxation Combination 
Spasmodic 3 3 3 
Congestive 12 12 12 
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These skin tempet·atut·e measut·es wet ·e obtained fot· the put·pose of 
detet·mining whethet· a non-subjective measut·e of t·elaxation con ·elated 
with subjective t·epot ·ts of t·elaxation (Luthe, 1969). 
Means and standat·d deviations fot · these data at·e pt ·esented in 
Table 30. Skin tempet·atut·e means by tt ·eatment gt·oup at Baseline 1 
ar-e similat·. (Desensitization Mean= 91.03, Relaxation Gt·oup Mean= 
90.00, Combination Gt·oup = 89.69.) No tt·eatment gt·oup exceeded a 
1 ° F change at any point in Session 4, al though all gt·oups r-epot ·ted 
some slight incr-ease in tempet ·atut ·e dut'ing theit· t·espective taped 
tt·eatment sessions . 
Skin temper ·atut ·e means wet·e analyzed using one-way analyses of 
vat·iance. The thr·ee-minute avet·aged skin tempet·atut ·e means at Base-
line1, Tt·eatment Segment 3, Baseline2, Self-Administt·ation, and Base-
l i ne 3 set ·ved as the dependent vat'i able and the tht-ee tt·eatment condi --
tions as the independent vat ·iables. None of these analyses wet·e 
significant , thus indicating no diffet·ences among the tht ·ee tr ·ea tment 
gt·oups. These t·esults at ·e pt ·esented in Table 31. t-tests of signif-
icance fot · conel ated samples wet ·e then conducted to compat·e the 
baseline means to each othet · and to tt ·eatment 3 to deter ·mine if skin 
tempet ·atut ·e incr·eased in a pat ·ticulat · gt ·oup ovet · time in Session 4. 
The tempet·atut ·e compat·i sons that wet ·e made wet ·e: 
(a) Baseline 1 to Baseline 2 
(b) Baseline 1 to Tt-eatment 3 
(cl Baseline 2 to Baseline 3 
Results of these analyses at ·e pt·esented below in Table 32. Thet ·e 
wet·e no diffet ·ences between Baseline 1 and 2 in any of the tht ·ee 
Table 30 
Session 4 Skin Temperature Means and 
Standard Deviations by Groups 
Group 
Desensi tization · Relaxation Combinati on 
(Standard ( St andard ( Standard 
Mean Deviation) n Mean Deviation) n Mean Deviation) n 
Base li ne1 91.03 (3.88) 12 90.00 (5. 91) 12 89.69 ( 4. 77) 14 
Treatment 91.50 (3.88) 12 90.02 (6 .08) 12 90.20 (5 .66) 14 
Segment 1 
Treatment 91.76 (3 . 99) 12 90 . 17 (6 .27) 12 90.37 (5.40) 13 
Segment 2 
Treatment 91.1 5 (4.07) 12 90. 39 ( 6 .10) 11 90.47 (5 . 26) 13 
Segment 3 
Treatment 90.37 (6 . 15) 11 90.39 (5 .15) 13 
Segment 4 
Treatment 90.39 (5 .82) 9 90.45 (5 . 34) 13 
Segment 5 
Treatment 90. 50 (5 .46) 13 
Segment 6 
Treatment 90.22 (5 . 43) 13 
Segment 7 
Baseline 2 91.40 (3 . 13) 12 90. 34 (5 . 96) 11 89.94 (4.85) 14 
Self- 90.97 (3 .04) 12 90.06 (5 . 78) 11 89.55 (4.99) 13 
Administration 
Segment 1 
Self - 90. 63 ( 3 .17) 12 90.48 (6:12) 11 89.23 (5 .06) 12 
Administration 
Segment 2 
Baseline 3 90.42 (3 . 13) 12 90.21 (5.86) 11 89.07 (5.06) 12 
Table 31 
Skin Temperature Means Analysis of 
Variance F Ratios and F Probabilities 
Time 
Baseline 1 
Treatment 3 
Baseline 2 
Baseline 3 
F Ratio 
.259 
.077 
.328 
.275 
Probabi 1 i ty 
. 773 
.926 
.723 
.762 
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Table 32 
Skin Temperature Means T-Tests for 
Correlated Means 
Groups 
Times Desensitization Relaxation Combination 
Baseline 1 Mean 
-.37 .160 -.26 
to Differences 
Baseline 2 
(Probability ( . 700) ( • 726) (. 660) 
1 eve 1 ) 
n 12 11 14 
Baseline 1 Mean 
-1.17 1.00 
-8 .00 
to Differences 
Treatment 3 
(Probabi l ity ( . 898) ( . 783) ( . 277) 
level) 
n 12 11 13 
Baseline 2 Mean .98 .13 . 72 
to Differences 
Baseline 3 
(Probability (.026)* ( . 650) (.001)* 
1 eve 1 ) 
n 12 11 12 
*p ~ . 05 
tt-eatment gr·oups. Al though al 1 gr·oups showed a slight warming tr ·end 
from Baseline 1 to Baseline 2, these differ·ences wer·e not signifi-
cant. t-t.ests of significance compar·ing Baseline 1 mean skin tem-
per ·atur·e scor ·es to Tr·eatment segment 3 scor ·es al so r·efl ected no 
differ ·ences in mean skin temper·atur ·e scor ·es over· time in any of the 
thr ·ee tr ·eatment gr·oups. 
On compar ·ison thr ·ee, which compar ·ed Baseline 2 to BaselinP 3, 
skin temper ·atur ·e means for · each of the thr·ee tr ·eatment gr·oups, both 
the Desensi ti zati on and the Combination Gr·oups evidenced a deet·ease 
in skin temper·atur ·e means over · time . The Relaxation Gr·oup had no 
c hange in skin temper ·atur ·e means from Baseline 2 to Baseline 3. 
The se r·esul ts wi 11 be fur ·ther · discussed in Chapter· V. 
Pr·acti ce Measur ·es 
As outlined in Chapter · III , each subject was given a Relax a tion 
Monitor·ing Sc a l e (RMS) after · each of the four · tr ·eatment se ssions to 
r·ecor ·d her · home pr·acti ce exper-i ence and was col 1 ected at each succes -
sive session and at follow-up. Both the number · of times a subject 
r·epor ·ted pr·acti ci ng at home and the r·epor·ted 1 evel of r·el axati on 
achieved wer·e r·ecor·ded on this seal e. These data ar·e pr·esen t ed 
below, along with r·esults of the statistical analyses per ·for ·med. 
"Pr·actice Segment #1" r·efer ·s to those home pr ·actices between Sessions 
1 and 2, "Pr·actice Segment #2" r·efer·s to those between Sessions 2 and 
3, "Pr·acti ce Segment #3" r·efer·s to those pr·acti ces between Sessions 3 
and 4, and "Pr·acti ce Segment #4" r·efer·s to those pr·acti ces between 
Session 4 and post.test. The RMS was collected from each subject at 
Sessions 2, 3, 4, and at post.test. 
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The mP.an number· of pt·acti ces and standat·d deviations by t:t·eat-
ment gt·oup at ·e ot ·esented in Table 33. To analyze these data, four· 
one-way analyses of vat ·i ance wet ·e pet ·fot ·med to test for · di ffet ·ences 
among the gr·ouos in number · of ot·actices after · Sessions 1, 2, 3 , and 
4. The mean number · of pt ·acti ces wet·e used as the dependent vat·i able 
and the tht ·ee tt·eatment conditions wet·e used as the independent 
vat·i able. 
Results indicate no diffet ·ences in number · of pt·actices among the 
tht ·ee gr·oups in each of the pt ·actice segments (p = .40 3, .612, .695, 
and .690). Fot · the Desensi ti zati on Gt·oup, the highest mean pt ·ac t i ces 
wet ·e a ft.et· Session 1 (x = 9.9) but was also quite similar · to mean 
pt·actices in Segment #4 (x = 9.3). Fot · the Relaxation and Combina-
tion Grnups, the l at ·gest numbet· of pt·acti ces wen ~ in Segment #4, 
which was after· Session 4 and befot ·e post.test: (x = 10.1 and 8.3, 
t·espectively). Segment #1 mean pr ·actices wet ·e slightly fewer · (Relr1x -
ati on Gt·oup = 8.9, Com bi nation Gr-ouo = 8.1 ). Mean or·act:i ces wer·e 
somewhat lower· for· all gt ·oups after · Sessions 2 and 3 and r·efl ect the 
shor ·tet · length of ti me in these pr·acti ce segments. Ti me dur·i ng Seg-
ment #1 was 7 days; tht ·ee days of pt·acti ce wet ·e r·efl ected in Seg -
ments #2 and #3. Segment #4 length var ·ied by subject, but aopeat·ed 
to aver·age about 6 days. These r·esul ts wi 11 be fut·thet· discussed in 
Chapter · V. 
Home oractice level of t·elaxation. Individual r·eoor·ts of level 
of t·elaxation achieved by subjects wet·e on a 5-point scale t·anging 
ft ·om "vet ·y tense" to "extt ·emely t·el axed" ( see Ao pen di x K ). These 
five levels of t·elaxation wet·e assigned numbet ·s on a 1 to 5 point 
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Table 33 
Number of Home Practice Units by Treatment 
Group for Each Practice Segment 
Probability 
Practice Level of the 
Numbers Desensitization Relaxation Combination Conducted AN0VA 
Practice X 9.9 8.9 8 .1 
Segment #1 (SD) ( 4 .1) (3.3) (2. 7) n.s. 
n 15 14 14 .403 
Practice X 7.6 6.9 6.5 
Segment #2 (SD) ( 4 .1) ( 3. 0) ( 2 .1) n.s. 
n 15 15 15 .612 
Practice X 7.5 8.4 7.6 
Segment #3 (SD) ( 3. 0) ( 3. 2) (3.4) n.s. 
n 15 15 15 .695 
Practice X 9.3 10.1 8.3 
Segment #4 (SD) (6.4) (5.1) (4.0) n.s. 
n 15 14 13 .690 
scale. Mean levels of r-elaxation fot· each pr·actice segment wet·e 
calculated fot · each subject by summing the levels of r-elaxation 
t·epot·ted and dividing the sum by the number · of completed pt ·ac tices 
subjects t·epor ·ted. The level of t·el axati on mean and standat ·d devi a-
tion data by tt·eatment gt ·oup at·e pt·esent e d in Table 34. Fout· on e-way 
analyses of vat ·i ance wet ·e then pet ·fot·med using the mean level of 
t·el axati on as the dependent vat ·i able and the tht·ee tt·eatment condi -
ti ons as the independent vat ·i able. These analyses wer·e made to 
detet ·mi ne if thet ·e existed any diffet·ences among the gt·oups in the 
level of t·elaxation t·epor-ted dur ·i ng any of the four· pt ·actice seg -
ments. 
Results of these analyses indicate no differ ·ences among the 
93 
gr·oups in the level of t·elaxation achieved dut ·ing home pt·actice fot · 
pt ·actice Segments #1 and #2 (p = .360 and .216, t·espectively). Fot· 
pt ·ac ti ce Segments #3 and #4, these analyses indicated di ffet ·ences among 
the tht·ee tt ·eatment gr·oups in the level of t·elaxation achieved dut ·ing 
home pr·acti ce ( p = .053 and .013 fot· Pr·acti ce Segments 3 and 4 ). To 
deter ·mine which of the tht·ee tr·eatment gr-oup means wer·e different, 
multiple r·ange tests wet·e computed using the Scheffe pt·ocedur ·e. As 
r-ecommended in Fer-guson (1976), a .10 alpha level was used to detet·-
mine significance. Results of these tests ar ·e pr·esented in Table 34. 
As can be observed from this table, in Pr·acti ce Segment #3, 
thet ·e was a di ffet·ence between the t·epot·ted level of t·el axati on 
between the Desensi ti zati on Gt'Oup and the Com bi nation Gt·oup, with the 
Combination Gt·oup t·epot ·ting a deeper· level of t·elaxation. In Pr·ac-
tice Segment #4, it was the Relaxation Gt·oup that t·epor·ted a deeper· 
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Table 34 
Mean Level of Home Relaxation by Treatment 
Group for Each Practice Segment 
Groups Probability 
Practice Level of the 
Segments Desensitization Relaxation Combination Conducted ANOVA 
Practice X 4.5 4.7 5.1 .360 
Segment #1 (SD) ( 1.6) ( 1.0) ( 1.0) 
n 15 14 14 
Practice X 4.9 5.3 5.6 .216 
Segment #2 (SD) ( 1.3) ( 1. 2) (0.9) 
n 15 15 15 
Practice X 4.7** 5.5 5.9** .053 
Segment #3 (SD) ( 1.6) ( 1.6) (0 . 5) 
n 15 15 15 
Pr actice X 4.3** 6.0** 5.4 .013 
Segment #4 (SD) ( 2 .1) ( 1.1) ( 1.1) 
n 15 14 13 
**indicates means significantly different from each other as indicated by 
multiple range test. 
level of t·el axation than the Desensitization Gt·oup. These t·esul ts 
wi 11 be fut·thet· discussed in Chapter· V. 
Visualization Data 
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As outlined in Chapter · III, both the Desensitization and the 
Combination Groups wet·e exposed to 14 menstt ·ual i maget·y i terns as pat ·t 
of their · t·espective tt·eatments (Reich, 1972). Finger-signal systems 
wer·e established with each subject so that data wet·e collected on 
each subject's t·epot ·ted ability to (a) imagine the items, (b) expe-
rience tension, and (c) successfully t·el ax away the tension. The 
put ·pose of collecting these data was to determine if thet ·e wer·e any 
di ff et ·ences bet ween the t wo tt·ea tment gt"Oups' t·epor ·ted expet ·i e nce of 
this desensitiz a tion pt·ocess. 
Each of the 14 hiet ·at ·chy items was pt·esented twice to ea ch 
subject. Fot · each of the 28 pt ·esentations, data wet·e collected to 
detet ·mi ne: 
1. whethet · ot · not the subject successfully visualized the 
image; 
2. if the subject vi sua 1 i zed the i tern, whethet · ot · not the 
subject expet·i enced tension; and 
3. ~ the subject expet'ienced tension, whethet · ot · not the 
subject successfully t·elaxed the tension away in the length 
of time pt·ovi ded ( appt ·oximately 1 minute). 
Responses for · the 28 pt·esentati ons wet·e summed and put into 
tht·ee 2 x 2 tables with gt·oup membet·ship as one classification and 
pt·esence or· absence of the tht·ee t·epot ·ts as the other · cl assifi cation. 
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The chi-squat·e statistic was calculated (Fet ·guson, 1976) to detet ·mine 
if thet ·e existed diffet·ences between the Desensitization and Combina-
tion Gt·oups in the expet ·ience of visualization, the expet ·ience of 
tension while visualizing, and the ability to successfully t·elax the 
tension away. The t·esults of these calculations at·e pt ·esented in 
Table 35, and t·eveal no diffet·ences between gt ·oups in the t·epot·ted 
expet ·ience of the desensitization pt ·ocess. The number · of times 
subjects t·epot ·ted expet'iencing tension betw een the two tt ·eatment 
gt·oups appt ·oached but did not t·each statistical significance (p > 
.06) . These t·esul ts wi 11 be fut ·thet· discussed in Chapter · V. 
Subjects Tes t ed Twi ce Pt'io t· 
t o Tt·eatment 
As pt·eviously not e d, subje c ts who wet·e cont acted on appt ·oxima te-
ly day 10-18 of their · t·espective menstt ·ual cycles wer ·e asked to fill 
out one set of the dependent measut ·es (RSS, MAS, MBS, and the MSD) 
fot · the i r· t·ecently completed cycle, and wet ·e given another· set to 
fill out at the end of theit · upcoming menstt ·ual pet ·iod. Thet ·efot ·e, 
these subjects wet·e admi ni stet·ed the pt ·etest measut ·es on two occa -
sions, these being appt ·oximately two weeks apat ·t, and both pt'iot · to 
tt ·eatment. These "twice tested" subjects wet ·e t·andomly di str-ibuted 
into the tht ·ee tr ·eatment gt·oups. These subjects wet·e asked to com-
plete these fot·ms twice in an attempt to maintain their · intet·est in 
par-ticipating in the study dut·ing the two ot · so weeks of lag time 
befot ·e the it- tt ·eatment could begin. 
Six one-way analyses of vat ·iance wer·e calculated using pt ·etest 
scot ·es on the fout · dependent measut·es, invalid hout ·s, and medication 
Table 35 
Visualization. Experience of Tension. and 
Experience of Relaxation During Desensitization 
by Treatment Group 
Visualize 
Experienced 
Visualization 
Yes 
No 
Experience Tension 
Experienced 
Tension 
Yes 
No 
Relax Tension Away 
Experienced 
Relaxation 
Yes 
No 
Desensitization 
396 
23 
Group 
Combination 
350 
32 
N = 801 
x2 = 2.60s. P > .10 
Group 
Desensitization 
139 
148 
Combination 
114 
164 
N = 565 
X2 = 3.15, p > .06 
Group 
Desensitization 
109 
139 
Combination 
87 
104 
N = 439 
X2 = 0.115, p > .70 
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units consumed as the dependent variables and the "twice tested" 
gr·oup, and the t·emaining subjects in the tht ·ee tr·eatment conditions 
as the independent var-iable to deter ·mine if this "twice tested" gr·oup 
wet·e differ ·ent from the t·emaining gr·oup membet·s in each of the tht-ee 
tt·eatment gr·oups. Results of these analyses at ·e presented in Tables 
36-41. No di ffet·ences between these "twice tested" subjects and the 
t·emaining subjects wet·e found. F t·atio levels of significance t·anged 
f r·om .2 to .8. 
Lastly, t-tests fot· con-elated samples wer·e calculated to detet ·-
mine if there existed any diffet·ences in the scot·es between the fit-st 
and the second pt·etest administt·ation fot · these subjects. These 
t·esul ts ar·e pt·esented in Table 42. No di ffet ·ences between the two 
pt·etest administt ·ation wet·e noted, so these "twice tested " subjects 
wet·e no 1 onger · consi det·ed a unique gr·oup. These t·esul ts wi 11 be 
fut ·thet · discussed in Chapter · V. 
Table 36 
Retrospective Symptom Scale Analysis of Variance 
of Pretest Scores Comparing "Twice Pretested" Subjects 
with Remaining Subjects in the Three Treatment Groups 
Sum of Mean 
squares Of squares F ratio 
Group 956.56 2 478.28 0.509 
Error 35733.19 38 940.35 
Total 36689.75 40 
Table 37 
Menstrual Behavior Scale Analysis of Variance 
of Pretest Scores Comparing "Twice Pretested Subjects 
with Remaining Subjects in the Three Treatment Groups 
Sum of Mean 
sguares Df squares F ratio 
Group 7 .87 2 3.9 0.202 
Error 740.91 38 19.50 
Total 748.78 40 
Significance 
1 evel 
0.605 n.s. 
Significance 
1 evel 
0.818 n.s. 
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Table 38 
Menstrual Semantic Differential Analysis of Variance 
of Pretest Scores Comparing "Twice Pretested" Subjects 
with Remaining Subjects in the Three Treatment Groups 
Sum of Mean 
squares Of squares F ratio 
Group 42.03 2 21.02 0.264 
Error 3019.48 38 79.46 
Total 3061. 51 40 
Table 39 
Menstrual Activities Scale Analysis of Variance 
Pretest Scores Comparing "Twice Pretested" Subjects 
with Remaining Subjects in the Three Treatment Groups 
Group 
Error 
Total 
Sum of 
squares 
40.49 
1143.26 
1183. 75 
Of 
2 
38 
40 
Mean 
squares 
20.25 
30.09 
F ratio 
0.673 
Significance 
1 evel 
0.769 n.s . 
Significance 
level 
0.516 n.s. 
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Table 40 
Invalid Hours Analysis of Variance of Pretest 
Scores Comparing "Twice Pretested" Subjects with 
Remaining Subjects in the Three Treatment Groups 
Group 
Error 
Total 
Table 41 
Sum of 
squares 
19.19 
226.71 
245.90 
Df 
2 
38 
40 
Mean 
squares 
9.60 
5.97 
F ratio 
1.609 
Medication Units Consumed Analysis of Variance of 
Pretest Scores Comparing "Twice Pretested" Subjects 
with Remaining Subjects in the Three Treatment Groups 
Group 
Error 
Total 
Sum of 
squares 
42.18 
1053.73 
1095.91 
Df 
2 
42 
44 
Mean 
squares 
21.09 
25.09 
F ratio 
0.841 
Significance 
level 
0.214 n.s. 
Significance 
level 
0.439 n.s. 
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Table 42 
t-tests of Significance Comparing Pretest 1 and 
Pretest2 of "Twice Tested" Subjects 
Mean T-
Measure difference value 
RSS -4.47 
-0.78 
MBS 2.33 1.34 
MSD 0.53 0.22 
MAS 1.89 1.48 
Invalid Hours 0.57 0.69 
Medication Units -0.69 
-0.52 
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2-tailed 
probability 
0.449 n.s. 
0.200 n. s. 
0.829 n.s. 
0.161 n.s. 
0.500 n.s. 
0.611 n.s. 
Limitations 
CHAPTER V 
DISCUSSION 
A number of limitations exist that affect the interpretation of 
these data, and will be discussed first. Generalization of this 
study's findings should be tempered by a discussion of the study's 
threats to internal and external validity. 
First, like most other studies, the results were obtained pri-
marily with a college population of volunteers who responded to a 
"free treatment program" offered by the Psychology Department. This 
group cannot be assumed to be representative of all dysmenorrheic 
women on two counts, (1) they are volunteers, and (2) they are 
college women. Although an attempt was made to broaden this pool of 
subjects by inclusion of some individuals from a mental health center 
population, the fact of their "volunteerism" status remains. 
The persuasiveness of the follow-up data to suggest the main-
tenance of treatment gains after three months should be tempered by 
the knowledge that experimental mortality had reduced the groups' 
sizes. There is no way to determine if the reports from these non-
reporting subjects would have been the same as those reporting the 
maintenance of therapeutic gains. A second related factor is that 
the loss of subjects across treatment groups was not equal. There is 
no way to determine if this differential attrition was due to the 
differential treatments. 
The third area of experimental mortality possibly affecting the 
study's results involves the 14 subjects who either did not complete 
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treatment or did not complete posttesting. Again, there exists no 
way to determine if their response to treatment would have been the 
same as those subjects that did complete their participation. 
104 
Probably the major threat to internal validity involves the fact 
that, except for the skin temperature data, all other measures were of 
a self-report nature, and therefore subject to all the biases to which 
this type of data is heir. Treatment results may be simply due to 
therapist attention inherent to this treatment. A second rival 
hypothesis involves attributing the results to an attempt of subjects 
to please the researcher. All of these factors could have more 
strongly been ruled out with the use of a placebo treatment and/or a 
delayed-treatment control group. 
The study also would have been strengthened by the use of a 
delayed treatment control group to control for other events besides 
the experimental treatment that occurred for subjects between the 
pretest and posttest administrations. Without such a control group, 
possible history effects influencing the study's results cannot be 
completely ruled out. However, since data were collected over the 
course of 12 months, the effect of any one event affecting the treat-
ment results can be ruled out. 
The present study was proposed to include such a delayed-treat-
ment control group to control for changes due to the passage of time 
and/or test taking. Due to this writer's ill-fated attempt to treat 
her control group as quickly as possible, the individuals who were to 
constitute this control group were instead treated exactly the same 
as the other subjects with the exception of their contact with the 
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measures on two separate occasions prior to treatment. The delayed 
treatment strategy has been previously labeled as an ethically sound 
research technique; however, this writer responded strongly to the 
discomfort of her subjects and their interest in the alleviation of 
their discomfort. By attempting a solution in which they would 
obtain their treatment as quickly as any other subjects while she 
obtained her "control group data," this writer erred. However, due to 
her error, the scientific design of this study was affected. 
After this writer realized the import of her error, the possi-
bility of collecting this control group data after the treatment 
group's data had been collected was entertained. This solution was 
dismissed due to the major history problems that this solution engen-
ders. The recent surge of interest in PMS-related symptoms in the 
popular press (Kingston, 1983; Witzleben, 1983) is an example of such 
possible hi story effects. 
Previous research in this area utilizing delayed treatment con-
trol groups and/or placebo treatment groups (Duson, 1977; Chesney & 
Tasto, 1975b; Reich, 1972) have all resulted in no posttreatment 
changes in symptoms for the pseudotreatment or no treatment groups. 
These results lend some support to the minimal effects of time, test 
taking, and attention/placebo to treatment results in past litera-
ture, and suggest that the effects of these threats to internal 
validity may be negligible in the present study as well. However, 
such effects cannot be ruled out in the present study due to the lack 
of a control group. Therefore, the results of the present study may 
possibly be due to attention and/or placebo effects and may not be 
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unique to these treatments. 
The fact that some subjects were "twice-tested" at pretest al so 
raises the possibility that the contact with the dependent measures 
on two occasions somehow influenced these subjects to respond to the 
treatment intervention in a different manner than the rest of the 
subjects. However, the effect of this possible pretest/treatment 
interaction is equalized since these subjects were randomly assigned 
across the three treatment groups, so that any possible effects would 
be randomized across treatment groups. Despite this randomization, 
the possibility continues to exist that these "twice tested" subjects 
might have responded to the treatment in a different way than the 
other subjects due to their differential treatment. Not only might 
they have reacted to treatment in a different manner due to being 
tested twice, but their posttest scores may also reflect a regression 
toward the mean. 
With these limitations in mind, the findings of the present 
study will be next presented. 
The experimental treatments hypothesis was accepted. As pre-
sented in Chapter IV, on all dependent measures there existed no 
differences at posttest among the treatment groups in the amount of 
primary dysmenorrhea experienced. These results suggest that none of 
the three treatment groups were either more or less effective than 
the others in reducing subjects' degree of experienced distress of 
primary dysmenorrhea. 
Although there were no differences among treatment groups, 
results indicated that all three treatment groups were equally effec-
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tive in reducing symptoms, negative attitudes, pain-mitigating behav-
iors, and invalid hours. On all of these measures, the time hypoth-
esis was rejected. On only one measure, that of medication units 
consumed, were any differences noted among the groups in possible 
treatment efficacy. On this one measure, both the Desensitization 
and the Combination Groups decreased the ingestion of medication 
units after treatment; the Relaxation Group did not. Also, at the 
three-month follow-up, the Relaxation Group consumed more medication 
units than at posttest, while the remaining two treatment groups 
maintained the decrease in medication units consumed that was 
observed at posttest. 
It is difficult to ascertain if th e noted superiority of t he 
Desensitization and the Combination Groups over the Relaxation Group 
posttreatment in this one measure reflects any real difference among 
groups in total treatment effectiveness. Rather than using this 
result as reason to consider the Relaxation Group treatment as less 
effective than the other two treatments, it appears that these data 
can instead suggest that the Relaxation Group treatment should not be 
considered to be the behavioral treatment of choice of the three. 
Without this finding, practicality might suggest that the relaxation-
only treatment would be the treatment of choice in a clinical set-
ting, since it is as easy as the desensitization treatment to admin-
ister but has the added advantage of apparent utility for subjects in 
other stress and pain-related areas of their lives. However, because 
of the lack of any decrease in medication units consumed by the 
Relaxation Group, the desensitization-only treatment instead appears 
to be the treatment of choice. This treatment is far shorter time-
wise than the Combination Group treatment, and is apparently as 
equally effective. 
As outlined in Chapter I I I, it is important to remember that, 
although termed "desensitization," the treatment condition titled as 
such is not a technically pure desensitization treatment, since the 
original specifications required training in progressive muscle 
relaxation, and the construction of individualized hierar chies 
(Wolpe, 1958). The "desensitization" treatment used in the study 
mi ght be more rea l istically termed a "flooding" or "implosion" 
therapy. 
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The reduction of symptoms as measured by the RSS in the tre at-
ment groups of 40% (Desensit i zation), 33% (Rela xation), and 27% 
(Combination) fall somewhere midrange to t he 28% reduct i on reporte d 
by Tasto and Chesney (1974), the 32% reduction of Chesn ey and Tasto 
(1975b), and 23% reported by Hart et al. (1981), the 42% reduction 
noted by Reich (1972) and the 52% noted by Cox and Meyer (1978). 
These results tend to support the growing body of literature support-
ing the effectiveness of behavioral strategies in the tr eatment of 
dysmenorrhea. 
One of the most important findings of the present study was that 
the apparent improvement of dysmenorrheic symptoms was not dependent 
upon training in relaxation per~- The group exposed to no training 
in relaxation improved posttreatment as much as a group exposed to 
relaxation or a combination treatment. 
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Although not a necessary condition, relaxation training also 
appears to be a sufficient treatment in and of itself as well, since 
similar improvements were noted in the relaxation only group that 
were observed in the other two treatment groups. As noted previous-
ly, the only measure that did not support the equality of the relaxa-
tion training to the other two treatments was the measure of medica-
tion units consumed. 
Ancillary Analyses 
Skin temperature. As outlined in Chapter IV, the improvement in 
dysmenorrhea symptoms of the three treatment groups at posttest was 
not correlated to skin temperature changes. While some temperature 
changes over the course of Session 4 were significantly different 
(see Table 30), the overall increase was most generally less than one 
and one-half degrees. Therefore, statistical significance did not 
translate into any clinically appreciable increases in skin tempera-
tures. Since many biofeedback researchers indicate that a hand 
temperature increase of at least 2° Fis necessary to infer signifi-
cant hand warming control (Luthe, 1969), these results support pre-
vious findings (Balick et al., 1982; Cox & Meyer, 1978; Hart et al., 
1981) of no link between physiologic measures of relaxation and 
decrease in dysmenorrh~a symptomatology. 
There exist two other possible hypotheses to explain the skin 
temperature findings. First, the lack of significant hand warming 
may be due to a ceiling effect. Since the hand temperatures were 
initially so warm (e.g., 90° F), a significant increase in hand 
temperature would have been more difficult to accomplish as compared 
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to if subjects ' hands had been cooler (e.g., 82° F). Secondly, the 
lack of correlation of skin temperature to the improvement in dysmen-
orrhea symptoms might suggest the possibility that the wrong para-
meter was sampled. The possibility of utilizing EMG measures should 
instead be entertained, although in at least one study (Balick et 
al., 1982), EMG measures were also not correlated to a decrease in 
dysmenorrhea symptoms. 
Visualization data. No differences between the Desensitization 
and the Combination Groups on the ability to visualize, experience 
tension, and relax the tension away during desensitization training 
was noted. Apparently, whether or not subjects are exposed to train-
ing in relaxation does not appreciably affect the desensitization 
process as measured by these reports. 
Practice data. Analyses calculated to determine if ther e existed 
any differences in either the numbers of, or the level of rela xation 
in the home pra ct ice sessions among treatment groups found : 
1. There existed no differences in the number of home prac-
tices among groups in each of the four practice segments, 
and 
2. During practice segments 1 and 2, there were no differences 
in the levels of relaxation achieved among the three treat-
ment groups during home practice. Practice Segment #3 
revealed that the Combination Group reported experiencing a 
deeper level of relaxation during home practices than the 
Desensitization Group. In Practice Segment #4, the Relaxa-
tion Group reported experiencing a deeper level of relaxa-
tion than the Desensitization Group. 
These results indicate that neither the type of home practice 
nor the length of the home practice sessions affected the number of 
home practices completed. (The three groups' tape-recorded home 
practices varied in length quite a bit, with the Combination Group 
tapes about 30% longer in duration than the other two groups.) 
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Treatm ent strategies adopted from Cox (1976) made explicit 
efforts to encourage daily home relaxation practice for all treatment 
groups. Strategies involved providing tape recorded home relaxation 
instructions, requesting daily monitoring of relaxation experience 
(see Appendix K), and therapist phone calls to subjects between 
Sessions 2 and 3, and 3 and 4 (see Appendices M, N, and 0). Since 
daily home practices were strongly recommended by the researcher, the 
fact that all of the three treatment groups averaged one practice a 
day during each of the four practice segments is considered an indi-
cation of success in the motivation of subjects to consistently 
practice. Although subjects were encouraged to practice twice daily, 
practicing once daily was considered adequate for the study's pur-
poses, since symptom improvement had been previously noted by Cox and 
Meyer (1978) using a similar practice schedule. 
Regarding the level of relaxation achieved during home prac-
tices, results suggest a trend toward the two groups trained in 
relaxation (e.g., the Relaxation and Combination Groups) to report 
deeper levels of relaxation during home practice than the Desensiti-
zation Group during the last two practice segments. Two separate 
conclusions are suggested by this finding. Firstly, as noted before, 
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these data support the previous conclusion presented regarding the 
nonessential nature of the experience of relaxation to the successful 
behavioral treatment of dysmenorrhea. Secondly, these data give some 
indication that the two groups being taught relaxation were in fact 
taught to relax. These data, as presented in Figure 2, suggest a 
positive trend toward deeper relaxation in the Relaxation and the 
Combination Groups over the course of the four practice segments, but 
no trend toward deeper relaxation in the Desensitization Group. 
The present study did not utilize any reliability measures to 
confirm if the subjects' self-report home practice data were, in 
fact, reliable. This writer assumed that such measures were unneces-
sary since there appeared to be little reason for subjects to simu-
late these data. However, future research utilizing such self-report 
data could benefit from reports of significant others to confirm 
subjects' self-reports. 
Practical Significance 
The question of the clinical significance of any behavioral 
program is imperative to address. Statistical significance is of 
only passing interest if clinical significance is not also observed. 
The present study is a partial replication of the Cox (1976) 
study, also outlined by Cox and Meyer (1978). Cox's "Distressed 
Group" treatment is essentially the same as the present study's 
Combination Group treatment. As outlined previously in Chapter III, 
Cox compared his Distressed Group at pretreatment and at posttreat-
ment to a group of specifically "nondistressed" women (Nondistressed 
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Figure 2. Treatment group mean scores achieved during home pra c tice on 
Relaxation Monitoring Scale for practice segments 1, 2 , 3 
and 4 . 
indicates desensitization group. 
indicates relaxation group. 
indicates combination group. 
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Group) and a group of women thought to include a random distribution 
of women so as to assess an "average" distribution of symptoms (Norm-
ative Contra l Group). 
Figure 3 presents a visual comparison between the present 
study's Combination Group MSD scores and Cox's (1976) Distressed, 
Nondistressed, and Normative Control Group scores. Visual inspection 
reveals that the present study's mean score at pretest for the Com-
bination Group was similar to but somewhat lower than that of Cox's 
( 1976) Di stressed Group. This lower mean score at pretest reflected 
a possible lower level of initial negative attitudes toward dysmenor-
rhea reported by the present study's Combination Group. This trend 
of slightly less negative attitudes as measured at pretest was also 
reflected in the present study's Desensitization Group scores as 
compared to Cox's Distressed Group, as presented in Figure 4. The 
present study's Relaxation Group MSD score at pretest was very simi-
lar to Cox's Distressed Group scores; these data are presented in 
Figure 5. Posttest mean scores for the three treatment groups were 
extremely similar to that of Cox's Distressed Group, indicating a 
decrease across all groups in negative attitudes. Follow-up scores 
for the present study's three treatment groups were somewhat lower 
than those of Cox's Distressed Group. These results suggest a suc-
cessful replication of the Cox study by the present study's Combina-
tion Group MSD data, and extremely similar results to Cox's Dis-
tressed Group for both the Desensitization and Relaxation Groups. 
These data also indicate that the mean MSD scores fo r all of the 
present study's three treatment groups were significantly higher at 
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Figure 3. A comparison of combination group MSD scores and Cox's 
(1976) distressed, nondistressed and normative group 
scores at pretest, posttest and follow-up. 
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indicates combination group. 
indicates Cox's (1976) distressed group. 
indicates Cox's (1976) normative control group. 
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Figure 4. A comparison of desensitization group MSD scores and Cox' s 
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indicates relaxation group. 
indicates Cox's (1976) distressed group. 
indicates Cox's (1976) normative control group. 
indicates Cox's (1976) nondistressed group. 
pretest than both Cox's Nondistressed Group and Normative Control 
Group. Construct validity of the MSD measure to differentiate atti-
tudes toward menstruation between groups of women experiencing pro-
nounced dysmenorrhea symptoms, "average" levels of symptoms, and few 
to no symptoms is thus suggested. 
' At posttest, all three of the present study's treatment group 
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mean scores were similar to Cox's Normative Control Group scores, but 
still higher than his Nondistressed Group score means. These results 
are again similar to Cox's (1976) Distressed Group results, which 
were highest pretreatment, but similar to the Normative Control Group 
scores posttreatment. However, even after treatment, Cox's Dis-
tressed Group's mean scores were still higher than the Nondistressed 
Group mean scores. Such a trend suggests that his behavioral treat-
ment resulted in improvement for his distressed subjects into the 
"average" range of attitudes toward dysmenorrhea, but not improvement 
to the point of cessation of all symptoms. A similar conclusion is 
al so suggested by the present study's data. 
The similarities in mean scores between the present study's 
three treatment groups and Cox's Distressed Group on the RSS are far 
less obvious than on the previously discussed MSD measure. Again, as 
noted above, the present study's Combination Group is a replication 
of Cox's Distressed Group treatment. A comparison of the Combination 
Group data with Cox's data is presented in Figure 6. The present 
study's Combination Group mean score at pretest is similar to that of 
Cox's Distressed Group, thus suggesting a similar level of distress 
pretreatment. After treatment, Cox's Di stressed Group means are (as 
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Figure 6. A comparison of combination group RSS scores and Cox's 
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on the MSD measure) reduced to the point of equality with his Norma-
tive Control group, again suggesting a reduction in scores into an 
"average" range of discomfort reported by a group of women judged 
"typical." However, the present study's Combination Group scores 
reflect a reduction in reported discomfort but not to an equivalent 
level of reduction as Cox's Distressed Group. The Combination Group 
scores are not reduced into an "average" range of discomfort. 
Instead, the mean score at posttest is approximately 16 points higher 
than Cox's Di stressed Group scores at posttest. 
Similar trends are noted for the Desensitization and the Relaxa-
tion Group RSS mean scores at pretest and posttest as compared to 
Cox's Distressed Group scores. Again, scores are similar to the 
Distressed Group scores at pretest, but are not reduced to the Norma-
tive Control Group range at posttest. These data are presented in a 
graph form in Figures 7 and 8. 
These analyses of the RSS scores give less support to the clini-
cal validity of the present study's treatments than do the MSD 
scores. Although a steady (and significant) reduction in symptoms is 
noted, the reduced level in reported discomfort after treatment is 
st i 11 higher than that of "typical" women. 
Therefore, RSS scores reflect a less successful replication of 
the Cox study by the present study's Combination Group mean scores. 
A decrease similar to that of the Combination Group for the Desensi-
tization and Relaxation treatment groups was also noted. These 
reductions in symptoms did not reduce distress scores to Cox's Norma-
tive Control Group's "typical" range of distress. However, RSS 
Mean 
Scores 
80 
70 
60 
50 
40 
30 
20 
10 
0 
_____ ....\~·-.. _ 
--- ... 
-,. ------- ', 
' 
............ 
----
' 
' 
' 
' 
' 
' 
' 
' 
' 
' 
' 
' 
' 
' 
............. .----~, 
............. -----·- -----
....... , ___ . ---
121 
... ~ 
---
--. 
Pretest# 1 Pretest# 2 
Menstrual Cycles 
Posttest Follow-up 
Figure 7. 
- - - -..... 
A comparison of desensitization group RSS scores and Cox's 
(1976) distressed, nondistressed and normative group 
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scores did suggest the construct validity of the RSS measure to 
successfully differentiate levels of menstrual distress between 
groups of women experiencing pronounced symptoms, "average" levels of 
symptoms, and women with few to no symptoms. 
Spasmodic vs. Congestive Oysmenorrhea 
The hypothesis comparing types of dysmenorrhea was not eval-
uated. As discussed in Chapter IV, this situation was due to the 
wide discrepancy between the number of subjects who experienced 
spasmodic dysmenorrhea and those who experienced congestive dysmenor-
rhea as measured by the MSQ. The discrepancy was so large that tests 
of significance could not be calculated. Basic assumptions for both 
the chi-square test and the analysis of variance statistic were not 
met; therefore neither of these tests was conducted. 
Chesney and Tasto's (1975a) reported dichotomous distribution of 
college women's responses on the MSQ that ranged either below a score 
of 69 or above a score of 81 was not supported by this study. In the 
current study, 51% of the 45 subjects obtained an MSQ score between 
69 and 81. The more normally distributed nature of this current 
sample adds support to the continuing questioning regarding the MSQ's 
validity (Cox, 1976; Webster et al., 1974). These results again 
suggest that primary dysmenorrhea has a continuous spasmodic-conges-
tive dimension, with the majority of women experiencing both types of 
symptoms. Also, as noted previously in Chapter III, while 73% of all 
subjects complained of menstrual symptoms (most commonly that of 
menstrual cramping), only 20% of subjects were classified as suffer-
ing from spasmodic dysmenorrhea. This study concurs with many others 
regarding the continued validity problems with the MSQ (Balick et 
al., 1979; Cox, 1978; Golub et al., 1959; Rosenthal, 1978), and adds 
to the growing body of research strongly indicating that the time is 
ripe for a re»amping of the MSQ scoring system. 
Possible interactions between type of dysmenorrhea (as measured 
by the MSQ) and treatment group was a fourth hypothesis which this 
writer had initially planned to address in the present study. How-
ever, the reported inappropriateness of using a test of significance 
to test the spasmodi c vs. congestive hypothes i s precluded the inves-
tigation into interactions between type of dysmenorrhea and type of 
treatment. 
Although the congestive vs. spasmodic data could not be statis-
tically analyzed, these data are presented in visual form. Mean 
scores for the congestive (n=36) and the spasmodic (n=9) subjects 
from all three treatment groups were computed for the RSS and the 
MSD. They are presented in graph form in Figures 9-12, again in 
comparison to Cox's Distressed, Nondistressed, and Normative Control 
Groups. Pretest RSS scores for the spasmodic group are much higher 
than that of the congestive group (97 pts. vs. 66 pts.). The conges -
tive group pretest RSS mean score is more similar to Cox's Distressed 
Group mean score than that of the spasmodic group. At posttest, both 
the congestive and the spasmodic group mean scores are higher than 
that of Cox's Nondistressed Group. Both spasmodic and congestive 
groups continue symptom reduction from posttest to follow-up in a 
si mi 1 ar manner to Cox's Di stressed Group. 
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Figure 9. A comparison of spasmodic group RSS scores and Cox's 
(1976) distressed, nondistressed and normative group 
scores at pretest, posttest and follow-up . 
. . . ... . . • indicates spasmodic group. 
- - - - - indicates Cox's (1976) distressed group . 
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Figure 10. A comparison of congestive group RSS scores and Cox's 
(1976) distressed, nondistressed and normative group 
scores at pretest, posttest and follow-up. 
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A comparison of spasmodic group MSD scores and Cox's 
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A similar overall trend is noted in the congestive and spasmodic 
group MSD mean scores. The congestive group score at pretest is 
somewhat lower than Cox's Distressed Group. The spasmodic group 
scored somewhat higher than the Cox group at pretest. At posttest, 
the scores are also similar to Cox's Distressed Group, with the 
spasmodic group still registering a slightly higher posttest mean 
score than the Cox group. Follow-up mean scores for the two dysmen-
orrhea groups are also similar. 
These results suggest that Cox's Distressed Group did, in fact, 
contain both types of dysmenorrhea sufferers as he indicated, since 
visual inspection suggests that the Cox Distressed Group pretest 
means are generally somewhere between the present study's congestive 
and spasmodic group means. 
These results also suggest the possibility that spasmodic dys-
menorrhea sufferers may be more responsive to treatment than conges-
tive sufferers. An inspection of the graphed score means of the 
spasmodic sufferers appear to reflect more of a reduction from pre-
test to posttest than those of the congestive group. An alternative 
hypothesis to account for these findings is that the RSS and the MSD 
measures are more sensitive to spasmodic symptoms, so that the 
dramatic decrease in the spasmodic group mean score at posttest may 
be at least partly due to an artifact of the RSS measure. Possible 
future research might involve an exploration of these two alternative 
hypotheses. 
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£ubjects Tested Twice Prior to Treatment 
Subjects in the present study who were contacted on day 10-18 of 
their respective menstrual cycles, and who were asked to fill out the 
~e~endent measures on two occasions prior to treatment were tested on 
thEse two occasions only two weeks apart. This constituted their 
Pretest 1 and Pretest 2 testings. The Cox (1976) subjects were 
sarrpled four weeks apart at Pretest 1 and Pretest 2. Despite this 
imrortant difference, and while keeping the caveat in mind that the 
" wice test" subjects do not represent a control group, the "twice-
t rested" group data for the RSS and the MSD from the present study 
were compared to Cox's (1976) Di stressed Group, Nondi stressed Group, 
and Normative Control Group scores. These are presented in Figures 
13 and 14. The "twice-tested" group RSS scores appear extremely 
simil ar to the Pretest 1 and Pretest 2 scores of Cox's Distressed 
Group. Both reflect a slight increase in reported symptomatology 
from Pretest 1 to Pretest 2; this increase has been observed pre-
viously and has been hypothesized to be due to subject anticipation 
regarding the treatment's possibilities (Balick et al., 1982; Chesney 
& Tasto, 1975b; Tasto & Chesney, 1974). 
The "twice tested" group MSD mean score is somewhat (i.e., 10 
points) lower than that of Cox's Distressed Group. However, these 
lower scores are most probably reflective of the present study's 
previously discussed generally lower MSD scores of all three treat-
ment groups as compared to Cox's Distressed Group scores. 
In conclusion, although sampled only two weeks apart, the 
present study's "twice tested" subjects' data appear to be similar to 
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Figure 13. A comparison of the RSS scores of subjects administered the 
pretest on two occasions, and ~x 1 s (1976) distressed, non-
distressed and normative group scores at pretest, postest 
and follow-up . 
••....•.. indicates subjects administered the pretest on two occasions. 
- - - - - indicates Cox's (1976) distressed group . 
• -.-.-.-. indicates Cox's (1976) normative control group. 
indicates Cox's (1976) nondistressed group. 
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Figure 14. A comparison of the MSD scores of subjects administered the 
pretest on two occasions, and Cox's (1976) distressed, 
nondistressed and normative group scores at pretest, 
posttest and follow-up. 
- - - -. . . . . 
indicates subjects administered the pretest on two 
indicates Cox's (1976) distressed group. 
indicates Cox's (1976) normative control group. 
indicates Cox's (1976) nondistressed group. 
occasions. 
Cox's {1976) more appropr ·iately termed "control group" data. The 
noted increase in RSS scores at Pretest 2 is a treatment artifact 
most probably related to subject anticipation (Balick et al., 1982; 
Chesney & Tasto, 1975b; Cox, 1976; Tasto & Chesney, 1974). 
Hypotheses of Treatment Response 
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The study was successful in producing a modest but measurable 
decrease in paramenstrual discomfort in subjects of all three treat-
ment groups. The study was not successful in shedding new 1 i ght on 
the theoretic locus of treatment effectiveness these results demon-
strate. Apparently, a desensit i zation - only treatment is effective, 
thus supporting the phobic model of Cox and Meyer (1978). Similarly 
appar ent is that a relaxation-only t reatment is also effective, whi ch 
fits the increased sense of self-control theory of Hart et al.(1981). 
What is the most apparent is that perhaps these two (supposedly 
different) theories both reflect a basic change in subject attitude 
toward dysmenorrhea. This change in attitude can apparently be a 
result of a decrease in subject anxiety or an i ncrease in subject 
sense of mastery. Theoretically, such a change in attitude could 
also stem from types of treatments (such as a straightforward educa-
tive program, or even the body awareness engendered by sports such as 
gymnastics) that are quite different from the ones explored in the 
present study. Perhaps future research in this area might focus on 
experimental ways of manipulating subject attitudes while controlling 
placebo effects. 
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Recommendations for Further Research 
It is recommended that future research in the behavioral treat-
ment of dysmenorrhea involve the use of other types of data than self-
report data. Benson et al. (1974) suggests that measures such as 
oxygen consumption may be a more appropriate measure of relaxation 
than localized skin temperature readings. Perhaps reports from "s i g-
ni fi cant others" regarding subjects I behavioral changes due to men-
strual cycle and reliability measures for practice data can replace 
some of the self-report measures used in this study. Lastly, the idea 
of measuring subjects' prostaglandin levels during treatment to deter-
mine if a correlation exists between a decrease in hormones and a 
decrease in reported discomfort should be strongly entertained 
(Lamsden, Kelly, & Baird, 1983). 
Finally, further research in this area might focus on the devel-
opment of measures that are established to be as sensitive to premen-
strual symptoms as they are to menstrual. Since all of the MAS items 
refer specifically to cramps, the inappropriateness of this instru-
ment to congestive dysmenorrhea symptoms is apparent. The RSS may be 
equally sensitive to both types of dysmenorrhea; however, it is 
recommended that this assumption be further evaluated by research 
methods before it is again assumed to be true. What we are presently 
learning about PMS symptoms may result in necessary changes to the 
self-report measures used in dysmenorrhea research (Halbreich, 
Endicott, Schacht, & Nee, 1982). In fact, research in this area may 
be best served by the careful exploration into specific subtypes of 
the congestive-spasmodic dysmenorrhea continuum. 
In conclusion, this study suggested the effectiveness of behav-
ioral treatments to reduce menstrual distress, identified possible 
weaknesses in the present study, reconfirmed procedures to encourage 
home practice, and discussed possible questions for future research 
to answer. 
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APPENDICES 
Appendix A. Treatment Contract 
I hereby consent to treatment by the Psychology Laboratory of Utah 
State University for dysmenorrhea. 
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1. I understand that this is an experimental study, and that no 
guarantee is made for success of treatment. I understand that 
the results of the study will be used in preparing a disserta-
tion and will be published in other professional articles. I 
also understand that I will not be identified in any way by name 
in any of the above published materials. 
2. I realize that considerable effort has been made to provide this 
treatment to me free of cost. I agree to deposit ten dollars 
($10) with the clinic as a sign of my good faith, of which five 
dollars ($5) will be refundable upon completion of the four 
treatment sessions, and an additional five dollars ($5) will be 
refunded at the conclusion of a three-month follow-up. The 
return of the deposit is contingent only upon completion of the 
project, and not on the degree of improvement which I might 
make. A two dollar ($2) deduction from the refundable deposit 
will be made for each session missed by myself . However, in the 
event that I desire to drop out of the project, I may do so via 
consultation with the experimenter with the full ten dollar 
($10) refund being returned. 
3. The treatment has been described to me to my satisfaction . I 
understand that if I have any further questions about the study 
at any later date, I may request a consultation with the 
researcher. 
4. I understand the importance of following the instructions of my 
personal physician with regard to my physical health and the use 
of prescribed medication. I am al so aware that as a student, I 
am able to contact the Student Health Center should any physical 
problems occur during the course of the study. I understand 
that I will in no way be deterred from seeking medical assist-
ance if deemed necessary at any time during this study. 
5. I am aware of the daily practice commitment required for the 
study and am wi 11 ing to accommodate to this schedule. I am 
further aware that the benefit to me that may be reasonably 
expected from my participation in the study will be the ability 
to produce a relaxation response when desired. 
Date:_______ Signature: 
Witness: 
Witness: 
---------------
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Appendix B. Client Data Sheet 
Home: Phone#: Address: 
Marital Status: Parity: 
Regularly taken medications: IUD or pill? 
Past training in relaxation: Chief complaint: 
Session # Scene Visualized Tension Relaxed Behavioral Notes: 
Date # ? ? Away? 
1 A Session #1 
B Date 
z A 
B 
j A 
B 
4 A 
B 
!) A 
B 
b A 
B 
I A 
B 
8 A 
B 
y A 
B 
lU A 
B ~ 11 A 
B 
lZ A 
B 
1J A 
B 
14 A 
B 
Appendix C. Physician 1 s Approval 
Form 
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My signature below indicates that my physician has clas siiied my 
menstrual distress as Primary Dysmenorrhea. Additionally, my 
physician is aware of and agreeable with my participation in the Pain 
Control Study currently being conducted at the Utah State University's 
Psychology Laboratory. 
Date: 
--------
Signature: 
--------------
Witness: 
Witness: 
Appendix D. Retrospective Symptom 
Scale 
Name:____________ Date: 
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Please rate each of these conditions for frequency of and severity of 
occurrence, on the basis of your experiences of your last menstrual 
period. Total frequency refers to the total amount of time you ex-
perienced a condition during your last period, while average severity 
refers to the average level of pain or distress of the condition when it 
did occur. 
Total Frequency Ratings 
O. Did not occur 
1. Lasted less than 3 hours 
2. Lasted 3-to- 7 hours 
3. Lasted an entire day 
4. La s ted several days 
Average Severity Ratings 
0. Not noticeable 
1. Slightly bothersome 
2. Moderately bothersome 
3. Severely bothersome 
4 . Very severely bothersome 
Condition 
cramps 
nausea 
vomiting 
Frequency Rating Severity Rating 
loss of appetite 
headaches 
backaches 
leg aches 
dizziness 
weakness 
diarrhea 
facial blemishes 
abdominal pain 
flushing 
sleeplessness 
general aching 
depression 
irritability 
nervousness 
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How much additional time did you spend in bed because of menstrual 
problems over the duration of your last period? Give estimated total 
number of hours: hours 
Considering the number of pills (any kind) taken for menstrual relief 
and the number of days you take such medication, how many pills did 
you take last menstrual period? 
Appendix E. Menstrual Semantic 
Differential 
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Name: ____________ Date: _____________ _ 
Below are several pairs of words which can be used to describe men-
struation . Place an 11X II on each line indicating the degree of feeling 
you have concerning your last menstrual period. 
1. Good Bad 
2. Happy Sad 
3. Healthy Sick 
4. Pleasure Pain 
5. Clean Dirty 
6. Relaxed Tense 
7. Nice Awful 
Appendix F. Menstrual Activities 
Seale 
---
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Instructions: Answer the following questions as they 1elc:d:e to ye .... r .c.;.St 
menstrual period by placing a check in the appropriate 
space. 
I. Do cramps hinder your daily activities? 
Never Not very often Sometimes To an extent Very often 
2. Do cramps change your eating habits? 
Never Not very often Son1etimes To an extent Very often 
3. If you eat, do you ever vomit once you finish a meal? 
Never Not very often Sometimes To an extent Very often 
4. Do cramps hinder your sleep? 
Never Not very often Sometimes To an extent Very often 
5. Do you get cramps more often than one time during the 7 days? 
Never Not very often Sometimes To an extent Very often 
6. Do cramps ever cause a change in your emotional behavior? 
Never Not very often Sometimes To an extent Very often 
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Appendix G. Menstrual Behavior Scale 
Instructions: Place a check in the space which indicates the extent to 
which your last menstrual period led you to engage more 
than you normally would in the following behaviors: 
1. Taking aspirin 
Not at all A little Some Much Very much 
2. Taking Painkillers (stronger than aspirin) 
Not at all A little Some Much Very much 
3. Drinking alcohol 
Not at all A little Some Much Very much 
4. Re sting in bed 
Not at all A little Some Much Very much 
5. Taking meals in bed 
Not at all A little Some Much Very much 
6. Sleeping 
Not at all A little Some Much Very much 
7. Using a heating pad or hot water bottle 
Not at all A little Some Much Very much 
8. Crying 
Not at all A little Some Much Very much 
9. Arguing 
Not at all A little Some Much Very much 
10. Losing your temper 
Not at all A little Some Much Very much 
Appendfx H. Menstrual Symptom 
Questionnaire 
Name: 
Please circle the best answer 
1. I feel irritable., easily agitated, 
and am impatient a few days 
before my period. 
2. I have cramps that begin on 
the first day of my period 
3. I feel depressed for several 
days before my period. 
4. I have abdominal pain or dis-
comfort which begins one day 
before my period. 
5 . For several days before my 
period I feel exhausted, 
lethargic or tired. 
6. I only know that my period is 
coming by looking at the 
calendar 
7. I take a prescription drug for 
the pain during my period. 
8. I feel weak and dizzy during 
my period. 
9. I feel tense and nervous before 
my period 
Date: 
'-i 
Q) 
> Q) 
z 
(I 
N 
N 
N 
N 
N 
N 
N 
N 
N 
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C/l 
Q) 
E 
C/l >- .... 
..... 
..., 
>-Q) Q) i::: c,:I 
'-i E Q) ~ c,:I 0 ~ ..... p:; CJ) 0 <x: 
2 3 4 5) 
R s 0 A 
R s 0 A 
R s 0 A 
R s 0 A 
R s 0 A 
R s 0 A 
R s 0 A 
R s 0 A 
R s 0 A 
10. !have diarrhea during my 
period. 
11. I have backaches several days 
before my period. 
12. I take aspirin for the pain during 
my period. 
13. My breasts feel tender and sore 
a few days before my period. 
14. My lower back, abdomen, and 
the inner sides of my thighs 
begin to hurt or be tender on 
the first day of my period. 
15. During the first day or so of 
my period, I feel like curling 
up in bed, using a hot water 
bottle on my abdomen, or 
taking a hot bath. 
16. I gain weight before my 
period. 
1 7. I am constipated during my 
period. 
18. Beginning on the first day of 
my period, I have pains which 
may diminish or disappear for 
several minutes and then re -
appear. 
19. The pain I have with my period 
is not intense; but a continuous 
dull aching. 
20. I have abdominal discomfort for 
more than one day before my 
period. 
~ 
(l) 
> (l) 
z 
( 1 
N R 
Cl) 
(l) 
s 
.... 
+> (l) 
s 
0 
CJ) 
3 
s 
i::: 
(l) 
~ 
0 
4 
0 
N R S 0 
N R S 0 
N R S 0 
N R S 0 
N R S 0 
N R S 0 
N R S 0 
N R s 0 
N R s 0 
N R s 0 
152 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
A 
21. I have backaches which be gin 
the same day as my period. 
22. My abdominal area feels bloated 
for a few days before my period. 
23. I feel nauseous during the first 
day or so of my period. 
24. I have headaches for a few days 
before my period. 
TYPE 1 
~ 
Q) 
> 
Q) 
z 
(1 
N 
N 
N 
N 
>, 
..... 
Q) 
~ 
cd 
iz 
2 
R 
R 
R 
R 
rn 
Q) 
8 rn 153 
"" .., >, Q) ~ cd 8 Q) ~ 
0 ~ ..... 
Cl) 0 <x: 
3 4 5) 
s 0 A 
s 0 A 
s 0 A 
s 0 A 
The pain begins on the first day of menstruation, often coming 
within an hour of the first signs of menstruation . The pain i s rr1ost 
severe the first day and may or may not continue on subsequent days. 
Felt as spasms, the pain may lessen or subside for awhile and then 
reappear. A few women find this pain so severe as to cause vomiting, 
fa i nting , or dizziness ; some others report that they are most com-
fortable in bed or taking a hot bath. This pain is limited to the lower 
abdomen, back and inner sides of the thighs. 
TYPE 2 
There is advanced warning of the onset of menstruation during 
which the woman feels an increasing heaviness, and a dull aching pain 
in the lower abdomen. The pain is sometimes accompanied by nausea, 
lack of appetite, and constipation. Headaches, backaches, and breast 
pain are also characteristic of this type of menstrual discomfort. 
The type that most closely fits my experience is TYPE 
---
Appendix I. Treatment Rationale 
Why Cramps and Menstrual Distr e ss ? 
Below is the current physiological explanation for menstrual distress and 
the rationale for this treatment's effectiveness. 
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1. As the menstrual cycle approaches, production of the hormone "estrogen" 
decreases which allows 
2. Increased production of progesterone from the overies that 
3. Begins to accumulate in the uterus at the beginning of the period which 
4 . Stimulates production of the hormone "postaglandin" by the inner layer 
of the uterus which 
5. Stimulates the ~uscular layer of the uterus to contract which results in 
6 . Constriction of the blood vessels in the uterine wall which 
7 . Reduces the blood and oxygen suppl y to the uterus and 
8 . The result of this temporary uterine muscle contraction and decreased 
blood and oxygen supply is momentar y sensati ons interpreted as pain that 
9 . The brain registers as unpleasant and consequentl y starts up the "fight 
or flight" reflex which 
10 . Results in the tightening of the major muscle systems throughout the body 
and reduced shallow breathing that stimulates multiple chain reactions: 
11. Fi rst, it initiates production of adrenalin which encourages the continued 
production of postaglandin (return to Step 4); second, the reduced breath-
ing lowers oxygen consumption throughout the body; and third, the general 
increased muscle tension and lowered oxygen consumption produces general 
disruption of the entire body which produces such side effects as nausea, 
vomiting, backaches, headaches, sleeplessness, etc., depending on the 
person's system. 
12. This general disruption interferes with your control of the uterus and 
other body systems and encourages more cramping and distress. 
13. The more cramping and general distress triggers the brain to press 
harder for the "fight or ·flight" response. 
14. The distress feeds upon itself and may progressively become worse over 
time until some link in this chain reaction is broken. This occurs when 
progesterone production (Step 2) is prevented with the use of birth con -
trol pills, when analgesic medication is able to prevent the initial 
temporary pain (Step 8), or the prevention of the "fight or flight" 
brain's reaction to the pain. 
Treatment Objective: 
As a consequence of four weeks of intensive relaxation training, you 
will be able to recognize the earliest signs of menstrual distress and 
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then automatically turn on your relaxation response. In this way you will 
interrupt the chain of Steps 9 and 10 and prevent any persistent and extreme 
local or general discomfort. 
This will reliably occur given two conditions: First, you must be dedi-
cated in your exercises so that you do become skilled in bringing on immedi-
ate relaxation response. This will require twice daily practice sessions. 
Second, it will require that you begin the relaxation response at the earliest 
signs of menstrual distress. The early recognition of these menstrual sig-
nals and subsequent immediate relaxation depends on how proficient you be-
come with the relaxation response. Again, proficiency comes only with con-
scientious practice. 
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Appendix J. Home Relaxation Sheet 
The purpose of home practice is: 1) to enhance awareness of your own 
internal sensations that signal different degrees of tension and relaxation, 
and 2) to develop skills in producing profound levels of relaxation. This 
is not accomplished by either magic or engaging in some ritual for the 
sake "of just getting it out of the way"; rather, it is achieved through 
frequent (twice daily) and conscientious practice involving careful passive 
observation of those bodily sensations, mental images and thoughts 
experienced when tense and relaxed. 
The success of your treatment depends on how effective you become in 
producing the relaxation response. Acquiring this skill is a sequential 
process requiring mastery of each step before moving on to the next. 
Consequently, continued quality practice is essential for final success. 
This is doubly important since training will only span an approximate 
21-day period ••. allowing no time for slacking up. 
In addition to frequent conscientious practice, effectiveness will in-
crease as care is taken to provide suitable conditions as suggested 
below : 
1. Have all parts of your body comfortably supported; you may con-
sider using a pillow under your head to prevent rolling of the neck. 
2. Ensure minimal distractions: dim the lights, take the phone from 
the hook, inform people not to disturb you, remove any contacts, 
or tight - fitting clothes and attempt to prevent any distracting 
noises. 
3. Do your exercise when you are not pressed for time, be sure that 
you have enough time to complete the exercises without worrying 
about doing something else. 
4. Do the exercises alone. 
5. If you find yourself thinking "busy thoughts," try to replace them 
with thoughts of currently experienced sensations of relaxation. 
Appendix K. Relaxation Monitoring 
Scale 
Extremely 
Relaxed 
Moderately 
Relaxed 
Slightly 
Relaxed 
Unchanged 
Tense 
1. A. Sensations: 
Itnages: 
Thoughts: 
Conditions: 
B. Sensations : 
Itnages: 
Thoughts: 
Conditions: 
2. A. Sensations: 
Images: 
Thoughts: 
Conditions: 
B. Sensations: 
Itnages: 
Thoughts: 
Conditions: 
3. A. Sensations: 
Itnages: 
Thoughts: 
Conditions: 
B. Sensations: 
Etc. 
A B A B 
1 2 
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A B AB AB AB 
3 4 5 6 
Appendix L. Standard Menstrual 
!:! i e r a I._c..!:!1. 
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1. You look at the calendar and you realize that your period is due to 
begin in ten days. 
2. You look at the calendar and you realize that your period is due to 
begin tomorrow. 
3. You know that your period is coming soon and at least one day of 
your month is going to be unpleasant. 
4. Your period is coming soon and you are beginning to feel bloated. 
5 . It I s the day before your period and you are beginning to feel 
irritable. 
6. Because of your period, you are beginning to have a dull. tired 
feeling. 
7. Because of your period, you feel aching in your neck and back. 
8. Due to your period , you feel hot and perspired. 
9. You are feeling nauseated because of your period. 
10. You are bothered by the odor of menstrual blood. 
1 l. You are changing your Kotex or Tampon, see the blood, and 
realize you are flowing heavily. 
12. You are wondering if you've stained your clothing. and are 
embarrassed by the thought. 
l 3. You notice the first sensation of mild cramping. 
14. You begin to feel severe pain and cramping. 
Appendix M. Combined Group Treatment 
Outline 
In the blank spaces marked Sl, S2, & S3, check when each step has bee n 
completed; e.g., Sl X 
I . Session 1 
A. Treatment Rationale 
1. Treatment Rationale Sheet -- any questions? 
2. Application--breaking the chain 
a . Elevate pain threshold via natural analgesic effect . 
b . Preventing "fight or flight" refle x with the conscious 
Relaxation Response. 
Sl S2 S3 
3 . Objecti v es 
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a. Increase sensitivity to internal sensations, especiall y 
biosignals of muscle tension and relaxation . 
b . Learn instantaneous Relaxation Response. 
c . Today I'm going to teach you how to rela x. 
Sl S2 S3 
B. Re l a x a t i on Train i ng 
1 . Tennis analogy~ 
a . Initiall y demanding a lot of practice. 
b . Initially requiring conscious attention to what is 
happening; it's not magical ex e r cises . 
c. With time and effort, it becomes automatic. 
Sl S2 S3 
2. Specific relaxation exercise explanation . 
a. Initially tighten and relax 16 muscles. 
i . Accents sensations of tension and relaxation. 
ii. Pendulum analogy; i.e., excessive tension allows 
excessive relaxation. 
b . Familiarization with internal signals to allow pin-
pointing tension, recognition of earliest tension signs 
to signal subsequent relaxation, and confirmation of 
the relaxation response. 
c . Four sessions to sharpen relaxation experience; pro-
vide overlearning; condense efforts from 30 minutes 
of practice to one minute; moving from very conscious 
to automatic response. 
i. Only possible with conscientious and frequent 
practice. 
Sl S2 S3 
C. Muscle tightening procedure 
1. R. lower arm-fist 
2. R. upper arm-elbow 
3. L. lower arm 
4. L. upper arm 
5. forhead upper scalp--raise eyebrows 
6. eyes and nose--squint and wrinkle 
7. jaws, cheeks, and tongue--grind, corners of mouth back, 
tongue to roof 
8. neck--counterpose 
9. shoulders, upper back, chest--hold breath and shoulders 
back 
10. abdomen--upper and lower areas 
11. R. upper leg--counterpose 
12. R. lower leg--toe to face 
13. R. foot--toe out, rotate in and curl 
14. L. upper leg 
15. L. lower leg 
16. L. foot 
17. Answer questions and assure understanding 
Sl S2 S3 
D. General Instructions 
1. Release muscle tension all at once. 
2. Keep rest of body relaxed while tensing a specific part. 
3. Starting with the shoulders, inhale while tensing and 
exhale while releasing. 
4 . Identify cue "now" and "relax". 
5 . Encourage avoidance of unnecessary movement . 
6. Explain cued breathing . 
7. Explain countdown . 
8. Prepare S (bathroom, shoes off, contact lenses, gum, etc . ) 
9. Adjust volume of tape and lights. Both should be low. 
10. Answer questions and assure understanding. 
11. Leave room, ask for closed eyes, turn on tape . 
Sl S2 S3 
E. Relaxation Exercises 
1. Combined tape. 
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2. Debrief on sensations, images, thoughts, individual exercises. 
(e.g., "How did it go?") 
3 . Explain home relaxation sheet and distribute. 
4. Inform about telephone call. 
5. Encourage home practice, twice daily, at least 3 hours apart. 
6. Establish next appointment in seven days. Schedule room. 
7. Distribute Relaxation Monitoring Scale, Home Relaxation 
Sheet, and CI Tape. 
Sl S2 S3 
II. Pione Contact; 2 days following first appointment 
A. Review frequency--resolve problems that prevent home practice. 
B. Review conditions--resolve any contextual conditions that 
disrupt home practice. 
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C. Review--sensations, images and thoughts; home relaxation sheets. 
D. Encourage continued practice, emphasize its essential contribu-
tion to subsequent training and final outcome. 
E. Reaffirm next appointment. 
Sl S2 S3 
III. Session 2 
A. Review Home Practice 
1. Consider context: time, setting, distractions, i.e. facilita-
ting and disruptive conditions . 
2 . Consider circumstances that prevented practice and remediate. 
3. Review use of cued breathing. 
4. Encourage continued practice. 
5. Collect sheets and return to file 
Sl S2 S3 
B. Explain D imagery 
1. Rationale 
a. "We are adding a ne w component so you can practice your 
relaxation skills in potentially tension producing situa-
tions." 
b. To disrupt automatic habitual tension associations with 
these events; and 
c. To practice use of cue-conditioned relaxation in poten-
tially menstrual pain-producing situations. 
S1 S2 S3 
2. Procedure 
a. "After the relaxation exercises the tape will continue 
on with some instructions that tell you to ..•.. " 
b. Vividly try to imagine scenes. 
c. Use of cued breathing at first sign of tension (i.e. 
saying "relax" to self while exhaling). 
d. "I want to set up a communicaiton system so I know how 
you're doing." 
e. Signal when: 1) clear (R-I), tense (L-I), and relaxed 
away (R-I). Review this. 
f. Home practice-similar imagining and use of cued breathing 
will be practiced at home. 
Sl S2 S3 
C. "We are combining the 16 muscle groups into 7 so I want to go 
over these with you." Establish seven muscle groups and tensing 
procedures 
1. 0 R. arm-fist clenched, elbow at 45 
2. L. arm 
3. Face-frown, squint, curl corners of mouth, tongue, grind 
4. Neck 
5. Shoulders, chest and abdomen 
6. R. leg 
7. L. leg 
8. Answer questions and assure understanding 
9. Prepare client, lights and tape. 
Sl S2 S3 
D. Exercies 
1. Combination Tape (CII) 
2. Observe finger signals. Record 
Sl S2 S3 
E . Debrief: 
1. Ability to: 
a. imagine 
b. experience tension 
c . reduce tension 
2 . Sensations of relaxation with seven muscles--inform S 
that with dedicated practice they will become as skilled 
with 7 as they are with 16 . 
Sl S2 S3 
F. Home Practice 
1. Encourage use of exercises, cued breathing, and images 
twice daily. 
2. Encourage use of cued breathing before meals for in vivo 
practice and facilitate digestion. (e.g. "Think 'relax' 
paired with 10 exhales before meals.") 
3. Distribute home relaxation sheets and explain; Combination 
Tape II. 
4. Inform about telephone call. 
5. Establish next session date and time, 4-5 days hence. 
Sl S2 S3 
IV . Home Phone Call: (2 days later) 
A. Discuss Relaxation Practice. 
B. Discuss D. imagery and cued breathing. 
C. Discuss use of cued breathing at meal time. 
D. Reaffirm next appointment. 
Sl S2 S3 
V. Session 3 
A. Review Home Practice. 
1. Context 
2. Frequency of practice 
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3. Review home relaxation sheets 
4. Review home D 
5. Review cued breathing at meal time; what can facilitate 
remembering doing this? 
6. Collect sheets, put in file. 
Sl S2 S3 
C. Relaxation Exercises 
1. ("This time we combine the 7 muscle groups into 4. ") 
2. Establish exercises 
a. arms 
b. face and neck 
c. torso 
d. legs 
3. Combination Tape III (C-3) 
4. Debriefing 
Sl S2 S3 
D. Self Directed Relaxation Exercises 
1. ("Try doing your relaxation right now without a tape . 
Use your own countdown. I'll be back in 5 minutes to 
debrief . ") 
2. Debrief 
Sl S2 S3 
E. Home Practice 
1. Twice daily exercises and images, one with and one without 
tape. 
2. Cued breathing at 
a. meal time 
b. times of tension-somatic and affective . 
3. Establish next appointment. 
4. Distribute home practice sheets, Combination Tape 3. 
(no phone call) 
Sl S2 S3 
VI. Session 4 
A. Review home practice 
1. Exercises 
2. Images 
3. Mealtime cued breathing 
4. Tension associated cued breathing 
5. Collect sheets, put in file 
B. Place skin temperature probe on S's R hand 
1. Rationale 
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2. Procedure ("In this process I'm asking you to just focus 
on the tension in your body and relax it away, recalling 
what it was previously like to release the tension in 
the various muscle groups.") 
Sl S2 S3 
C. Exercise 
1. Combination Tape IV (C-4) 
2. Debrief ("Well, how was it?") 
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3. Have S self-administer conditioned relaxation and D images. 
("Do it by yourself now without the tape. Do 1 or 2 images.") 
4. Debrief 
Sl S2 S3 
D. Encourage continued mealtime cued breathing 
Sl S2 S3 
E. Application of cued breathing with menstrual distress 
1. Use at initial signs of distress . 
2. Interpret initial signs of distress as "relaxation signals" 
as cues for relaxation instead of pain. Recall we did this 
on the tape, and there will be a carry-over effect. 
3. Anticipate some failures. 
4. Anticipate improved skills with practice. 
5. If possible, used cued breathing instead of medication. 
6. Imaginative practice in evening of previous day's tensions 
and relax it away. 
Sl S2 S3 
F . Distribute home practice sheets, C-4 tape, and posttest packet . 
Sl S2 S3 
Appendix N. Desensitization Group 
Treatment Outline 
In the blank spaces marked Sl and S2, check when each step has been 
completed; e.g., Sl X • 
I. Session 1 
A. Treatment Rationale: Sl S2 S3 
1. Application--breaking the chain. 
a. Elevate pain threshold via natural analgesic effect. 
b. Prevent "fight or flight" reflex with the conscious 
relaxation response. 
2. Objectives: Sl S2 S3 
a. Increase sensitivity to internal sensations. 
b. Practice relaxation. 
B. Explain Desensitization imagery: Sl S2 S3 
1. Rationale: 
a . to disrupt automatic habitual tension associations 
with these events; and 
b. to practice use of cue-conditioned relaxation in 
potentially menstrual pain-producing situations. 
2. Procedure: 
a. Follows self-relaxation. 
b. Attempts to vividly imagine scenes. 
c. Signal when: (1) clear (R-I), tense (L-I), and 
relaxed away (R-I). (Use hierarchy fonn to keep 
track of responses, therapist.) 
d. Avoid unnecessary movement. 
e. Countdown. 
3. Home practice-similar imagining will be practiced at 
home, but won't need to signal at home. 
a. Answer questions and assure understanding. 
b. Review signals. 
C. Desensitization Exercise: Sl 
1. Desensitization Tape I 
2. Countdown. 
S2 S3 
3. Debrief on sensations, images, thoughts, individual 
experience. 
4. Explain home practice sheet and distribute. 
5. Infonn about telephone call. 
6. Encourage home practice. 
7. Establish next appointment in seven days. 
8. Distribute Relaxation Monitoring Scale, Home Relaxation 
Sheet, and Desensitization Tape I. 
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II. Phone Contact; 2 days following appointment: 
Sl S2 S3 S3 
A. Review frequency--resolve problems that prevent home 
practice. 
8. Review conditions--resolve any contextual conditions that 
disrupt home practice. 
C. Review sensations, images, and thoughts; home practice 
sheets. 
D. Encourage continued practice, emphasize its essential con-
tributions to subsequent training and final outcome. 
III. Session 2 
A. Review Home Practice: Sl S2 S3 
1. Consider context: time, setting, distractions, i . e., 
facilitating and disruptive conditions. 
2. Consider circumstances that prevented practice and 
remediate. 
3. Encourage continued practice. 
4. Review finger signal . 
5. Adjust volume of tape. 
B. Desensitization Exercise: Sl S2 S3 
1. Desensitization Tape II -
2. Self-administered relaxat i on 
3. Imagery 
4. Countdown 
5. (Therapists, be sure to keep track of responses on the 
hierarchy form.) 
C. Debrief : Sl S2 S3 
Ability to: -
1. imagine 
2. experience tension 
3. reduce tension 
D. Home Practice: Sl S2 S3 
1. Encourage practice with imagery twice daily. 
2. Distribute home practice sheets and explain. Distribute 
Tape I I. 
3. Inform about telephone call. 
4. Establish next session date and time. 
VI. Home Phone Call: Sl S2 
A. Discuss practice sessions. 
8. Reaffirm next appointment. 
S3 
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V. Session 3 
A. Review Home Practice: Sl S2 S3 
1. Context 
2. Frequency of practice 
3. Review home practice sheets 
4. Review home desensitization 
B. Desensitization Exercises: Sl S2 S3 
1. Desensitization Tape III -
2. Self-administered relaxation 
3. Images 
4. Countdown 
C. Debriefing: Sl S2 S3 
D. Self-administered Desensitization (5 min.) 
E. Home Practice: Sl S2 S3 
1. Encourage twicedailypractice with images, with and 
without tape. 
F. Establish next appointment : Sl S2 S3 
G. Distribute home practice sheet and Tape III. 
VI. Session 4 
A. Review home practice: Sl S2 S3 
B. Desensitization Exercises: Sl S2 S3 
(Therapist: place skin temp probe on""""5"1""s haricr.) 
1. Tape IV 
2. Self-administered relaxation 
3. Imagery 
4. Countdown 
5. Debriefing 
6. Have S self-administer images 
C. Application of desensitization with menstrual distress: 
Sl S2 S3 
1.--iJse atlnitiai-signs of distress. 
2. Interpret initial signs of distress as "relaxation 
signals" instead of pain. 
3. Anticipate some failures. 
4. Anticipate improved skills with practice. 
D. Distribute home practice sheets, posttest packet. 
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Treatment Outlfne 
In the blank spaces marked Sl and S2, check when each step has been 
completed; e.g., Sl X . 
I. Session 1 
A. Treatment Rationale: Sl S2 S3 
1. Application--breakingthe chain 
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a . Elevate pain threshold via natural analgesic effect . 
b. Preventing "fight or flight'' reflex with the con-
scious Relaxation Response. 
2. Objectives: Sl S2 S3 
a. Increase sens1tivity to internal sensations, espe-
cially biosignals of muscle tension and relaxation . 
b. Learn nearly instantaneous Relaxation Response. 
B. Relaxation Training 
c. 
1. Tennis analogy: Sl S2 S3 
a. Initially demanrng a lot of practice. 
b. Initially requiring conscious attention to what is 
happening; it's not magical exercises. 
c . With time and effort, it becomes automatic. 
2. Specific relaxation exercise explanation: 
Sl S2 S3 
a.--rnitia!Ty tighten and relax 16 muscles. 
i. Accents sensations of tension and relaxation. 
ii . Pendulum analogy; i.e., excessive tension allows 
excessive relaxation. 
b. Familiarization with internal signals to allow pin-
pointing tension, recognition of earliest tension 
signs to signal subsequent relaxation. 
c. Four sessions to sharpen relaxation experience; pro-
vide overlearning; condense efforts from 30 minutes 
of practice to one minute; moving from very con-
scious to automatic response. 
i. Only possible with conscientious and frequent 
/ practice. 
Muscle Tightening Procedure: Sl 
1. D. lower arm-fist 
2. D. upper arm-elbow 
3. N.D. lower ann 
4. N.D. upper arm 
5. forehead upper scalp--frown 
6. eyes and nose--squint and curl 
7. jaws, cheeks, and tongue--grind, 
tongue to roof 
8. neck--counterpose 
S2 S3 
corners of mouth back, 
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9. shoulders, upper back, chest--hold breath and shoulders 
back 
10. abdomen--upper and lower areas 
11. R. upper leg--counterpose 
12. R. lower leg--toe to face 
13. R.D. foot--toe out, rotate in and curl 
14. L. upper leg 
15. L. lower leg 
16. L. foot 
17. Answer questions and assure understanding. 
D. Relaxation Exercise : Sl S2 S3 
1. Relaxation Tape 
2. Cued breathing 
3. Countdown 
4. Debrief on sensations, images, thoughts, individual 
exercises. 
5. Explain home relaxation sheet and distribute. 
6. Infonn about telephone call . 
7. Encourage home practice. 
8. Establish next appointment in seven days. 
9. Distribute Relaxation Monitoring Scale, Home Relaxation 
Sheet, and Relaxation Tape I. 
II . Phone Contact; 2 days following first appointment : 
Sl S2 S3 
A. Review frequency--resolve problems that prevent home 
practice. 
B. Review conditions--resolve any contextual conditions that 
disrupt home practice. 
C. Review--sensations, images, and thoughts; home relaxation 
sheets. 
D. Encourage continued practice, emphasize its essential con-
tribution to subsequent training and final outcome. 
III. Session 2 
A. Review Home Practice: Sl S2 S3 
1. Consider context: time, setting, distractions, i.e., 
facilitating and disruptive conditions. 
2. Consider circumstances that prevented practice and 
remediate. 
3. Review use of cued breathing. 
4. Encourage continued practice and use of cued breathing 
practice at home. 
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B. Establish seven muscle groups and tensing procedures: 
Sl S2 S3 
1.D. arm-fist clenched, elbow at 45° 
2. N.D. arm 
3. Face-grown, squint, curl corners of mouth, tongue, grind 
4. Neck, shoulders, chest, upper back 
5. Abdomen: upper, lower, and sides 
6. R. leg 
7. L. leg 
C. Relaxation Exercise: Sl S2 S3 
1. Relaxation Tape 
2. Cued breathing 
3. Countdown 
D. Debrief: Sl S2 S3 
1. Sensations of relaxation with seven muscles--inform S 
that with dedicated practice they will become as skilled 
with 7 as they are with 16. 
E. Home Practice: Sl S2 S3 
1. Encourage use ofexercises anctcued breathing twice 
daily. 
2. Encourage use of cued breathing before meals for in vivo 
practice and facilitate digestion. ---
3. Distribute home relaxation sheets and explain; 
Relaxation Tape II. 
4. Inform about telephone call. 
5. Establish next session date and time. 
IV. Home Phone Call: Sl S2 S3 
A. Discuss Relaxation Practice. 
B. Discuss use of cued breathing at meal time. 
C. Reaffirm next appointment. 
V. Session 3 
A. Review Home Practice: Sl S2 S3 
1. Context. 
2. Frequency of practice. 
3. Review home relaxation sheets. 
B. Review cued breathing at meal time: Sl S2 S3 
1. What can facilitate remembering doingthis-r--
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C. Relaxation Exercises: SI 
1. Establish exercises. 
a. arms 
b. face and neck 
c. torso 
d. 1 egs 
2. Relaxation Tape I I 
3. Cued breathing 
4. Countdown 
D. Debriefing: Sl S2 
S2 
S3 
E. Self-directed relaxation exercises: 
F. Home practice: SI S2 S3 
S3 
Sl S2 
1. Twice daily exercises with an'crwithout tape. 
2. Cued breathing at 
a. meal time 
b. times of tension-somatic and affective. 
G. Establish next appointment: Sl S2 S3 
H. Distribute home practice sheet, Practice Tape III. 
VI. Session 4 
A. Review home practice: SI S2 S3 
1. Exercises 
2. Mealtime cued breathing 
S3 
3. Tension associated cued breathing 
(Therapist, place skin temperature probe on S's hand) 
B. Relaxation through recall (Chapter 8): Sl S2 S3 
1. Rationale 
2. Procedure 
3. Implementation (Tape IV) 
4. Summary 
5. Review 
6. Cued breathing 
7. Countdown 
8. Debreifing 
9. Have S self-administer conditioned relaxation 
C. Mealtime cued breathing: Sl S2 S3 
D. Application of cued breathing with menstrual distress: 
SI S2 S3 
I.use aCTnitiai-signs of distress. 
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2. Interpret initial signs of distress as "relaxation 
signals" instead of pain. 
3. Anticipate some failures. 
4. Anticipate improved skills with practice. 
5. If possible, use cued breathing instead of medication. 
6. Imaginative practice in evening of previous day's 
experiences. 
Distribute home practice sheet. 
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